{"meta":{"query_hash":"65fff5cca68e","filters":{"venue":"Expert Opinion on Drug Safety"},"cohort_total":120,"direct_labels_cover":0,"predictions_cover":120,"exported":120,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/65fff5cca68e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Opinion+on+Drug+Safety"},"results":[{"id":"W1718269887","doi":"10.1517/14740338.2015.1046836","title":"Vortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Centre for Addiction and Mental Health","funders":"","keywords":"Vortioxetine; Antidepressant; Tolerability; Medicine; Major depressive disorder; Pharmacology; Cognition; Psychiatry; Adverse effect; Anxiety","score_opus":0.02663966568627249,"score_gpt":0.35669402024114133,"score_spread":0.33005435455486887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1718269887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010010947,0.9993531,0.000035427245,0.00016184337,0.000075354874,0.0000053725016,0.000024629182,0.0000028096722,0.0002413369],"genre_scores_gemma":[0.000676024,0.9988955,0.00009221266,0.00012897248,0.00006182103,0.0000062173744,0.00002518892,6.467639e-7,0.00011338673],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99973446,0.000048378024,0.00007221061,0.000041696432,0.00008627129,0.000016898035],"domain_scores_gemma":[0.9993297,0.0003678104,0.0001378433,0.000010572143,0.00012775086,0.000026418755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079857465,0.00073165674,0.0015972051,0.002302613,0.00021820524,0.00074867054,0.00082512345,0.0007612028,0.0034259683],"category_scores_gemma":[0.0014789735,0.0002740324,0.0011144249,0.0025308933,0.00025239168,0.00082674355,0.00043579336,0.00093568617,0.00073089544],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016260795,0.000052648138,0.00020933287,0.12647259,0.00042153086,0.00013697991,0.00009125578,0.0002540374,0.001019443,0.0011415277,0.024487227,0.8455508],"study_design_scores_gemma":[0.00012315015,0.00042539838,0.0035964227,0.08135931,0.0029088242,0.0020156738,0.00015518694,0.00025586292,0.00065746857,0.0018503284,0.9066023,0.000050022656],"about_ca_topic_score_codex":0.0014642884,"about_ca_topic_score_gemma":0.0032241466,"teacher_disagreement_score":0.0034259683,"about_ca_system_score_codex":0.0005060107,"about_ca_system_score_gemma":0.0012911132,"threshold_uncertainty_score":0.01146096},"labels":[],"label_agreement":null},{"id":"W1858597556","doi":"10.1517/14740338.4.4.795","title":"The use of electrocardiograms in clinical trials: a public discussion of the proposed ICH E14 regulatory guidance","year":2005,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imperial College London","keywords":"Medicine; Guideline; QT interval; Clinical trial; Christian ministry; Cardiology; Internal medicine; Pathology","score_opus":0.0868578007545821,"score_gpt":0.3849547911325002,"score_spread":0.2980969903779181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1858597556","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036702014,0.011047212,0.0039643394,0.96960217,0.010239421,0.0001575324,0.000092089605,0.00006948802,0.004460769],"genre_scores_gemma":[0.009367557,0.009307918,0.014952186,0.92936796,0.03245403,0.0007296643,0.00014599829,0.00013953938,0.003535085],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.65111196,0.22909376,0.046211075,0.0107451705,0.05627938,0.0065586637],"domain_scores_gemma":[0.39937702,0.49491364,0.01825188,0.013267069,0.06743294,0.0067574675],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.34822714,0.002195577,0.0060203252,0.005336648,0.006698198,0.016706826,0.013484633,0.119519144,0.0034329318],"category_scores_gemma":[0.41903943,0.003053038,0.007330079,0.0053819274,0.024462579,0.015035205,0.008427502,0.0691674,0.0031366765],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040961182,0.00014748858,0.0007518164,0.0017223842,0.00015613908,0.0011254328,0.003114417,0.00090706866,0.0010406915,0.0981409,0.7963201,0.09616389],"study_design_scores_gemma":[0.0005059654,0.0004404558,0.0018748557,0.007762439,0.0002255097,0.0010241247,0.0013293354,0.001560659,0.00064522267,0.056688637,0.9276666,0.00027613167],"about_ca_topic_score_codex":0.007541975,"about_ca_topic_score_gemma":0.009704988,"teacher_disagreement_score":0.34822714,"about_ca_system_score_codex":0.011762756,"about_ca_system_score_gemma":0.02843553,"threshold_uncertainty_score":0.80375195},"labels":[],"label_agreement":null},{"id":"W1934513595","doi":"10.1517/14740338.2015.1073710","title":"The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunology; Virus; Virology; Human papilloma virus; Internal medicine; Cancer; Cervical cancer","score_opus":0.048832654778220484,"score_gpt":0.39756835048697386,"score_spread":0.3487356957087534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1934513595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022131616,0.9972326,0.000090456095,0.0009924772,0.00019511237,0.000004915609,0.000030882184,0.00000384495,0.0012284617],"genre_scores_gemma":[0.0026787226,0.9956096,0.00013238755,0.00059145037,0.00037666003,0.000007217647,0.00003668487,0.0000012291263,0.00056605274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994135,0.00016026788,0.00009176451,0.0000762577,0.00022773836,0.000030478348],"domain_scores_gemma":[0.9983443,0.0009806767,0.00033658982,0.000024391622,0.00027587544,0.000038204053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096611894,0.000339759,0.0009588402,0.0011435584,0.00016748848,0.0008460114,0.000563093,0.001274781,0.0051742364],"category_scores_gemma":[0.0022723847,0.00014657769,0.0006922243,0.0009080652,0.0003928508,0.0008457498,0.00037084715,0.0011329137,0.0013639521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001360618,0.00003805958,0.0006438236,0.037491135,0.00024516362,0.00032062773,0.0000912645,0.0001981769,0.001327892,0.0039581233,0.030484257,0.9250655],"study_design_scores_gemma":[0.000053669533,0.00024200273,0.0024068358,0.025645077,0.00057041395,0.0036840392,0.00015351517,0.00012914285,0.0011874317,0.0034124895,0.9624801,0.000035303467],"about_ca_topic_score_codex":0.00090717623,"about_ca_topic_score_gemma":0.0013138264,"teacher_disagreement_score":0.0051742364,"about_ca_system_score_codex":0.00043726063,"about_ca_system_score_gemma":0.0010897388,"threshold_uncertainty_score":0.017309606},"labels":[],"label_agreement":null},{"id":"W1966041444","doi":"10.1517/14740338.2010.485189","title":"Famciclovir: a focus on efficacy and safety","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Health Sciences Centre; University of Toronto; University of Manitoba; Sunnybrook Health Science Centre","funders":"","keywords":"Famciclovir; Penciclovir; Medicine; Tolerability; Herpes simplex virus; Varicella zoster virus; Virology; Dermatology; Adverse effect; Virus; Pharmacology","score_opus":0.04135512242433964,"score_gpt":0.3753422967079179,"score_spread":0.33398717428357827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966041444","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011586677,0.99740076,0.00007789551,0.0013567922,0.00021824596,0.0000060353377,0.00001170031,0.000002602,0.0008101644],"genre_scores_gemma":[0.0045730714,0.99078476,0.00026826755,0.0021710563,0.001635133,0.000025095074,0.000021943133,0.00000639272,0.00051426556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956554,0.0016383135,0.0008289586,0.00047026353,0.0012299374,0.00017714672],"domain_scores_gemma":[0.9812602,0.014442129,0.0017232156,0.00024732735,0.002055721,0.00027142724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0103717735,0.0010701122,0.004409636,0.0025172972,0.0003218241,0.003176695,0.0010744573,0.003670892,0.0062603783],"category_scores_gemma":[0.01555892,0.00042445023,0.001331866,0.002615431,0.0014741641,0.0049628853,0.0011613301,0.0029627795,0.0016099119],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056931213,0.000058284983,0.00042487934,0.09115431,0.00034595028,0.00042651824,0.000288874,0.00017645651,0.0025815803,0.008942271,0.02461503,0.8704165],"study_design_scores_gemma":[0.00039822364,0.0017270675,0.004722319,0.1089236,0.0014137966,0.006367988,0.00053794915,0.00022026988,0.0023370285,0.009421239,0.8638514,0.000079074896],"about_ca_topic_score_codex":0.0012361882,"about_ca_topic_score_gemma":0.0011729817,"teacher_disagreement_score":0.0103717735,"about_ca_system_score_codex":0.0021569703,"about_ca_system_score_gemma":0.0024138235,"threshold_uncertainty_score":0.05485183},"labels":[],"label_agreement":null},{"id":"W1991718710","doi":"10.1517/14740338.2012.712682","title":"Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Institut universitaire en santé mentale de Montréal","funders":"","keywords":"Aripiprazole; Ziprasidone; Quetiapine; Medicine; Risperidone; Akathisia; Extrapyramidal symptoms; Tolerability; Internal medicine; Antipsychotic; Schizophrenia (object-oriented programming); Olanzapine; Side effect (computer science); Psychiatry; Meta-analysis; Adverse effect","score_opus":0.10230004570858303,"score_gpt":0.3839283334062759,"score_spread":0.2816282876976929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991718710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05003254,0.94583416,0.0016981262,0.00028862996,0.00028395146,0.0004851455,0.0008546915,0.00007910007,0.00044367163],"genre_scores_gemma":[0.7425221,0.2505898,0.0030584217,0.0006705543,0.00030896842,0.00087506784,0.0013994416,0.000060704046,0.0005150188],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99427634,0.0028724673,0.0012777373,0.0007684442,0.000616609,0.00018842799],"domain_scores_gemma":[0.9912548,0.0056257993,0.001749343,0.00043491303,0.0007095993,0.00022554384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012092049,0.0031735923,0.01461734,0.0042336816,0.0005423563,0.002712073,0.0019330676,0.0017876261,0.0025114827],"category_scores_gemma":[0.016245186,0.001463282,0.060347155,0.0040421435,0.00050800835,0.0013242087,0.0011374614,0.0016263811,0.00021389204],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053769806,0.00004395047,0.0040820935,0.030643972,0.95537466,0.00007179074,0.000031016498,0.0006251276,0.0002271163,0.000037214297,0.00014295235,0.0033432124],"study_design_scores_gemma":[0.0008419478,0.0003083455,0.003430197,0.0010482921,0.9936014,0.000040773342,0.00001671274,0.0002976118,0.0000801268,0.00006727826,0.00025512057,0.000012187859],"about_ca_topic_score_codex":0.0050929952,"about_ca_topic_score_gemma":0.009708275,"teacher_disagreement_score":0.01461734,"about_ca_system_score_codex":0.002081456,"about_ca_system_score_gemma":0.0015233285,"threshold_uncertainty_score":0.063949645},"labels":[],"label_agreement":null},{"id":"W1998398742","doi":"10.1517/14740338.2015.983071","title":"Drug safety assessment of oral formulations of ketoconazole","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Ketoconazole; Drug; Pharmacology; Intensive care medicine; Safety profile; Adverse effect; Dermatology; Antifungal","score_opus":0.052724582042721395,"score_gpt":0.4216115641743533,"score_spread":0.3688869821316319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998398742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005813081,0.99677616,0.0002019073,0.00021924733,0.00012616566,0.00002897703,0.00007070735,0.000005496858,0.0019900985],"genre_scores_gemma":[0.011380957,0.9863057,0.0004641679,0.00038361712,0.00021763206,0.00004326799,0.00015088553,0.0000031649092,0.0010505447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986633,0.00037448775,0.00024124484,0.00011916637,0.0005558607,0.00004595355],"domain_scores_gemma":[0.9982589,0.00078964507,0.00050325954,0.00002665187,0.00038343697,0.000038190225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015150576,0.0005597099,0.0015096406,0.0018675188,0.0001994762,0.00083807367,0.00076359493,0.0011700117,0.0056757205],"category_scores_gemma":[0.0029807833,0.00020975865,0.0010697097,0.0014449842,0.00028074204,0.00073498883,0.00037589716,0.00083664985,0.0009505914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025518585,0.00005738958,0.00031481945,0.06812931,0.00024637664,0.00034852437,0.000075788936,0.00024650642,0.0025977113,0.0014008424,0.008933096,0.91739446],"study_design_scores_gemma":[0.00025066768,0.0013542246,0.004983285,0.04742259,0.0015566582,0.0049734004,0.00018492684,0.00040346003,0.006578413,0.0020513812,0.9301759,0.000065027205],"about_ca_topic_score_codex":0.0011492968,"about_ca_topic_score_gemma":0.001507539,"teacher_disagreement_score":0.0056757205,"about_ca_system_score_codex":0.0005034771,"about_ca_system_score_gemma":0.001264296,"threshold_uncertainty_score":0.018987238},"labels":[],"label_agreement":null},{"id":"W1999940036","doi":"10.1517/14740330902797081","title":"Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"University of Ottawa","keywords":"Medicine; Clopidogrel; Perioperative; Aspirin; Coronary artery disease; Regimen; Randomized controlled trial; Platelet aggregation inhibitor; Surgery; Ticlopidine; Artery; Anesthesia; Intensive care medicine; Internal medicine","score_opus":0.04322694386965911,"score_gpt":0.32378122526984554,"score_spread":0.28055428140018646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999940036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066500093,0.9988053,0.000027393136,0.00025290827,0.000060279126,0.000014508633,0.000037561105,7.187601e-7,0.00013634156],"genre_scores_gemma":[0.016586153,0.98237807,0.0002155062,0.0004229321,0.00024499622,0.00005669356,0.0000564532,0.0000012133651,0.00003798447],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98807913,0.005216604,0.0037087891,0.00056748366,0.0022350503,0.00019300978],"domain_scores_gemma":[0.9440747,0.039798655,0.012143482,0.00046641842,0.0032353986,0.00028133485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009086252,0.00070452277,0.0042733788,0.004071441,0.00031473397,0.002080241,0.00074084295,0.0018022844,0.001785433],"category_scores_gemma":[0.04439982,0.00056734757,0.00447906,0.004953252,0.00083625014,0.0012786484,0.00065472565,0.0012254799,0.00018465264],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008167659,0.000049077902,0.007817239,0.8042666,0.022747228,0.00020653172,0.0002750966,0.0002776102,0.00032553254,0.00080796384,0.003662661,0.15874769],"study_design_scores_gemma":[0.00093888567,0.0010704703,0.0415754,0.77144474,0.13878345,0.0018318078,0.00039856523,0.00034257484,0.00051093224,0.0016388024,0.0413784,0.00008596374],"about_ca_topic_score_codex":0.0033970724,"about_ca_topic_score_gemma":0.007339692,"teacher_disagreement_score":0.009086252,"about_ca_system_score_codex":0.0015469438,"about_ca_system_score_gemma":0.005221126,"threshold_uncertainty_score":0.048053265},"labels":[],"label_agreement":null},{"id":"W2003254367","doi":"10.1517/14740338.2015.1040389","title":"Safety of medication options for treating pediatric esophagitis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Observational study; Intensive care medicine; Esophagitis; Randomized controlled trial; Reflux esophagitis; Proton-pump inhibitor; Antacid; Internal medicine; Omeprazole; Safety profile; Adverse effect; Disease; Reflux","score_opus":0.05999688029611553,"score_gpt":0.3971398556687936,"score_spread":0.33714297537267807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003254367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009359897,0.9982811,0.00008928585,0.00046463526,0.00015919155,0.000009388143,0.000044059685,0.000003960062,0.00085472065],"genre_scores_gemma":[0.0015581973,0.9972283,0.00022049087,0.00045665316,0.00020454358,0.000013645416,0.000051469277,0.0000014235009,0.0002653051],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9992163,0.0002136248,0.00017406442,0.000091175265,0.0002690407,0.000035782057],"domain_scores_gemma":[0.9987218,0.00071855274,0.00032179413,0.000021671,0.0001885946,0.000027628852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094243453,0.00058253814,0.0014338093,0.0015610987,0.00018978145,0.00088989554,0.00069641613,0.0013898668,0.0070833573],"category_scores_gemma":[0.0025900358,0.00016356636,0.0012036327,0.0013029823,0.00034736103,0.0008362043,0.00046976414,0.0012370062,0.0012861559],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009747117,0.000029725097,0.000243433,0.10085643,0.0004103122,0.00017315884,0.000068187976,0.00020705217,0.0005094246,0.0028748722,0.027436284,0.86709374],"study_design_scores_gemma":[0.00011943133,0.00014693961,0.002342,0.10693881,0.0012001668,0.002399713,0.00013529522,0.00018560194,0.00060321734,0.0029928095,0.8829021,0.000033938093],"about_ca_topic_score_codex":0.0012365044,"about_ca_topic_score_gemma":0.0018720431,"teacher_disagreement_score":0.0070833573,"about_ca_system_score_codex":0.00048767717,"about_ca_system_score_gemma":0.001268893,"threshold_uncertainty_score":0.023696184},"labels":[],"label_agreement":null},{"id":"W2005125564","doi":"10.1517/eods.3.2.113.27343","title":"The safety of antithrombotic therapy during pregnancy","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Antithrombotic; Warfarin; Pregnancy; Heparin; Anticoagulant; Low molecular weight heparin; Thrombosis; Fetus; Intensive care medicine; Surgery; Obstetrics; Internal medicine","score_opus":0.03836150301545036,"score_gpt":0.35399748430092187,"score_spread":0.3156359812854715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005125564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017822671,0.94138414,0.0011108554,0.03976955,0.003630423,0.000024037441,0.00029498414,0.000029145865,0.011974639],"genre_scores_gemma":[0.037740182,0.9207591,0.0009946245,0.026778307,0.009121413,0.00008367366,0.00041505753,0.000019058245,0.0040886556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997242,0.0009970525,0.00033539254,0.0002808616,0.00097574544,0.00016901613],"domain_scores_gemma":[0.99412006,0.0029962019,0.00091790146,0.00010884233,0.0016842909,0.00017275946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023899511,0.0003267191,0.0011927567,0.00030471495,0.0002484034,0.00151673,0.0008933767,0.0030620233,0.0053599216],"category_scores_gemma":[0.007872226,0.00010356623,0.00058891065,0.00030765007,0.00073493033,0.0008071366,0.0005053819,0.0024850126,0.0020407701],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000575238,0.00007252606,0.0014147448,0.009982253,0.00027296756,0.0009302283,0.00013227963,0.00040749155,0.0026040215,0.0061858487,0.11768292,0.8597396],"study_design_scores_gemma":[0.00018071022,0.00048487697,0.0041243643,0.007439242,0.00029425943,0.0033083768,0.00016821506,0.00026958017,0.002115693,0.0053508626,0.9762171,0.000046743902],"about_ca_topic_score_codex":0.00097413803,"about_ca_topic_score_gemma":0.00086372264,"teacher_disagreement_score":0.0053599216,"about_ca_system_score_codex":0.00083354244,"about_ca_system_score_gemma":0.0013215635,"threshold_uncertainty_score":0.017930686},"labels":[],"label_agreement":null},{"id":"W2010173526","doi":"10.1517/14740338.2014.905540","title":"Do we need to worry about mycophenolate overdose?","year":2014,"lang":"en","type":"letter","venue":"Expert Opinion on Drug Safety","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Western Ontario; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Mycophenolic acid; Pharmacokinetics; Intensive care medicine; Mycophenolate; Drug overdose; Observational study; Pharmacology; Emergency medicine; Transplantation; Internal medicine; Poison control","score_opus":0.028488780113973947,"score_gpt":0.3206889158818539,"score_spread":0.29220013576787995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010173526","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015831677,0.024278,0.0016743558,0.9320444,0.016918613,0.000046460802,0.00016465866,0.000099415054,0.008942356],"genre_scores_gemma":[0.17551944,0.03767399,0.002205678,0.63948745,0.13682225,0.000087983535,0.00020279671,0.000075089905,0.007925374],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986811,0.000500289,0.00019725571,0.00025624398,0.0002168001,0.00014821978],"domain_scores_gemma":[0.9936194,0.0035250736,0.0010813834,0.00016250681,0.0009822309,0.0006294587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011461934,0.00048862246,0.0008977277,0.00087073736,0.0013693555,0.0015233656,0.0009137496,0.011294351,0.006862647],"category_scores_gemma":[0.018635761,0.00026771985,0.00056969334,0.0007585157,0.0015239589,0.003573328,0.0008121135,0.008767511,0.0035879298],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021926838,0.00008766148,0.028850673,0.0014074119,0.00011553749,0.38303563,0.0022395134,0.00041782283,0.00088818383,0.0063752644,0.4899422,0.08642093],"study_design_scores_gemma":[0.00010206714,0.00010385952,0.006400287,0.0026153384,0.0000883037,0.72999924,0.0027285684,0.00075923634,0.00047376854,0.020002645,0.23661709,0.00010959338],"about_ca_topic_score_codex":0.0011501444,"about_ca_topic_score_gemma":0.0010933471,"teacher_disagreement_score":0.011294351,"about_ca_system_score_codex":0.0015990142,"about_ca_system_score_gemma":0.0009776093,"threshold_uncertainty_score":0.022957802},"labels":[],"label_agreement":null},{"id":"W2011083031","doi":"10.1517/14740338.2.5.451","title":"Recent differing expert opinions regarding the safety profile of hepatitis B vaccines: is there really a controversy?","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Medicine; Hepatitis B; Safety profile; Expert opinion; Family medicine; Intensive care medicine; Adverse effect; Virology; Immunology; Pharmacology","score_opus":0.02449876780380497,"score_gpt":0.30239588522140387,"score_spread":0.2778971174175989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011083031","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068085403,0.13026573,0.0057959603,0.82857126,0.018280897,0.000053683463,0.0003176021,0.00006083627,0.009845472],"genre_scores_gemma":[0.09482225,0.16237661,0.009033201,0.67701226,0.05287345,0.00014634093,0.0005463602,0.00011158839,0.003077877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9595712,0.015556165,0.00829432,0.0029699348,0.012028568,0.0015798775],"domain_scores_gemma":[0.7002455,0.21207966,0.014909895,0.004391625,0.06362928,0.0047441106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09779813,0.0008603701,0.0025680147,0.0049152053,0.0020616425,0.0051253526,0.006035421,0.012388306,0.004455307],"category_scores_gemma":[0.1764841,0.0006852859,0.00195875,0.004904589,0.008210268,0.0056791524,0.0030304887,0.010979401,0.0026228987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010365628,0.00016413399,0.008035219,0.016649814,0.0016147367,0.0027030236,0.010892739,0.00051296677,0.0021344558,0.038442835,0.35511,0.56270355],"study_design_scores_gemma":[0.00047213363,0.0005416579,0.017498672,0.023971768,0.0027771178,0.005063837,0.027428575,0.0011546836,0.0030218326,0.12145653,0.7960376,0.0005756536],"about_ca_topic_score_codex":0.0022971118,"about_ca_topic_score_gemma":0.0030275167,"teacher_disagreement_score":0.09779813,"about_ca_system_score_codex":0.003396622,"about_ca_system_score_gemma":0.0029144664,"threshold_uncertainty_score":0.51721215},"labels":[],"label_agreement":null},{"id":"W2012393743","doi":"10.1517/14740338.5.2.231","title":"Adverse reactions to first-line antituberculosis drugs","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":316,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Ethambutol; Incidence (geometry); Pyrazinamide; Isoniazid; Discontinuation; Adverse effect; Tuberculosis; Hepatitis; Internal medicine; Intensive care medicine; Pathology","score_opus":0.17355412632767034,"score_gpt":0.47612585258496404,"score_spread":0.30257172625729367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012393743","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006631537,0.99658763,0.00025148905,0.00032433655,0.00016995225,0.000012718442,0.000019181762,0.000017571432,0.0019539385],"genre_scores_gemma":[0.0051372955,0.992401,0.00031596475,0.00027764382,0.0002997834,0.000012292432,0.00004417043,0.0000017326189,0.0015100273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993469,0.00015479882,0.00008338459,0.00006366025,0.0003161741,0.000034995497],"domain_scores_gemma":[0.9991899,0.00029612155,0.00023722755,0.000018770996,0.00021899994,0.000038817812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007936213,0.0008132717,0.0014554393,0.001189493,0.000184909,0.0005721519,0.00071774353,0.000939596,0.0047743204],"category_scores_gemma":[0.0010346521,0.00015230391,0.00048466265,0.0010469696,0.0002686503,0.0005428153,0.00028702506,0.0006006927,0.0020999608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008978661,0.00007800677,0.0009451498,0.017001644,0.00013264564,0.0011208673,0.0000622374,0.00023630276,0.0026027984,0.00043545358,0.013960771,0.96333426],"study_design_scores_gemma":[0.00014385238,0.0008351864,0.014087234,0.0159112,0.00066635525,0.036905643,0.00024487835,0.00036801526,0.0063682343,0.0023118146,0.9221114,0.00004604349],"about_ca_topic_score_codex":0.00067682966,"about_ca_topic_score_gemma":0.00110731,"teacher_disagreement_score":0.0047743204,"about_ca_system_score_codex":0.00033941146,"about_ca_system_score_gemma":0.0006591562,"threshold_uncertainty_score":0.01597172},"labels":[],"label_agreement":null},{"id":"W2015413787","doi":"10.1517/14740338.4.3.591","title":"Are rates of gastrointestinal bleeding higher following the introduction of COX-2 inhibitors?","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Adverse effect; Intensive care medicine; Population; Drug; Gastrointestinal bleeding; Pharmacology; Internal medicine; Environmental health","score_opus":0.0429082140253849,"score_gpt":0.3567286536502824,"score_spread":0.3138204396248975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015413787","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006189774,0.9969291,0.00009437662,0.0013528895,0.00018783125,0.000006677657,0.00006162283,0.000003360165,0.00074519025],"genre_scores_gemma":[0.00328768,0.9954216,0.00013330579,0.0005463781,0.00025758124,0.000007459618,0.000051106817,9.0775745e-7,0.00029396568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987558,0.00038816957,0.00018999724,0.00017533303,0.00043629218,0.00005446747],"domain_scores_gemma":[0.9973845,0.0011152505,0.00094376743,0.00003742268,0.00047723195,0.000041751675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021645464,0.0004293351,0.0026335644,0.0013106625,0.000120131546,0.0008762559,0.0009524921,0.001865031,0.004044941],"category_scores_gemma":[0.0050508003,0.0002593728,0.0012607415,0.0026057668,0.00032930743,0.0010569113,0.00020713975,0.0008959263,0.0013834975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046001337,0.000050191218,0.0040760194,0.050423417,0.0014942797,0.00079854677,0.000121916804,0.0003046463,0.0010580792,0.0014912267,0.019948792,0.9197729],"study_design_scores_gemma":[0.0007762609,0.0018903101,0.0710441,0.048213966,0.0063872943,0.015974093,0.0009736409,0.0005157338,0.0028429509,0.00669555,0.844524,0.00016208341],"about_ca_topic_score_codex":0.0022737926,"about_ca_topic_score_gemma":0.003375276,"teacher_disagreement_score":0.004044941,"about_ca_system_score_codex":0.000632815,"about_ca_system_score_gemma":0.0011918935,"threshold_uncertainty_score":0.013531685},"labels":[],"label_agreement":null},{"id":"W2019625594","doi":"10.1517/14740338.2012.643866","title":"Adverse reactions to β-lactam antimicrobials","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Shared Health; St. Boniface Hospital","funders":"","keywords":"Medicine; Adverse effect; Intensive care medicine; Antibiotics; Penicillin; Allergy; Culprit; Desensitization (medicine); Antimicrobial; Cephalosporin; Beta-lactam; Drug allergy; Dosing; Pharmacovigilance; Pharmacology; Immunology; Internal medicine","score_opus":0.09243773285328258,"score_gpt":0.397935331244841,"score_spread":0.30549759839155843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019625594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009199173,0.9679797,0.0016281528,0.0056337933,0.0011873451,0.00014658882,0.000893361,0.00008479858,0.013247094],"genre_scores_gemma":[0.13790095,0.8365148,0.0024154289,0.012674507,0.0023178996,0.00015902198,0.0012574511,0.000028292836,0.006731687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996506,0.0011797869,0.00069877505,0.00030920884,0.0011595006,0.00014676532],"domain_scores_gemma":[0.9916049,0.0039056626,0.0026538859,0.00013521546,0.0015847363,0.00011562206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017341973,0.00044661495,0.00071351853,0.0007203416,0.0002392825,0.00080125785,0.0005925586,0.0011503855,0.0102311745],"category_scores_gemma":[0.008710512,0.00011852231,0.0010806662,0.00081225706,0.00040641538,0.0006529587,0.0005222472,0.0009474908,0.0017458575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008325121,0.00013501158,0.018319178,0.08402114,0.00089499453,0.0075482163,0.0008040661,0.00059211213,0.0072205607,0.00203257,0.07880059,0.79879904],"study_design_scores_gemma":[0.00020351176,0.00094618386,0.039319936,0.08237499,0.0017387964,0.055781588,0.0013041266,0.00048209174,0.008880649,0.005079654,0.80375534,0.00013311874],"about_ca_topic_score_codex":0.0007693087,"about_ca_topic_score_gemma":0.0008991782,"teacher_disagreement_score":0.0102311745,"about_ca_system_score_codex":0.00046100802,"about_ca_system_score_gemma":0.00070295576,"threshold_uncertainty_score":0.034226656},"labels":[],"label_agreement":null},{"id":"W2021941886","doi":"10.1517/14740338.2014.896455","title":"Painful decision-making at FDA","year":2014,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Oxycodone; Oxymorphone; Intensive care medicine; Opioid; Hydrocodone; Postmarketing surveillance; Hydromorphone; Risk analysis (engineering); Pharmacology; Adverse effect","score_opus":0.009102172697563944,"score_gpt":0.32075933512620725,"score_spread":0.3116571624286433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021941886","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005669246,0.009484699,0.00037744775,0.30355263,0.6813732,0.0000330994,0.00003089909,0.00007141123,0.0050200373],"genre_scores_gemma":[0.0014386502,0.008002504,0.0004861841,0.2625476,0.7099116,0.000059318827,0.00003175308,0.000055719353,0.01746666],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.975333,0.0075254473,0.002623899,0.0019513037,0.011414775,0.0011514745],"domain_scores_gemma":[0.9295831,0.039986234,0.0028630097,0.0020302844,0.021097615,0.0044397325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02180805,0.0025463293,0.0026359693,0.0020013447,0.0040138946,0.009763589,0.003926436,0.033033617,0.01734234],"category_scores_gemma":[0.104718305,0.0011371061,0.0026348464,0.0010844149,0.005746905,0.011580408,0.0029120941,0.039541252,0.013546396],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012188682,0.000009192011,0.000010304119,0.00012277832,0.0000074135382,0.000080120975,0.000040399165,0.00001829436,0.00003824763,0.0015746356,0.99204457,0.0060418625],"study_design_scores_gemma":[0.000031579377,0.000016807018,0.000049768303,0.00037985478,0.000013554934,0.00014421208,0.000054942895,0.000067829445,0.00005780811,0.0033563285,0.9958121,0.000015147256],"about_ca_topic_score_codex":0.0013992585,"about_ca_topic_score_gemma":0.002645056,"teacher_disagreement_score":0.033033617,"about_ca_system_score_codex":0.0065203765,"about_ca_system_score_gemma":0.008224889,"threshold_uncertainty_score":0.11533332},"labels":[],"label_agreement":null},{"id":"W2022539355","doi":"10.1517/14740338.2014.926887","title":"Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Observational study; Cancer; Intensive care medicine; Confounding; Metformin; Clinical trial; Diabetes mellitus; Internal medicine; Oncology","score_opus":0.027585024756647505,"score_gpt":0.3338255132818152,"score_spread":0.3062404885251677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022539355","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046308676,0.99955815,0.00002009955,0.00015504342,0.00006803735,0.0000025570776,0.000016753651,0.0000014967023,0.0001315174],"genre_scores_gemma":[0.00037970868,0.9993056,0.000055798337,0.00010044198,0.000072578194,0.0000039955594,0.000018541225,3.9140676e-7,0.000062927385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994356,0.00010735576,0.00013134613,0.000092758164,0.00019893878,0.000033977853],"domain_scores_gemma":[0.9986682,0.00075146114,0.00029764546,0.000017588713,0.00021842349,0.000046667294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001106486,0.0009636341,0.0021733276,0.0041335206,0.00029489724,0.00091927854,0.001251495,0.0012571327,0.004121304],"category_scores_gemma":[0.0024253065,0.00036966644,0.0014057076,0.004934186,0.0003549334,0.0011326127,0.00063398824,0.0011608292,0.0007580551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013174689,0.00005432046,0.00072223874,0.14153276,0.0007724321,0.0002328472,0.00008917254,0.0003270552,0.00036209443,0.0013132892,0.039475504,0.81498665],"study_design_scores_gemma":[0.00008562365,0.00023553388,0.008950783,0.15961553,0.0043270756,0.004554973,0.00029785806,0.00030781436,0.00039146544,0.0032042924,0.81795144,0.0000775513],"about_ca_topic_score_codex":0.0028043785,"about_ca_topic_score_gemma":0.0047892905,"teacher_disagreement_score":0.0041335206,"about_ca_system_score_codex":0.0009719937,"about_ca_system_score_gemma":0.0023715475,"threshold_uncertainty_score":0.01378715},"labels":[],"label_agreement":null},{"id":"W2024028287","doi":"10.1517/14740338.2014.970164","title":"Antihistamines and birth defects: a systematic review of the literature","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Medicine; Antihistamine; Systematic review; Pediatrics; Population; Pregnancy; Loratadine; MEDLINE; Pharmacology; Environmental health","score_opus":0.02039990993667317,"score_gpt":0.34534024351459125,"score_spread":0.3249403335779181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024028287","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007568005,0.9978029,0.000070462695,0.00043542992,0.0001107249,0.000120858895,0.00050189544,0.000004469117,0.00019644875],"genre_scores_gemma":[0.011079012,0.98718446,0.0002775564,0.00072616164,0.0001341686,0.00020917435,0.00027707877,0.0000031155264,0.00010932272],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9943071,0.0017306012,0.0019360321,0.0005349391,0.0012962909,0.00019507688],"domain_scores_gemma":[0.9722507,0.019086527,0.0059290333,0.0003112549,0.0021982577,0.0002242398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062564192,0.0011123933,0.0049465587,0.006880118,0.00039469075,0.0016099357,0.0015513786,0.0016537154,0.006391918],"category_scores_gemma":[0.03155774,0.00075688853,0.0053933547,0.008661165,0.00060583634,0.0013851224,0.0009426617,0.00093512563,0.00037920775],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019318762,0.000012761344,0.0016309373,0.9533851,0.00855536,0.00018241565,0.000111940826,0.000083840285,0.000112704154,0.00014914552,0.003623965,0.031958513],"study_design_scores_gemma":[0.0002723167,0.0001688795,0.0109131895,0.9036531,0.061309535,0.0007414675,0.00019797127,0.000077766585,0.00012722613,0.00031385667,0.022191633,0.00003311336],"about_ca_topic_score_codex":0.008900032,"about_ca_topic_score_gemma":0.022662625,"teacher_disagreement_score":0.008900032,"about_ca_system_score_codex":0.0025571124,"about_ca_system_score_gemma":0.007978399,"threshold_uncertainty_score":0.033087492},"labels":[],"label_agreement":null},{"id":"W2029520632","doi":"10.1517/14740338.2015.1029915","title":"Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Infliximab; Inflammatory bowel disease; Adverse effect; Intensive care medicine; Disease; Crohn's disease; Current (fluid); Internal medicine","score_opus":0.037470537964966945,"score_gpt":0.3357740852289325,"score_spread":0.2983035472639655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029520632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006656907,0.9985649,0.00008708365,0.0007197449,0.000121184064,0.0000037647897,0.00001792301,0.0000031639672,0.00041558422],"genre_scores_gemma":[0.0011301122,0.9977227,0.00014280569,0.0005162663,0.00027003608,0.000008238082,0.00002960102,0.0000012643706,0.00017905598],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985985,0.0004126447,0.00025116612,0.00015995464,0.00052415754,0.000053534575],"domain_scores_gemma":[0.9958009,0.0027046362,0.00071376044,0.00006770995,0.00063220423,0.0000806971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025645506,0.0007244049,0.002051409,0.0013343849,0.00021796153,0.0012034086,0.0010023204,0.0016798818,0.004326565],"category_scores_gemma":[0.00470585,0.00021600461,0.0014058836,0.0015228601,0.0005209908,0.0009951086,0.0005337775,0.0018315825,0.0010746041],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121620265,0.000027753971,0.00025852094,0.04211272,0.00047010352,0.00012026791,0.000053152587,0.00026336024,0.0005512574,0.0022829066,0.029904637,0.92383385],"study_design_scores_gemma":[0.00015376626,0.0002452713,0.002828309,0.04846365,0.0019784153,0.002671601,0.0001120854,0.00030419312,0.0006660423,0.006220803,0.9363034,0.000052473184],"about_ca_topic_score_codex":0.0009580854,"about_ca_topic_score_gemma":0.0016528277,"teacher_disagreement_score":0.004326565,"about_ca_system_score_codex":0.00074178225,"about_ca_system_score_gemma":0.0016500085,"threshold_uncertainty_score":0.014473736},"labels":[],"label_agreement":null},{"id":"W2032077631","doi":"10.1517/14740338.5.4.523","title":"The effect of antidepressants on lipid homeostasis: a cardiac safety concern?","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Mirtazapine; Venlafaxine; Medicine; Bupropion; Lipid profile; Internal medicine; Cholesterol; Pharmacology; Endocrinology; Psychiatry; Antidepressant; Anxiety; Pathology","score_opus":0.03599538423764926,"score_gpt":0.40012128186646556,"score_spread":0.3641258976288163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032077631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018222186,0.99821556,0.00008301114,0.00093952776,0.00019965287,0.000023050834,0.000051093753,0.0000027109525,0.0003031809],"genre_scores_gemma":[0.002811507,0.99519014,0.00043794914,0.0008527501,0.00043522695,0.00005171473,0.00006325076,0.000001378716,0.00015607564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955729,0.0014074205,0.0016926196,0.00023397311,0.0009816514,0.00011142763],"domain_scores_gemma":[0.9868237,0.007952887,0.003401252,0.00018161803,0.001531197,0.00010935011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057935743,0.001105035,0.0050483113,0.0070625613,0.0002951698,0.0025572304,0.0013565955,0.002665125,0.0035189327],"category_scores_gemma":[0.018479979,0.00045229777,0.0018006174,0.0061232224,0.00055058196,0.002018451,0.0007113754,0.00093751954,0.0010793812],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038501024,0.00004516122,0.0006968261,0.47483653,0.0022279124,0.0007105213,0.00027611872,0.00022440193,0.0012209046,0.0015007942,0.01264839,0.5052274],"study_design_scores_gemma":[0.00056879036,0.0012800432,0.008178659,0.5676977,0.021988014,0.0056911977,0.0010455947,0.00022880809,0.0019587239,0.00374825,0.38751617,0.00009806446],"about_ca_topic_score_codex":0.0014796808,"about_ca_topic_score_gemma":0.00427415,"teacher_disagreement_score":0.0070625613,"about_ca_system_score_codex":0.001696928,"about_ca_system_score_gemma":0.005381667,"threshold_uncertainty_score":0.030639708},"labels":[],"label_agreement":null},{"id":"W2034607233","doi":"10.1517/14740338.2.2.161","title":"Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Menstrual Health and Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Premenstrual dysphoric disorder; Dysphoria; Tolerability; Medicine; Psychiatry; Mood; Population; Affect (linguistics); Clinical psychology; Adverse effect; Menstrual cycle; Psychology; Internal medicine; Anxiety","score_opus":0.04837717828652159,"score_gpt":0.3692788410502523,"score_spread":0.3209016627637307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034607233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047332115,0.99709845,0.00024266198,0.0004175069,0.00010930302,0.000009034431,0.000015450158,0.000010016878,0.0016242757],"genre_scores_gemma":[0.0030096502,0.99495333,0.00036364142,0.00034908028,0.00019649974,0.000009741901,0.000031763633,0.0000022665606,0.0010840246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972934,0.00007144381,0.000031959753,0.000042073854,0.00010713965,0.000018088733],"domain_scores_gemma":[0.9995976,0.00019070692,0.000092023314,0.000012038712,0.00008612418,0.00002152431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008263041,0.0006191936,0.0018674051,0.0011860394,0.00014906132,0.00053897186,0.0007646136,0.0011451729,0.0035814252],"category_scores_gemma":[0.0006624859,0.0001629378,0.00045890457,0.0011281564,0.00028625087,0.0007408035,0.00027833943,0.00092797366,0.0018438436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010737934,0.00008218061,0.00015435825,0.0116668055,0.000102324106,0.00040727985,0.000050777922,0.00029693093,0.0024590958,0.0011712378,0.01233603,0.9711655],"study_design_scores_gemma":[0.00024365619,0.00080361136,0.004179919,0.008949312,0.00037090722,0.0074857394,0.00017749118,0.00035430037,0.0025485675,0.002201766,0.9726514,0.000033306507],"about_ca_topic_score_codex":0.00071931735,"about_ca_topic_score_gemma":0.0015489579,"teacher_disagreement_score":0.0035814252,"about_ca_system_score_codex":0.0003791859,"about_ca_system_score_gemma":0.0004585679,"threshold_uncertainty_score":0.01198107},"labels":[],"label_agreement":null},{"id":"W2037388690","doi":"10.1517/14740330903188413","title":"Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Perioperative; Statin; Coronary artery disease; Atrial fibrillation; Internal medicine; Cardiology; Cardiopulmonary bypass; Coronary artery bypass surgery; Artery; Revascularization; Adverse effect; Surgery; Myocardial infarction","score_opus":0.035373376346846425,"score_gpt":0.3393196265184218,"score_spread":0.3039462501715754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037388690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018533543,0.99764156,0.000025013016,0.00026797957,0.000032006817,0.000012011647,0.00005481559,6.2772585e-7,0.000112573776],"genre_scores_gemma":[0.04053717,0.95839465,0.00030008395,0.0004002915,0.00018376175,0.000055336688,0.000086255866,0.0000012143638,0.00004125814],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.991235,0.003780488,0.0029057413,0.0005062826,0.0014233253,0.00014908036],"domain_scores_gemma":[0.9663272,0.022714736,0.008784087,0.000263069,0.0016788114,0.00023207479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059419423,0.0005580343,0.0040450892,0.0034667598,0.0002686869,0.0015443189,0.00050231756,0.0015925248,0.0014085049],"category_scores_gemma":[0.030271107,0.0005363791,0.0037845802,0.00390617,0.00066280825,0.0010234655,0.0005070277,0.00095673226,0.00012946517],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025620619,0.00009626814,0.02661327,0.65736514,0.031135192,0.0002672022,0.0002843333,0.0004050119,0.0006544517,0.0008288578,0.0030939223,0.27669427],"study_design_scores_gemma":[0.002989981,0.002792841,0.16057558,0.5952734,0.18636742,0.0028162354,0.0007594621,0.0009129351,0.0012750714,0.0024382393,0.043614082,0.00018478511],"about_ca_topic_score_codex":0.003757605,"about_ca_topic_score_gemma":0.008791146,"teacher_disagreement_score":0.0059419423,"about_ca_system_score_codex":0.001353996,"about_ca_system_score_gemma":0.0030731936,"threshold_uncertainty_score":0.031424344},"labels":[],"label_agreement":null},{"id":"W2044795877","doi":"10.1517/14740338.4.2.273","title":"The safety of antidepressant use in pregnancy","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Antidepressant; Pregnancy; Depression (economics); Psychiatry; Drugs in pregnancy; Intensive care medicine; Fetus; Anxiety","score_opus":0.06972261786582652,"score_gpt":0.38779825670822105,"score_spread":0.31807563884239454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044795877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003101944,0.99769443,0.00007244887,0.00032670828,0.00009835349,0.0000062095255,0.00002382821,0.000002458937,0.0014653183],"genre_scores_gemma":[0.0029012465,0.9962908,0.00011909172,0.00020643661,0.00011821104,0.000008374615,0.000024629086,6.0874726e-7,0.00033056687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912125,0.0002642167,0.00017302558,0.0000760271,0.00033593358,0.000029631548],"domain_scores_gemma":[0.9988599,0.00057132414,0.0002961582,0.000019016214,0.00023127111,0.000022392862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011164991,0.00044597403,0.0015480724,0.00096045126,0.00019058479,0.0007922329,0.0006765843,0.0013025792,0.0027877728],"category_scores_gemma":[0.0024673631,0.0001899913,0.0005625176,0.0011574158,0.00021138815,0.00048188897,0.0003086672,0.0005956795,0.0009291468],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010573171,0.000034591587,0.00053924095,0.033913527,0.00027526883,0.0004864269,0.00011082987,0.00020788074,0.0014937161,0.0009007132,0.012969503,0.94896245],"study_design_scores_gemma":[0.00015085444,0.0007305388,0.008837148,0.04769965,0.0016011402,0.009009653,0.0003398763,0.0002744769,0.0028081024,0.0023841658,0.9261182,0.000046154742],"about_ca_topic_score_codex":0.0017493048,"about_ca_topic_score_gemma":0.00265506,"teacher_disagreement_score":0.0027877728,"about_ca_system_score_codex":0.00052162836,"about_ca_system_score_gemma":0.0012358992,"threshold_uncertainty_score":0.009326041},"labels":[],"label_agreement":null},{"id":"W2055017324","doi":"10.1517/14740338.2011.584531","title":"Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Drug reaction; Adverse effect; Drug; Adverse drug reaction; Pediatrics; Adverse drug event; Intensive care medicine; Pharmacology","score_opus":0.14124959565047093,"score_gpt":0.4633750617566379,"score_spread":0.322125466106167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055017324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023752027,0.9984127,0.00015551681,0.00044859207,0.00007899117,0.000005311682,0.000026966689,0.000008454548,0.0006258906],"genre_scores_gemma":[0.002220549,0.9966509,0.00041425636,0.0002709384,0.00012954658,0.0000072937764,0.000048630256,0.0000013711502,0.00025654354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932325,0.00016740523,0.00013281673,0.00008790915,0.00025259578,0.0000361328],"domain_scores_gemma":[0.9985434,0.00064651284,0.00043523576,0.000019549081,0.00030325618,0.000052056163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012916108,0.00074375496,0.0016280628,0.0017412356,0.00016228408,0.0008890379,0.0007347416,0.0010146484,0.0022119493],"category_scores_gemma":[0.0021952896,0.00019142729,0.0008646544,0.0017859438,0.00024079182,0.00078023697,0.00042458338,0.0011237373,0.00088145665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009401265,0.000031696254,0.001458603,0.016763555,0.00021625351,0.0003942138,0.00006202276,0.00020137851,0.0005687777,0.0008364366,0.012263298,0.9671098],"study_design_scores_gemma":[0.00013281037,0.0004039353,0.021491177,0.04211142,0.0019024527,0.018315298,0.00041619377,0.000637809,0.0018085643,0.0039016532,0.90879434,0.00008430396],"about_ca_topic_score_codex":0.0025793654,"about_ca_topic_score_gemma":0.0032369997,"teacher_disagreement_score":0.0025793654,"about_ca_system_score_codex":0.0005680074,"about_ca_system_score_gemma":0.0016915301,"threshold_uncertainty_score":0.007399738},"labels":[],"label_agreement":null},{"id":"W2055503279","doi":"10.1517/14740338.6.3.279","title":"The safety and efficacy of IFN-β products for the treatment of multiple sclerosis","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Multiple sclerosis; Adverse effect; Clinical trial; Disease; Dimethyl fumarate; Internal medicine; Intensive care medicine; Immunology","score_opus":0.201271851586892,"score_gpt":0.4185231491944807,"score_spread":0.21725129760758868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055503279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009717654,0.998966,0.000044966582,0.000162223,0.00006696877,0.000004639103,0.000011392733,0.0000029147195,0.00064368884],"genre_scores_gemma":[0.0005374124,0.99891436,0.00010032313,0.00012195074,0.00006322589,0.000005689701,0.000017039609,5.8175135e-7,0.00023940297],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99957114,0.00009883807,0.000066002736,0.000050079336,0.00019408055,0.000019800464],"domain_scores_gemma":[0.9994259,0.0002809151,0.00012581477,0.000014844486,0.00012243795,0.00003010319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009988772,0.0007652558,0.0020094372,0.0017551456,0.00021804072,0.0008352912,0.0008455423,0.0012677116,0.0051524593],"category_scores_gemma":[0.0013237112,0.00019502595,0.0005352405,0.0021477237,0.0003800968,0.0008681969,0.00042733987,0.0009884019,0.0025692496],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008484498,0.000036480895,0.00007951733,0.029622791,0.00011546522,0.00017779056,0.00003842659,0.00012541069,0.0013943893,0.0010280617,0.014510837,0.95278597],"study_design_scores_gemma":[0.000086994645,0.00022721553,0.0016618466,0.012491547,0.00046815185,0.0022757507,0.000115888855,0.000060880204,0.00091417605,0.0013996181,0.9802737,0.00002416049],"about_ca_topic_score_codex":0.0010071328,"about_ca_topic_score_gemma":0.001631962,"teacher_disagreement_score":0.0051524593,"about_ca_system_score_codex":0.00048006175,"about_ca_system_score_gemma":0.0010874951,"threshold_uncertainty_score":0.01723671},"labels":[],"label_agreement":null},{"id":"W2063320747","doi":"10.1517/14740338.2014.973846","title":"Is it safe to use smoking cessation therapeutics during pregnancy?","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Varenicline; Smoking cessation; Pregnancy; Nicotine replacement therapy; Bupropion; Addiction; Intensive care medicine; Nicotine; Obstetrics; Psychiatry","score_opus":0.13800878853301513,"score_gpt":0.41268243722773235,"score_spread":0.2746736486947172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063320747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001279575,0.9969791,0.00010816986,0.0015147236,0.00023228452,0.000007145511,0.000029348717,0.0000042843453,0.0009969689],"genre_scores_gemma":[0.0012477214,0.99723154,0.00011836273,0.00075377524,0.00025388473,0.000009148662,0.000028771497,0.0000015316675,0.00035519217],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99939406,0.00016994799,0.00009496496,0.00008679225,0.000222829,0.000031466705],"domain_scores_gemma":[0.99875927,0.0008043384,0.0002376494,0.000018893697,0.00014515156,0.000034727833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010596148,0.0004159741,0.0015125199,0.00078912725,0.00021190415,0.0009636419,0.0007265042,0.0019550566,0.0070777186],"category_scores_gemma":[0.0028165006,0.00020015158,0.00074419915,0.0007747259,0.00058774377,0.0009831978,0.00044347477,0.0015303793,0.0022192693],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082771134,0.000028191338,0.00015973506,0.043898072,0.00016711077,0.00016165266,0.00010021001,0.000108096785,0.0007660048,0.002132386,0.019710014,0.93268585],"study_design_scores_gemma":[0.00006309157,0.00022011694,0.001618257,0.058600053,0.0005212049,0.0023555718,0.00025627422,0.00011260092,0.00059877825,0.0038351237,0.9317824,0.000036420905],"about_ca_topic_score_codex":0.001241037,"about_ca_topic_score_gemma":0.0019469395,"teacher_disagreement_score":0.0070777186,"about_ca_system_score_codex":0.0003972589,"about_ca_system_score_gemma":0.0011196192,"threshold_uncertainty_score":0.02367735},"labels":[],"label_agreement":null},{"id":"W2064807159","doi":"10.1517/14740338.2012.705828","title":"Anticonvulsant hypersensitivity syndrome: an update","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lamotrigine; Anticonvulsant; Carbamazepine; Phenobarbital; Phenytoin; Pharmacovigilance; Incidence (geometry); Genetic testing; Drug; Pharmacology; Intensive care medicine; Epilepsy; Internal medicine; Psychiatry","score_opus":0.09170839139657168,"score_gpt":0.39039477450406573,"score_spread":0.29868638310749407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064807159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000104675884,0.9981798,0.00006958853,0.00048921345,0.0003179683,0.0000051478182,0.000025158366,0.000007029553,0.0008015131],"genre_scores_gemma":[0.000631069,0.99809176,0.00017441473,0.00034631212,0.00035698235,0.000005541477,0.000041888045,0.0000011346233,0.00035090063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972147,0.000048922873,0.000060436752,0.00004000237,0.00010642221,0.000022684346],"domain_scores_gemma":[0.9992329,0.0003078003,0.0001644102,0.000014835422,0.00022791141,0.000052215008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056570687,0.0010919393,0.0017200902,0.003134168,0.0002636726,0.0009996525,0.0011667585,0.001404306,0.0054482413],"category_scores_gemma":[0.0011798115,0.0003044629,0.0006807389,0.0033928505,0.00040508056,0.0016386353,0.0005393043,0.0016595528,0.0023257635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006676105,0.000072570794,0.00037071737,0.028960584,0.00013114844,0.0007869259,0.0000589737,0.00025488267,0.0005061375,0.0010162332,0.08153878,0.88623625],"study_design_scores_gemma":[0.000040523464,0.000097031785,0.0021424803,0.014843132,0.00040831926,0.009124091,0.00010731798,0.00015179173,0.00019456327,0.0010104718,0.9718517,0.000028582657],"about_ca_topic_score_codex":0.0018797491,"about_ca_topic_score_gemma":0.0039464245,"teacher_disagreement_score":0.0054482413,"about_ca_system_score_codex":0.00075984217,"about_ca_system_score_gemma":0.0013372214,"threshold_uncertainty_score":0.018226206},"labels":[],"label_agreement":null},{"id":"W2068882964","doi":"10.1517/14740338.6.3.315","title":"Managing cardiotoxicity in anthracycline-treated breast cancers","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cardiotoxicity; Medicine; Trastuzumab; Anthracycline; Breast cancer; Oncology; Internal medicine; Metastatic breast cancer; Cancer; Chemotherapy; Malignancy","score_opus":0.06337415341656599,"score_gpt":0.43531622394368896,"score_spread":0.37194207052712297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068882964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004126935,0.99629754,0.00034802692,0.0006537411,0.00018762992,0.000014004113,0.000011355898,0.000010523714,0.0020645296],"genre_scores_gemma":[0.0019289699,0.9960074,0.0005576238,0.0004979815,0.00026151008,0.000012918129,0.000026918557,0.0000018243098,0.00070497405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974614,0.00007496762,0.000026578135,0.000023083865,0.000113113536,0.00001617466],"domain_scores_gemma":[0.9997825,0.000091673195,0.000052353404,0.000005112164,0.000054707325,0.000013691956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005984819,0.0005966781,0.0017883017,0.0013465052,0.00021335167,0.00069701474,0.00076225214,0.0011935896,0.0022824535],"category_scores_gemma":[0.00064076664,0.00014580805,0.00042901683,0.001059849,0.00027498428,0.0006772827,0.00039506285,0.0011772672,0.0017819529],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076044664,0.00011736285,0.00018291903,0.014476459,0.000113844,0.00079400203,0.0000785017,0.00035393395,0.0025940891,0.0013606326,0.020897742,0.9589545],"study_design_scores_gemma":[0.00018397826,0.00046666173,0.0030366562,0.008846513,0.00031732768,0.01130868,0.00019652578,0.00033016782,0.0017530608,0.0035395615,0.9699885,0.00003243902],"about_ca_topic_score_codex":0.00070581044,"about_ca_topic_score_gemma":0.0016527522,"teacher_disagreement_score":0.0022824535,"about_ca_system_score_codex":0.00042861482,"about_ca_system_score_gemma":0.00064150593,"threshold_uncertainty_score":0.007635534},"labels":[],"label_agreement":null},{"id":"W2072337394","doi":"10.1517/14740331003752694","title":"Interactions between antifungal and antiretroviral agents","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Alberta Health Services; University of Alberta","funders":"","keywords":"Fluconazole; Medicine; Intensive care medicine; Drug; Antifungal drug; Antiretroviral therapy; Antifungal; Antifungal drugs; Life expectancy; Amphotericin B; Pharmacology; Human immunodeficiency virus (HIV); Immunology; Viral load; Population; Environmental health","score_opus":0.028559828394123552,"score_gpt":0.3488578652823199,"score_spread":0.3202980368881963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072337394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050881337,0.96366507,0.0009989504,0.012521888,0.0015800892,0.00004780926,0.00023600525,0.000038405782,0.015823701],"genre_scores_gemma":[0.103400484,0.8615602,0.00284017,0.013228571,0.009024691,0.00010098569,0.0002837916,0.00002338904,0.009537738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955656,0.0013972248,0.0007165262,0.00027168397,0.0018950987,0.00015392364],"domain_scores_gemma":[0.99347705,0.0044923723,0.0011953616,0.00010634255,0.0006234395,0.00010554086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013837354,0.000443183,0.0014468934,0.0009775362,0.00039371537,0.0018347297,0.00049838435,0.0020675245,0.009312647],"category_scores_gemma":[0.0068763685,0.00019740587,0.00089450565,0.0012307772,0.0003455051,0.0011800054,0.00069098023,0.0013321565,0.0019420692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049763493,0.00017484323,0.014501202,0.021337941,0.0015711951,0.009148532,0.00034704874,0.00059415324,0.0069296183,0.005720732,0.07046387,0.86871326],"study_design_scores_gemma":[0.00017546084,0.00072921306,0.034657873,0.0082593085,0.0018973551,0.03814211,0.0003506982,0.0007014412,0.0053806915,0.008637515,0.9009842,0.00008416375],"about_ca_topic_score_codex":0.0006626078,"about_ca_topic_score_gemma":0.0010173798,"teacher_disagreement_score":0.009312647,"about_ca_system_score_codex":0.0006098517,"about_ca_system_score_gemma":0.0008232292,"threshold_uncertainty_score":0.031153977},"labels":[],"label_agreement":null},{"id":"W2081580615","doi":"10.1517/14740338.2015.998197","title":"Labetalol for hypertension in pregnancy","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; B.C. Women's Hospital & Health Centre; British Columbia Centre of Excellence for Women's Health; University of British Columbia","funders":"","keywords":"Labetalol; Medicine; Hypertension in Pregnancy; Pregnancy; Preeclampsia; Obstetrics; Blood pressure; Internal medicine","score_opus":0.11883709888130402,"score_gpt":0.3873821814656408,"score_spread":0.2685450825843368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081580615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005695775,0.999027,0.000020052788,0.0003396054,0.00009483661,0.0000103962675,0.000026724267,0.0000025943025,0.00042185292],"genre_scores_gemma":[0.0010816903,0.9980312,0.00011237527,0.0004194601,0.00011619926,0.000019227855,0.000028844152,9.0245874e-7,0.00019009384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998789,0.00042757488,0.00029399936,0.00009527783,0.0003368814,0.000057309906],"domain_scores_gemma":[0.9969994,0.002002837,0.00064535195,0.00003451411,0.00025296435,0.0000650433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018995816,0.00055777456,0.0018823668,0.004561242,0.0003047995,0.0013369425,0.0008230743,0.0013102177,0.013002965],"category_scores_gemma":[0.005577984,0.00022322728,0.0018285216,0.0040826416,0.00048588312,0.0010665089,0.00070183986,0.0012757108,0.0013155995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020429661,0.000043658463,0.00025580171,0.30986375,0.0007855699,0.0001607801,0.00011554544,0.00009131474,0.00031734718,0.0015264796,0.022971874,0.6636635],"study_design_scores_gemma":[0.0003774054,0.0002685934,0.003226813,0.41258883,0.005912325,0.0017399924,0.00023299285,0.00009387029,0.0005431798,0.0019821597,0.5729963,0.000037513273],"about_ca_topic_score_codex":0.0030896273,"about_ca_topic_score_gemma":0.005618358,"teacher_disagreement_score":0.013002965,"about_ca_system_score_codex":0.001129344,"about_ca_system_score_gemma":0.0029033374,"threshold_uncertainty_score":0.04349923},"labels":[],"label_agreement":null},{"id":"W2084298979","doi":"10.1517/14740330903427969","title":"Genetic predisposition of life-threatening antiepileptic-induced skin reactions","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Carbamazepine; Pharmacogenetics; Allele; Genetic predisposition; Drug; Drug reaction; Adverse effect; Adverse drug reaction; Human leukocyte antigen; Dermatology; Pharmacology; Epilepsy; Genotype; Psychiatry; Gene; Internal medicine; Genetics; Immunology; Disease","score_opus":0.054149346747096885,"score_gpt":0.3602607732001855,"score_spread":0.30611142645308864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084298979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033189802,0.9972832,0.00015585848,0.0005770177,0.0001900773,0.000004245376,0.000018789537,0.00001101379,0.0014279147],"genre_scores_gemma":[0.0026411102,0.9957799,0.00018717222,0.00034393376,0.00033108183,0.0000058199334,0.0000330867,0.0000013070976,0.0006766263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997738,0.00005118533,0.000029912053,0.000038945018,0.00008988832,0.000016270906],"domain_scores_gemma":[0.9996668,0.00014791836,0.00006667018,0.000009656652,0.00008577995,0.000023201253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040390663,0.0006042433,0.0013003962,0.0010036071,0.00015027093,0.000498092,0.00053908024,0.0011850658,0.004940181],"category_scores_gemma":[0.0007951269,0.00011705879,0.00039639225,0.0011641313,0.00021946905,0.00068263104,0.00029757209,0.00076287525,0.0024592574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008187725,0.0000698218,0.001267658,0.013277006,0.00015147885,0.0014726688,0.0000462073,0.00020587964,0.0019791108,0.0012566791,0.03890012,0.94129145],"study_design_scores_gemma":[0.000093586284,0.0002728241,0.013245016,0.0091568455,0.00043027487,0.029103722,0.00018780491,0.00022859093,0.0015509888,0.003170564,0.9425126,0.00004715783],"about_ca_topic_score_codex":0.000713092,"about_ca_topic_score_gemma":0.000760054,"teacher_disagreement_score":0.004940181,"about_ca_system_score_codex":0.00030363674,"about_ca_system_score_gemma":0.0006713783,"threshold_uncertainty_score":0.01652658},"labels":[],"label_agreement":null},{"id":"W2086717153","doi":"10.1517/14740338.6.6.685","title":"The safety of drugs for the treatment of nausea and vomiting of pregnancy","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Nausea; Pregnancy; Hyperemesis gravidarum; Vomiting; Adverse effect; Obstetrics; Intensive care medicine; Quality of life (healthcare); Pediatrics; Surgery; Internal medicine; Nursing","score_opus":0.07937431068445187,"score_gpt":0.4155390722052983,"score_spread":0.3361647615208464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086717153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003409925,0.99717796,0.00011825482,0.0002800922,0.00011871121,0.000010109794,0.000023713119,0.000005858788,0.0019242573],"genre_scores_gemma":[0.0030419598,0.995366,0.0003275153,0.0003046551,0.00014030002,0.000015186948,0.000032584147,0.000001508457,0.00077032734],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99937683,0.00015580558,0.00009606622,0.000047770733,0.00029667848,0.00002700746],"domain_scores_gemma":[0.9993412,0.00031455033,0.00016456342,0.000012599904,0.0001438878,0.000023247729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068378873,0.0005608815,0.0014390525,0.0016096828,0.0002122659,0.0005538537,0.00065611326,0.0012542618,0.0030715873],"category_scores_gemma":[0.0013345516,0.00017963602,0.00059906574,0.0013992005,0.00026093496,0.0005968209,0.00029119203,0.0008209813,0.0014082749],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083709434,0.00005295276,0.00026419378,0.022615608,0.00016604514,0.00035963312,0.00006833142,0.00019250756,0.0022145973,0.0010621153,0.015798105,0.95712227],"study_design_scores_gemma":[0.00010166577,0.0004003045,0.0039013505,0.010795742,0.0004669486,0.0058642305,0.00012711386,0.00016739838,0.0024291915,0.0010490215,0.974667,0.000029970115],"about_ca_topic_score_codex":0.0010739435,"about_ca_topic_score_gemma":0.0017015558,"teacher_disagreement_score":0.0030715873,"about_ca_system_score_codex":0.00035945297,"about_ca_system_score_gemma":0.0006465024,"threshold_uncertainty_score":0.0102754235},"labels":[],"label_agreement":null},{"id":"W2087313521","doi":"10.1517/14740330903405593","title":"Clinically based evidence of drug–herb interactions: a systematic review","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine","funders":"","keywords":"Medicine; Drug; Herb; Drug interaction; Pharmacology; Traditional medicine; Medicinal herbs","score_opus":0.26412354879274036,"score_gpt":0.5583105977799898,"score_spread":0.29418704898724946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087313521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039814386,0.99826837,0.000108918386,0.00032564875,0.00012322077,0.00017178874,0.00022131986,0.0000051019406,0.00037751446],"genre_scores_gemma":[0.0060250075,0.99245775,0.0004754587,0.0004616184,0.000075648924,0.000235805,0.00014385108,0.0000030127346,0.00012194299],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99272645,0.0026279404,0.0023428733,0.00038859207,0.0017551326,0.0001590638],"domain_scores_gemma":[0.96324515,0.02599637,0.006538298,0.00038987192,0.0034602655,0.00037016303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007811985,0.0013794156,0.00839479,0.0086631505,0.00043024158,0.0018772333,0.0023700397,0.002280723,0.0119302105],"category_scores_gemma":[0.044558886,0.0008790264,0.0041306834,0.011796877,0.0007895815,0.002752377,0.0011633309,0.0011068949,0.0010131834],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025082653,0.000018926365,0.0005017069,0.91678625,0.004432037,0.00021220869,0.00009487844,0.00008285142,0.00016180021,0.00019274522,0.003936197,0.07332944],"study_design_scores_gemma":[0.00053286785,0.00028231807,0.0047841715,0.9100526,0.04064134,0.0007886298,0.00027043023,0.00009302363,0.00026955912,0.00040969567,0.04184048,0.000034884262],"about_ca_topic_score_codex":0.0048266654,"about_ca_topic_score_gemma":0.015838953,"teacher_disagreement_score":0.0119302105,"about_ca_system_score_codex":0.003069087,"about_ca_system_score_gemma":0.010160067,"threshold_uncertainty_score":0.041314185},"labels":[],"label_agreement":null},{"id":"W2090926478","doi":"10.1517/14740338.4.4.707","title":"The safety of fondaparinux for the prevention and treatment of venous thromboembolism","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Fondaparinux; Medicine; Pulmonary embolism; Antithrombotic; Deep vein; Thrombosis; Venous thrombosis; Regimen; Surgery; Intensive care medicine; Venous thromboembolism; Internal medicine","score_opus":0.06068070712323103,"score_gpt":0.3829024978731514,"score_spread":0.32222179074992036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090926478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011585396,0.9981591,0.00009793178,0.00029517047,0.00011712485,0.000005475699,0.000013274117,0.0000035876485,0.0011924867],"genre_scores_gemma":[0.0010211915,0.99790215,0.0001897467,0.000231104,0.00012896692,0.000007485935,0.000027693248,9.383678e-7,0.0004906443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938774,0.00015111628,0.0000878714,0.00006871056,0.00027433495,0.000030079142],"domain_scores_gemma":[0.999368,0.0002890079,0.00013984897,0.000016151527,0.00015848779,0.000028505894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012011474,0.00071706116,0.0021304677,0.0021235158,0.00022914441,0.00094602956,0.00086007337,0.0012990846,0.0043539586],"category_scores_gemma":[0.0013402043,0.00021059152,0.0006476346,0.0023401792,0.00030193417,0.0008706735,0.00038944863,0.0009892258,0.0024561465],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007943349,0.000046207828,0.00012446012,0.019882938,0.0001810751,0.00025119082,0.000046485176,0.0001795947,0.0014018265,0.0016034382,0.021487419,0.95471597],"study_design_scores_gemma":[0.000093829556,0.00019785106,0.0013495397,0.009304606,0.00038161656,0.002455038,0.00007034254,0.00011866167,0.0007472523,0.0017707554,0.9834868,0.000023675684],"about_ca_topic_score_codex":0.0011706783,"about_ca_topic_score_gemma":0.0018359125,"teacher_disagreement_score":0.0043539586,"about_ca_system_score_codex":0.0005950916,"about_ca_system_score_gemma":0.0011761732,"threshold_uncertainty_score":0.014565468},"labels":[],"label_agreement":null},{"id":"W2091770334","doi":"10.1517/14740338.5.1.157","title":"The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Fluoxetine; Venlafaxine; Glucose homeostasis; Antidepressant; Desipramine; Serotonergic; Mianserin; Insulin; Phenelzine; Diabetes mellitus; Homeostasis; Internal medicine; Pharmacology; Reuptake inhibitor; Agomelatine; Endocrinology; Insulin resistance; Monoamine oxidase; Serotonin; Receptor; Chemistry","score_opus":0.021629832394163034,"score_gpt":0.3248997841848692,"score_spread":0.30326995179070615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091770334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014863619,0.9991934,0.00005809009,0.00015202146,0.000120896955,0.000024916184,0.000068519876,0.000002305046,0.00023119591],"genre_scores_gemma":[0.0011903212,0.9980488,0.000242969,0.00015044783,0.00012276044,0.000039742055,0.00006433257,8.373314e-7,0.00013980734],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987897,0.00026662546,0.00041508736,0.00013027515,0.00034423865,0.000054110522],"domain_scores_gemma":[0.99677783,0.0015686592,0.001048707,0.00006476143,0.00048537663,0.00005456721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021725253,0.001615952,0.004551505,0.0074374527,0.000241485,0.0017811507,0.0011678549,0.0014897735,0.006448689],"category_scores_gemma":[0.0055499272,0.00060452905,0.001753742,0.0066910824,0.00043211647,0.0015379157,0.00068377244,0.00068805506,0.0013047484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033644144,0.000042258434,0.0003171372,0.6334023,0.0014681047,0.0003964442,0.00012379244,0.00029740363,0.0019850463,0.0008577776,0.010722304,0.35005105],"study_design_scores_gemma":[0.00042938688,0.0010602666,0.0111238295,0.46754065,0.021998618,0.0037968447,0.00036347256,0.00024581613,0.0028122547,0.002628745,0.48790413,0.00009594074],"about_ca_topic_score_codex":0.0025951106,"about_ca_topic_score_gemma":0.005712008,"teacher_disagreement_score":0.0074374527,"about_ca_system_score_codex":0.0019698574,"about_ca_system_score_gemma":0.003802187,"threshold_uncertainty_score":0.021573007},"labels":[],"label_agreement":null},{"id":"W2096035113","doi":"10.1517/14740338.2010.511611","title":"Everolimus: efficacy and safety in cardiac transplantation","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Everolimus; Tolerability; Transplantation; Heart transplantation; Calcineurin; Immunosuppression; Cardiotoxicity; Malignancy; Basiliximab; Internal medicine; Oncology; Intensive care medicine; Adverse effect; Tacrolimus; Chemotherapy","score_opus":0.045028555899963914,"score_gpt":0.3952464022490669,"score_spread":0.35021784634910297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096035113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014620734,0.999037,0.00005351152,0.00027293933,0.00008073759,0.0000030352096,0.0000072758626,0.0000031069833,0.0003962573],"genre_scores_gemma":[0.0012694377,0.99788445,0.00013614846,0.00021867146,0.00016154928,0.0000063275647,0.000010884062,0.0000010651322,0.00031152688],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995555,0.00009935925,0.00008578112,0.000044850418,0.00019599256,0.000018442892],"domain_scores_gemma":[0.9991937,0.0003948075,0.00018671878,0.00001685049,0.00017623756,0.00003160727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013028075,0.00048573306,0.0017141731,0.001137825,0.00018048623,0.00088292215,0.000592871,0.0010723145,0.0027171387],"category_scores_gemma":[0.0016666331,0.00019725441,0.0005798261,0.0015668992,0.00029422686,0.0008303623,0.00036603308,0.0010793761,0.0012688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011994497,0.00004478239,0.00020890744,0.024646502,0.00018152944,0.00011740648,0.000039580067,0.00016226912,0.0015734993,0.0009689777,0.012580692,0.9593559],"study_design_scores_gemma":[0.00013871632,0.0005635768,0.0051201773,0.018568918,0.0009508537,0.0029143093,0.00011403085,0.00022132057,0.0022871548,0.002494993,0.9665868,0.000039067636],"about_ca_topic_score_codex":0.00066290994,"about_ca_topic_score_gemma":0.0011492573,"teacher_disagreement_score":0.0027171387,"about_ca_system_score_codex":0.00042639519,"about_ca_system_score_gemma":0.0011202156,"threshold_uncertainty_score":0.009089708},"labels":[],"label_agreement":null},{"id":"W2097906965","doi":"10.1517/14740338.2011.521740","title":"Oral hypoglycemic agents for gestational diabetes mellitus?","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gestational diabetes; Offspring; Pregnancy; Diabetes mellitus; Insulin; Complication; Obstetrics; Gestation; Pediatrics; Endocrinology; Internal medicine","score_opus":0.11112100055468162,"score_gpt":0.4033479606627848,"score_spread":0.2922269601081032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097906965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000722538,0.99662066,0.00008644605,0.000624428,0.0006630255,0.000009716513,0.000023403234,0.0000068860127,0.0018930832],"genre_scores_gemma":[0.0007196416,0.99624735,0.00024476135,0.00082407054,0.0005681146,0.000013666684,0.00004701986,0.0000020797004,0.0013332876],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996259,0.00009235862,0.00006324348,0.000048659596,0.0001430687,0.000026604483],"domain_scores_gemma":[0.99963105,0.00014749709,0.00011494823,0.000013107777,0.000071680486,0.000021647045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005407927,0.0010660549,0.001668385,0.0019090571,0.00022357341,0.0008320176,0.0008061227,0.0016188456,0.008961791],"category_scores_gemma":[0.0011601201,0.00022796787,0.0005690367,0.0022589604,0.00046503215,0.0010418296,0.00065575854,0.0017445028,0.0055269604],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009358593,0.000052941446,0.00010030906,0.021803655,0.000087668865,0.0003285263,0.00004694899,0.000159651,0.00054780813,0.002128551,0.053539816,0.9211105],"study_design_scores_gemma":[0.000054591663,0.000059035767,0.0004647069,0.009613481,0.00009901614,0.0021177086,0.00004032845,0.0000527859,0.00023748208,0.001292157,0.9859553,0.000013523882],"about_ca_topic_score_codex":0.0013634007,"about_ca_topic_score_gemma":0.0016112991,"teacher_disagreement_score":0.008961791,"about_ca_system_score_codex":0.0005037234,"about_ca_system_score_gemma":0.00079759787,"threshold_uncertainty_score":0.029980183},"labels":[],"label_agreement":null},{"id":"W2098884513","doi":"10.1517/14740338.4.6.1005","title":"Celecoxib and cardiovascular risks","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Rofecoxib; Celecoxib; Medicine; Valdecoxib; Concomitant; Pharmacology; Drug; Internal medicine; Intensive care medicine; Cyclooxygenase; Enzyme","score_opus":0.06752630300762029,"score_gpt":0.37637547173223196,"score_spread":0.30884916872461166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098884513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077619094,0.99838614,0.000041356478,0.00035178327,0.00017475909,0.0000027428905,0.000004712721,0.0000029188202,0.0009579717],"genre_scores_gemma":[0.0009080586,0.9972371,0.00009765068,0.0004056599,0.00034549128,0.000005378209,0.000014657572,5.881841e-7,0.0009854938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948263,0.00011736384,0.00006759664,0.00006148808,0.00024307269,0.000027917034],"domain_scores_gemma":[0.9996117,0.00017085011,0.00009153096,0.000011909477,0.00009410437,0.000019981935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007290287,0.000755676,0.0016030349,0.0015539823,0.00023229426,0.00094934826,0.0005468459,0.0014947641,0.006389069],"category_scores_gemma":[0.0012918334,0.0002402172,0.00043115963,0.002051128,0.00035467313,0.00096672616,0.00045373122,0.0010608374,0.0028959422],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011106715,0.000045363777,0.00021548882,0.015185308,0.00013693841,0.00031904792,0.00006863124,0.00015544512,0.0011111498,0.0022143938,0.02687041,0.9535669],"study_design_scores_gemma":[0.000090020876,0.0001578673,0.002332944,0.0086307945,0.00025572805,0.0027343738,0.00010221862,0.000090583395,0.00055089407,0.0031575207,0.98187745,0.000019701398],"about_ca_topic_score_codex":0.0014662155,"about_ca_topic_score_gemma":0.0028888874,"teacher_disagreement_score":0.006389069,"about_ca_system_score_codex":0.00067840406,"about_ca_system_score_gemma":0.0014452031,"threshold_uncertainty_score":0.02137363},"labels":[],"label_agreement":null},{"id":"W2106362781","doi":"10.1517/14740338.3.1.25","title":"The safety of antihypertensives for treatment of pregnancy hypertension","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre","funders":"","keywords":"Medicine; Pregnancy; Observational study; Hypertension in Pregnancy; Antihypertensive drug; Ambulatory; Ambulatory blood pressure; Drugs in pregnancy; Blood pressure; Intensive care medicine; Pharmacotherapy; Drug; Fetus; Obstetrics; Preeclampsia; Internal medicine; Pharmacology","score_opus":0.08163984770021554,"score_gpt":0.3625396005674635,"score_spread":0.28089975286724794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106362781","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000891515,0.99909925,0.000040486768,0.00016478974,0.000092486895,0.0000034832228,0.000008297942,0.0000014249833,0.0005005759],"genre_scores_gemma":[0.00081458146,0.99860805,0.000102386875,0.0001935551,0.00010959991,0.0000064859455,0.000009923756,5.543743e-7,0.00015494096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988065,0.00033943143,0.00026070717,0.000100679164,0.0004541596,0.00003853107],"domain_scores_gemma":[0.99841344,0.0010138039,0.00030268135,0.000028877688,0.00021388677,0.000027317492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001398228,0.0006776432,0.002457086,0.0020831174,0.0002393991,0.00092938007,0.0007061731,0.0014302778,0.003365133],"category_scores_gemma":[0.0026067968,0.00027672297,0.00088306103,0.0020831244,0.00031864658,0.0009237666,0.00042176383,0.0009953518,0.0010370238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014138664,0.000043360906,0.00017351196,0.068210185,0.00039781764,0.00031017634,0.00009129235,0.00015430266,0.0016562281,0.0015845227,0.01123671,0.9160005],"study_design_scores_gemma":[0.00021549535,0.0006392825,0.0041856435,0.057323817,0.0022246426,0.004990165,0.00026022672,0.00014109934,0.0018541138,0.0031788647,0.92493755,0.000049192622],"about_ca_topic_score_codex":0.0009147702,"about_ca_topic_score_gemma":0.0018228341,"teacher_disagreement_score":0.003365133,"about_ca_system_score_codex":0.0005035777,"about_ca_system_score_gemma":0.0012958476,"threshold_uncertainty_score":0.01125747},"labels":[],"label_agreement":null},{"id":"W2106887884","doi":"10.1517/14740330902808169","title":"Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Western Ontario; University of Toronto; Western University","funders":"Chinese Academy of Agricultural Sciences","keywords":"Nephrotoxicity; Ifosfamide; Medicine; Pharmacology; Oxidative stress; Toxicity; Fanconi syndrome; Kidney; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.06319356294589396,"score_gpt":0.4022509506249844,"score_spread":0.33905738767909044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106887884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031539524,0.99666744,0.00034116342,0.0011342865,0.0002104924,0.0000083411005,0.000013564766,0.000009691056,0.0012997387],"genre_scores_gemma":[0.0016701117,0.99673456,0.00057488,0.0002876159,0.00017794114,0.000011965894,0.000018136203,0.0000011183939,0.0005235717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987745,0.00003562283,0.000018270557,0.000017219918,0.000040078343,0.000011399073],"domain_scores_gemma":[0.99979407,0.00008491738,0.000041561314,0.0000064169976,0.00005609405,0.000016940512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046198093,0.0006244554,0.0012323415,0.0010528031,0.00020027242,0.0005339483,0.0007707191,0.001236422,0.0025085707],"category_scores_gemma":[0.00055373996,0.00016324522,0.0003727169,0.000742625,0.0004112277,0.0009527794,0.00033744547,0.00147693,0.0012627858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010178925,0.00020261829,0.00054453866,0.017879577,0.00012656527,0.0010370855,0.00011569221,0.0005366329,0.0046829977,0.0080344165,0.024473554,0.94226456],"study_design_scores_gemma":[0.00006325624,0.00028577034,0.0029305802,0.007249674,0.00019548394,0.0049889833,0.0001788426,0.0002514352,0.0020496263,0.004836666,0.97694415,0.000025498231],"about_ca_topic_score_codex":0.0008115635,"about_ca_topic_score_gemma":0.0015790211,"teacher_disagreement_score":0.0025085707,"about_ca_system_score_codex":0.0005485158,"about_ca_system_score_gemma":0.0009961592,"threshold_uncertainty_score":0.008392036},"labels":[],"label_agreement":null},{"id":"W2111463664","doi":"10.1517/14740338.4.4.779","title":"Safety review of kava (<i>Piper methysticum</i>) by the Natural Standard Research Collaboration","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Medicinal Plant Extracts Effects","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Kava; Medicine; Dosing; Traditional medicine; Pharmacology","score_opus":0.058603490882086155,"score_gpt":0.4599951406542317,"score_spread":0.40139164977214553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111463664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000582589,0.99677855,0.00026847952,0.0005847741,0.00019008225,0.00029180557,0.00025707926,0.000006672969,0.0010400327],"genre_scores_gemma":[0.0065653496,0.9903065,0.0012107716,0.00063580956,0.000108710774,0.0004119168,0.00023401405,0.0000047834833,0.0005221624],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940224,0.0027324862,0.001659039,0.00030598423,0.0011795866,0.00010043209],"domain_scores_gemma":[0.9879439,0.0052587995,0.0037180036,0.0002495576,0.0026679111,0.00016193168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008554285,0.0009389257,0.0037752988,0.0036641404,0.00040074726,0.0012238473,0.0011881131,0.0014110558,0.007572796],"category_scores_gemma":[0.018218327,0.0005195106,0.0032042083,0.0034732546,0.0003803884,0.001170956,0.0007122342,0.0008123813,0.0010395473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010278294,0.00004703773,0.00041586792,0.55699545,0.004056318,0.00018992364,0.00018236197,0.00015305902,0.001420454,0.00073639664,0.01311546,0.42165992],"study_design_scores_gemma":[0.0018515127,0.0025053748,0.008095131,0.571003,0.038043264,0.0011650007,0.00035657303,0.00016375624,0.0026435761,0.0011229343,0.37297538,0.00007447779],"about_ca_topic_score_codex":0.0039749895,"about_ca_topic_score_gemma":0.01182002,"teacher_disagreement_score":0.008554285,"about_ca_system_score_codex":0.0018389534,"about_ca_system_score_gemma":0.007951607,"threshold_uncertainty_score":0.045239925},"labels":[],"label_agreement":null},{"id":"W2112690253","doi":"10.1517/14740338.2012.677026","title":"Drug safety evaluation of pregabalin","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pregabalin; Medicine; Adverse effect; Neuropathic pain; Sedation; Peripheral edema; Anesthesia; Anticonvulsant; Intensive care medicine; Pharmacology; Epilepsy; Psychiatry","score_opus":0.11937211517498823,"score_gpt":0.4190687416217234,"score_spread":0.29969662644673517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112690253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006836084,0.9934174,0.00025163373,0.00050079724,0.00024612344,0.000057739806,0.00011512866,0.000011212892,0.0047162324],"genre_scores_gemma":[0.009156449,0.98655534,0.00054931745,0.0007113898,0.00022554061,0.000066375316,0.0002189927,0.0000047730096,0.0025119288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932444,0.00016983133,0.000092707516,0.00007137987,0.00030250225,0.000039263854],"domain_scores_gemma":[0.9991047,0.00028682713,0.00025925133,0.00001996209,0.00029147125,0.000037759048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011203383,0.00076112885,0.0017034132,0.0015912531,0.0002385517,0.00086606026,0.00092936633,0.0012208296,0.011986336],"category_scores_gemma":[0.0015141375,0.00017572011,0.0011507757,0.0013161523,0.00024498682,0.0006288919,0.00041228055,0.0010619274,0.0025104985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026551992,0.00008902366,0.00016119072,0.04160419,0.00023533346,0.00033672526,0.00004569039,0.0003025836,0.0023880862,0.0018836473,0.015609092,0.93707895],"study_design_scores_gemma":[0.00034520822,0.0012126897,0.0027566808,0.028324235,0.0011967426,0.0037327406,0.0001316278,0.00039150356,0.0056777652,0.0026621684,0.9535166,0.000052073785],"about_ca_topic_score_codex":0.0010970926,"about_ca_topic_score_gemma":0.0019005355,"teacher_disagreement_score":0.011986336,"about_ca_system_score_codex":0.0007020045,"about_ca_system_score_gemma":0.0015752907,"threshold_uncertainty_score":0.04009831},"labels":[],"label_agreement":null},{"id":"W2120113397","doi":"10.1517/14740338.2014.947958","title":"Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients","year":2014,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Manitoba; Child and Family Research Institute; Dalhousie University; BC Children's Hospital; University of British Columbia; University of British Columbia Hospital","funders":"Canadian Institutes of Health Research; London Health Sciences Centre","keywords":"Medicine; Hazard ratio; Internal medicine; Cohort; Retrospective cohort study; Multiple sclerosis; Liver injury; Drug; Proportional hazards model; Adverse effect; Confidence interval; Pharmacology; Immunology","score_opus":0.11568749489911455,"score_gpt":0.3493558357500897,"score_spread":0.23366834085097515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120113397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998808,0.00018495823,0.00003099431,0.000030095714,0.0000018839336,0.0000146147,0.0004993763,0.0000019758486,0.00042815876],"genre_scores_gemma":[0.9992065,0.000084555875,0.00004701349,0.000026297863,0.0000037446925,0.000007933769,0.0004804398,0.0000010253278,0.00014254912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956745,0.00005113954,0.00004269113,0.00007593414,0.00014817854,0.00011455462],"domain_scores_gemma":[0.9989091,0.000077442455,0.0005982689,0.00004130461,0.00018407684,0.00018981485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033037533,0.00025331933,0.00030405767,0.0007690137,0.0007841225,0.0005587488,0.0003381978,0.0003060884,0.0013267423],"category_scores_gemma":[0.0012842739,0.00018619273,0.00031036718,0.0013482769,0.0002672562,0.00019974817,0.0003357764,0.00038833034,0.0001679308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005626988,0.000007126736,0.9994497,0.000004279336,0.000012413363,0.000040329145,0.000020555648,0.000010983784,0.000071769726,0.0000030624742,0.000041786367,0.00028164417],"study_design_scores_gemma":[0.000003830928,0.000040271545,0.99941003,0.00000452233,0.000011688414,0.000248958,0.000082634775,0.000045534875,0.00003284715,0.000004233824,0.00011344893,0.0000019818626],"about_ca_topic_score_codex":0.24240519,"about_ca_topic_score_gemma":0.26524428,"teacher_disagreement_score":0.24240519,"about_ca_system_score_codex":0.0017732446,"about_ca_system_score_gemma":0.002131933,"threshold_uncertainty_score":0.48198843},"labels":[],"label_agreement":null},{"id":"W2127157324","doi":"10.1517/14740338.2014.908182","title":"Serotonergic antidepressants and perioperative bleeding risk: a systematic review","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; McGill University; Jewish General Hospital; Concordia University; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Perioperative; MEDLINE; Context (archaeology); Intensive care medicine; Odds ratio; Meta-analysis; Systematic review; Adverse effect; Odds; Internal medicine; Surgery; Logistic regression","score_opus":0.03918097329417711,"score_gpt":0.4102195454294999,"score_spread":0.37103857213532276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127157324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053405046,0.99893886,0.00005663284,0.0001250715,0.000041209954,0.000072785595,0.00011134967,0.0000027800422,0.000117293836],"genre_scores_gemma":[0.008911293,0.9901821,0.00030920014,0.00023344236,0.000060630457,0.00013840635,0.00009893447,0.0000013966719,0.000064517895],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968651,0.0009916058,0.0010813216,0.00027138877,0.00069007464,0.000100556426],"domain_scores_gemma":[0.9872421,0.009053947,0.0024834662,0.00013267888,0.0009579985,0.0001298033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039593824,0.0011984983,0.005578383,0.0061881496,0.0004070171,0.0015444601,0.0013028863,0.0015087941,0.0033647188],"category_scores_gemma":[0.018042237,0.000739764,0.0055330074,0.007156962,0.0004806098,0.0011693983,0.00076396944,0.0007879952,0.00023093547],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019965913,0.00001600978,0.0014357524,0.9310818,0.012553268,0.00013081958,0.00008496299,0.00011146032,0.00014802624,0.00015086838,0.0019790968,0.052108385],"study_design_scores_gemma":[0.0004252934,0.00032256966,0.012215787,0.79818195,0.15974112,0.00097388605,0.00023591699,0.00020908406,0.00031064192,0.00047225697,0.026859408,0.000052030297],"about_ca_topic_score_codex":0.0061806147,"about_ca_topic_score_gemma":0.018259995,"teacher_disagreement_score":0.0061881496,"about_ca_system_score_codex":0.0019153319,"about_ca_system_score_gemma":0.005881875,"threshold_uncertainty_score":0.02093947},"labels":[],"label_agreement":null},{"id":"W2131201627","doi":"10.1517/14740338.4.3.473","title":"Efficacy and safety of basiliximab in kidney transplantation","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondazione Arpa; University of Lethbridge","keywords":"Basiliximab; Medicine; Adverse effect; Transplantation; Kidney transplantation; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.04208344527182806,"score_gpt":0.3744033903799206,"score_spread":0.33231994510809254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131201627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001315108,0.99915993,0.00004776064,0.000120255536,0.00005363112,0.0000024287674,0.000006836533,0.000002038237,0.00047557268],"genre_scores_gemma":[0.0011430818,0.9983316,0.00008763502,0.00011981782,0.000086666914,0.0000038605835,0.000011992476,5.2800823e-7,0.0002149618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963593,0.00010019798,0.00005959297,0.00004232288,0.00014337034,0.000018614477],"domain_scores_gemma":[0.9994456,0.00030212977,0.00012457458,0.000008873087,0.000096227894,0.000022516568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010587943,0.0005467143,0.0019096695,0.0015942954,0.00018576821,0.0008104193,0.000869133,0.0010116608,0.0033883692],"category_scores_gemma":[0.0010868955,0.00019119288,0.00051451183,0.001977649,0.00029791272,0.000668357,0.0003150997,0.00077682507,0.0013751122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117184674,0.00005534425,0.00018322981,0.026879212,0.00020591202,0.00027542014,0.000035580186,0.00028132356,0.0010243342,0.00090480107,0.013391395,0.95664626],"study_design_scores_gemma":[0.00014381969,0.0004533252,0.0037990077,0.019996762,0.0009259288,0.004004583,0.0001235349,0.00028140596,0.0015861765,0.002409804,0.9662379,0.00003774665],"about_ca_topic_score_codex":0.00089634344,"about_ca_topic_score_gemma":0.0019157579,"teacher_disagreement_score":0.0033883692,"about_ca_system_score_codex":0.0005238411,"about_ca_system_score_gemma":0.0007542917,"threshold_uncertainty_score":0.011335254},"labels":[],"label_agreement":null},{"id":"W2134746903","doi":"10.1517/14740338.4.6.1027","title":"The safety and efficacy of the use of vasopressin in sepsis and septic shock","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vasopressin; Septic shock; Medicine; Sepsis; Intensive care medicine; Shock (circulatory); Internal medicine","score_opus":0.14739981652905867,"score_gpt":0.4014445665321733,"score_spread":0.25404475000311466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134746903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006722699,0.99921215,0.00003516406,0.00024345276,0.000069253925,0.0000021542014,0.000007840537,0.0000012294842,0.00036151236],"genre_scores_gemma":[0.00089043396,0.9985318,0.000098735865,0.00020595659,0.00010319423,0.000005077838,0.0000110345745,4.825908e-7,0.00015328694],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9990264,0.00029673456,0.00018391557,0.000098893455,0.00036160703,0.000032537417],"domain_scores_gemma":[0.9985298,0.0008037261,0.0003634339,0.000022473312,0.00024418326,0.000036386547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014054164,0.00064588926,0.0025200516,0.0015544078,0.00022976768,0.0010770023,0.00089826924,0.0016851624,0.002832768],"category_scores_gemma":[0.002839412,0.00019465791,0.0006193476,0.0021915117,0.0004555208,0.0009601064,0.0004225677,0.00097500434,0.0013233147],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016037,0.000046488996,0.00021788404,0.054066952,0.00034168665,0.00036296088,0.00006026448,0.00019157071,0.0013106255,0.001358322,0.014043068,0.9278398],"study_design_scores_gemma":[0.0001919799,0.00079199916,0.004613343,0.044529013,0.0015283736,0.0059011243,0.00030390336,0.00018892874,0.0018654112,0.0038173792,0.9361987,0.00006995199],"about_ca_topic_score_codex":0.0011975653,"about_ca_topic_score_gemma":0.0018026412,"teacher_disagreement_score":0.002832768,"about_ca_system_score_codex":0.0006531075,"about_ca_system_score_gemma":0.001521381,"threshold_uncertainty_score":0.0094765425},"labels":[],"label_agreement":null},{"id":"W2137748785","doi":"10.1517/14740338.4.2.149","title":"What to do with TNF failures","year":2005,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.010035532026141686,"score_gpt":0.3142949200650003,"score_spread":0.30425938803885866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137748785","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003114481,0.10730779,0.00042181523,0.32952982,0.5575436,0.00002997956,0.000063155116,0.000087723936,0.0047046077],"genre_scores_gemma":[0.0033902812,0.07445653,0.00053569645,0.22822018,0.68507814,0.000035010118,0.00006191809,0.000044357334,0.008177898],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964568,0.000990355,0.00070394826,0.00043901496,0.0011824511,0.00022741243],"domain_scores_gemma":[0.9854371,0.008363218,0.0012621721,0.0003746394,0.0031864992,0.0013764928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064874673,0.0015822087,0.0034187136,0.0011447127,0.0018435532,0.004395914,0.0022688857,0.015262834,0.004724249],"category_scores_gemma":[0.02969115,0.0007099254,0.0013643767,0.0008027645,0.003255707,0.0071081743,0.0009710903,0.02027496,0.0037271809],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006779711,0.000017929378,0.0001793219,0.00084782206,0.000052260304,0.0008350687,0.00008327092,0.000037464804,0.00008717276,0.0013820854,0.9544238,0.041986108],"study_design_scores_gemma":[0.0001292035,0.000048210524,0.00061126414,0.0015066387,0.00008918965,0.002717967,0.00022350543,0.00009064526,0.00014181447,0.003339546,0.99106675,0.000035159403],"about_ca_topic_score_codex":0.0017799109,"about_ca_topic_score_gemma":0.0043126587,"teacher_disagreement_score":0.015262834,"about_ca_system_score_codex":0.0024408058,"about_ca_system_score_gemma":0.0021915608,"threshold_uncertainty_score":0.034309447},"labels":[],"label_agreement":null},{"id":"W2138834969","doi":"10.1517/14740338.1.1.71","title":"The gastrointestinal tolerability and safety of oral bisphosphonates","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Bone health and treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Clinical trial; Postmarketing surveillance; Osteoporosis; Intensive care medicine; Dosing; Clinical significance; Internal medicine","score_opus":0.05328660371399697,"score_gpt":0.3657822182065015,"score_spread":0.3124956144925045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138834969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063381164,0.996872,0.000114622104,0.00050902343,0.00009621013,0.000008770034,0.000025887124,0.0000036690897,0.0017359724],"genre_scores_gemma":[0.005935883,0.9921159,0.00027022543,0.0005181479,0.00020638105,0.00001672759,0.00004044166,0.0000015832342,0.00089484185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990281,0.00025915998,0.00013596538,0.00008251745,0.0004588311,0.00003536948],"domain_scores_gemma":[0.9990175,0.00045920885,0.00023908063,0.00001975725,0.00023599326,0.000028326442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013165685,0.0005727237,0.002038338,0.000861888,0.0001635085,0.0008051774,0.00069673546,0.0011667713,0.0037344496],"category_scores_gemma":[0.0020406244,0.00015973728,0.00068489515,0.0010001647,0.00024035279,0.0006306668,0.00025936315,0.0006072321,0.0012044425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016354045,0.000052363164,0.0004046665,0.019761372,0.00020638404,0.00028821806,0.000038538772,0.00017502478,0.0021173274,0.00054115563,0.00944124,0.9668102],"study_design_scores_gemma":[0.00037331396,0.002115219,0.016487006,0.023607355,0.0018897157,0.008917655,0.00033140025,0.0004484771,0.0053793467,0.0031544648,0.9372279,0.00006810574],"about_ca_topic_score_codex":0.0009134867,"about_ca_topic_score_gemma":0.0018292981,"teacher_disagreement_score":0.0037344496,"about_ca_system_score_codex":0.00040784266,"about_ca_system_score_gemma":0.00071685825,"threshold_uncertainty_score":0.012492955},"labels":[],"label_agreement":null},{"id":"W2141339944","doi":"10.1517/14740338.3.5.425","title":"The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Galantamine; Medicine; Rivastigmine; Donepezil; Adverse effect; Cholinesterase; Dementia; Memantine; Disease; Pharmacology; Drug; Internal medicine; Intensive care medicine","score_opus":0.11806681484227145,"score_gpt":0.3888932999723099,"score_spread":0.2708264851300385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141339944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03299753,0.9444895,0.00045853178,0.013768757,0.0006263374,0.00003431152,0.00028057487,0.000010851898,0.0073336787],"genre_scores_gemma":[0.45334205,0.53159565,0.0014788754,0.0060329884,0.0052683074,0.00009374672,0.00026045876,0.000012168533,0.0019157472],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926801,0.0044711684,0.00083375827,0.00031725309,0.0015105117,0.00018719057],"domain_scores_gemma":[0.98184973,0.013512296,0.002803512,0.00030752475,0.0009899368,0.0005370288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0080373995,0.0006117591,0.0020784382,0.00091542664,0.00060015614,0.0018565224,0.0005547598,0.0017360928,0.004318221],"category_scores_gemma":[0.022950392,0.00031247459,0.0028434128,0.0009719534,0.0009528011,0.0013597596,0.00095847435,0.0028886166,0.00040472735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023379028,0.00059879094,0.038505923,0.033223324,0.01467238,0.0018932405,0.0006490071,0.001297273,0.0019493707,0.009703134,0.015904501,0.85822403],"study_design_scores_gemma":[0.014042082,0.018855736,0.47988215,0.049938716,0.069602385,0.016862629,0.0025995723,0.004404582,0.0032698722,0.11581287,0.22402734,0.00070209336],"about_ca_topic_score_codex":0.0013549571,"about_ca_topic_score_gemma":0.0032979036,"teacher_disagreement_score":0.0080373995,"about_ca_system_score_codex":0.0011072082,"about_ca_system_score_gemma":0.0010864633,"threshold_uncertainty_score":0.042506337},"labels":[],"label_agreement":null},{"id":"W2141490624","doi":"10.1517/14740338.2011.583917","title":"Antidepressant use in pregnancy","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Pregnancy; Antidepressant; Affect (linguistics); Depression (economics); Psychiatry; Drugs in pregnancy; Obstetrics; Intensive care medicine; Family medicine; Anxiety; Fetus","score_opus":0.10990325148139715,"score_gpt":0.38788316994212785,"score_spread":0.27797991846073067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141490624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011153534,0.999175,0.0000152122575,0.00013002065,0.000097391916,0.000005338141,0.000018637593,0.0000012504344,0.00044554012],"genre_scores_gemma":[0.0019740555,0.99755377,0.00005406454,0.00012631826,0.00009524834,0.0000087112485,0.000024412086,3.3986205e-7,0.0001631604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993973,0.00016583399,0.0001426163,0.00007912384,0.00018353383,0.000031578755],"domain_scores_gemma":[0.99903834,0.0005218583,0.00029700596,0.000012547289,0.00010587105,0.000024419243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076327776,0.00073772797,0.001622322,0.001635747,0.00021744262,0.0008275999,0.00062222994,0.0009440415,0.004348323],"category_scores_gemma":[0.002536957,0.00024333656,0.0008038519,0.0022729123,0.00024377798,0.00053280336,0.00040928897,0.00072503963,0.0007832943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015496794,0.000034379547,0.0009533855,0.10707266,0.00046563242,0.00035276898,0.000112776856,0.0001633432,0.0003680659,0.0006730804,0.020344127,0.86930484],"study_design_scores_gemma":[0.00024926924,0.00046765542,0.021923572,0.2298564,0.0044860765,0.010456147,0.00037351256,0.000279496,0.0007720577,0.0017439754,0.7293357,0.00005605337],"about_ca_topic_score_codex":0.0040804683,"about_ca_topic_score_gemma":0.0069681364,"teacher_disagreement_score":0.004348323,"about_ca_system_score_codex":0.0007371047,"about_ca_system_score_gemma":0.0014416511,"threshold_uncertainty_score":0.014546633},"labels":[],"label_agreement":null},{"id":"W2142102791","doi":"10.1517/14740330902778180","title":"Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton General Hospital","funders":"University of Otago; GlaxoSmithKline","keywords":"Medicine; Anaphylaxis; Heparin; Anaphylactoid reactions; Angioedema; Anesthesia; Immunology; Allergy; Internal medicine","score_opus":0.08887042483451926,"score_gpt":0.3882741692421307,"score_spread":0.2994037444076114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142102791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20996957,0.7548078,0.011333188,0.0034284873,0.00070002995,0.00030932296,0.0003867581,0.00028305515,0.018781886],"genre_scores_gemma":[0.76920426,0.2166223,0.0051218867,0.0031419718,0.0018287083,0.00017836191,0.00071562995,0.000031732787,0.0031552108],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989458,0.00021625328,0.0002948194,0.00016523003,0.00019790519,0.0001800173],"domain_scores_gemma":[0.9985089,0.0004463523,0.00072267326,0.000043637297,0.0001540406,0.00012442887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053905224,0.0014210165,0.0014604137,0.0018231388,0.00037870684,0.0010714128,0.00062075263,0.0018840788,0.0022802632],"category_scores_gemma":[0.0020262548,0.00031019887,0.0007821431,0.0017571092,0.0010648506,0.0018367087,0.0012952251,0.0012583259,0.0006081229],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012735996,0.00042738917,0.1404685,0.011605907,0.0008107281,0.53241545,0.0024366968,0.00081930513,0.017697332,0.013072921,0.01207612,0.266896],"study_design_scores_gemma":[0.00013474883,0.00023968531,0.044298116,0.0007866061,0.0003000596,0.9238474,0.0008105075,0.00035928632,0.0012710091,0.0030751897,0.024827525,0.000049939823],"about_ca_topic_score_codex":0.0004135447,"about_ca_topic_score_gemma":0.00032572294,"teacher_disagreement_score":0.0022802632,"about_ca_system_score_codex":0.00046498765,"about_ca_system_score_gemma":0.0006284449,"threshold_uncertainty_score":0.007628262},"labels":[],"label_agreement":null},{"id":"W2142106904","doi":"10.1517/14740338.2014.867015","title":"Development and application of indicators for the reduction of potentially preventable hospital admissions related to medications","year":2013,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Pharmacy; Performance indicator; Medical emergency; Database; Family medicine; Business","score_opus":0.03065182027426445,"score_gpt":0.3720130291358453,"score_spread":0.34136120886158083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142106904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73802596,0.02146499,0.11157686,0.027633833,0.0011460561,0.008983697,0.048677843,0.0025531165,0.039937768],"genre_scores_gemma":[0.7937058,0.00532067,0.17675222,0.00079568365,0.00026818088,0.0033970417,0.018599259,0.00007516862,0.0010859336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9406091,0.029021198,0.011272634,0.0023804419,0.015387366,0.0013292161],"domain_scores_gemma":[0.8511618,0.047371093,0.052229654,0.0070432276,0.03932664,0.0028676616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.056183677,0.0010694906,0.0014221119,0.008469336,0.0004986785,0.0028391827,0.002033302,0.0009345921,0.0014963698],"category_scores_gemma":[0.15613148,0.00039556614,0.0014408544,0.0077350144,0.00036845508,0.0026866372,0.0020014988,0.0011603473,0.00041416526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005562693,0.0006240601,0.5956588,0.0037648708,0.00064385025,0.000055460794,0.0008847422,0.0055666557,0.0008987237,0.0013938334,0.016264506,0.37368822],"study_design_scores_gemma":[0.00021622716,0.002014543,0.94639397,0.0031292306,0.00048317708,0.00012270651,0.0016105189,0.017162083,0.004456754,0.0010082999,0.023298193,0.000104258506],"about_ca_topic_score_codex":0.016133463,"about_ca_topic_score_gemma":0.014691922,"teacher_disagreement_score":0.056183677,"about_ca_system_score_codex":0.004885832,"about_ca_system_score_gemma":0.01152439,"threshold_uncertainty_score":0.29713124},"labels":[],"label_agreement":null},{"id":"W2143666642","doi":"10.1517/14740338.2011.533168","title":"Lapatinib for breast cancer: a review of the current literature","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lapatinib; Medicine; Breast cancer; Trastuzumab; Cancer; Oncology; Metastatic breast cancer; Internal medicine; Tyrosine-kinase inhibitor; Disease","score_opus":0.0746250945156274,"score_gpt":0.4797467624904513,"score_spread":0.40512166797482385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143666642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004688298,0.9993419,0.000026310332,0.00018655727,0.000109169945,0.0000037298873,0.000012599096,0.0000025932147,0.00027022787],"genre_scores_gemma":[0.00026749127,0.9992638,0.000069782334,0.00016967372,0.00009482101,0.0000053687486,0.000013818924,5.9968824e-7,0.000114723465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960965,0.000076970726,0.0000894364,0.00005480281,0.00014698156,0.000022141621],"domain_scores_gemma":[0.9992163,0.00041333513,0.00014577436,0.000013308873,0.00016855929,0.00004261948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008841311,0.0009741227,0.0020137106,0.003532989,0.00029678075,0.0010477608,0.0010776228,0.0011532838,0.004637272],"category_scores_gemma":[0.0015643887,0.00031850688,0.00088405574,0.005348185,0.00035061556,0.00147843,0.00048733634,0.00115715,0.0015744736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010432686,0.00005856059,0.00026594268,0.10436321,0.00026206239,0.00033321136,0.00012517981,0.0002494693,0.0007621682,0.0010368704,0.053662807,0.83877623],"study_design_scores_gemma":[0.00005819167,0.00026737497,0.0024809933,0.06302494,0.0009868413,0.0030065218,0.00022354892,0.00013437076,0.00029900146,0.0014111343,0.92806643,0.00004068869],"about_ca_topic_score_codex":0.0017662336,"about_ca_topic_score_gemma":0.0031562857,"teacher_disagreement_score":0.004637272,"about_ca_system_score_codex":0.00082525046,"about_ca_system_score_gemma":0.0017800608,"threshold_uncertainty_score":0.015513241},"labels":[],"label_agreement":null},{"id":"W2143694203","doi":"10.1517/14740338.6.4.445","title":"Safety considerations with mycophenolate sodium","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Western Ontario; Western University","funders":"","keywords":"Medicine; Mycophenolic acid; Mycophenolate; Bioequivalence; Pharmacokinetics; Ciclosporin; Dosing; Pharmacology; Prodrug; Transplantation; Concomitant; Internal medicine","score_opus":0.0723134514616224,"score_gpt":0.386728963412423,"score_spread":0.31441551195080064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143694203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004982153,0.9943368,0.0003274182,0.0015898851,0.00031070458,0.000010034774,0.000013075089,0.000011928665,0.0029018314],"genre_scores_gemma":[0.0055392953,0.9876003,0.0008304143,0.0024009056,0.0008248274,0.000029323935,0.000035188885,0.000004643412,0.0027349812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908686,0.00027868175,0.00014170176,0.00009034694,0.00035487156,0.000047410856],"domain_scores_gemma":[0.99904984,0.00047224518,0.00020508455,0.000025331048,0.00020449006,0.000042977772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017211606,0.0005391496,0.001660288,0.0011125157,0.00036644278,0.001046477,0.00089400256,0.0023355635,0.0036738107],"category_scores_gemma":[0.0018408203,0.00023349156,0.0008153528,0.0009410461,0.0004569329,0.0011092531,0.00044232345,0.0017052371,0.0026773126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015432619,0.00006694581,0.00021468081,0.011829542,0.00010172904,0.0010046876,0.00010211512,0.0002004468,0.0027901498,0.003129711,0.024135154,0.9562706],"study_design_scores_gemma":[0.00012645726,0.00032294396,0.0009662782,0.004619685,0.00018191202,0.0065656365,0.00010583387,0.00013412687,0.0023309833,0.0025713535,0.9820535,0.000021276019],"about_ca_topic_score_codex":0.0010865114,"about_ca_topic_score_gemma":0.0017759631,"teacher_disagreement_score":0.0036738107,"about_ca_system_score_codex":0.00054232427,"about_ca_system_score_gemma":0.0012757308,"threshold_uncertainty_score":0.01229018},"labels":[],"label_agreement":null},{"id":"W2144075042","doi":"10.1517/14740338.2014.914168","title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Rivastigmine; Donepezil; Galantamine; Medicine; Memantine; Clinical trial; Disease; Intensive care medicine; Alzheimer's disease; Dementia; Pharmacology; Psychiatry; Internal medicine","score_opus":0.055667495834188986,"score_gpt":0.37620101864618094,"score_spread":0.32053352281199193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144075042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024807817,0.99861133,0.000041878204,0.00022514974,0.00009949741,0.000006203519,0.00003935745,0.0000023461218,0.0007261393],"genre_scores_gemma":[0.003658277,0.99526453,0.00013876827,0.00027288077,0.0001672346,0.000015905804,0.00007813469,0.0000010606796,0.0004032491],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995919,0.00010394921,0.000092666465,0.000053960244,0.00013215476,0.00002536174],"domain_scores_gemma":[0.9994823,0.00022493365,0.00014455293,0.000008488365,0.00011992927,0.000019734985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009336531,0.0006001287,0.0016372467,0.0009455776,0.00012661237,0.0006228568,0.00064584,0.0008325505,0.0043539447],"category_scores_gemma":[0.0015907275,0.00011467699,0.0010616553,0.0008491587,0.0001732918,0.00053505076,0.0002985189,0.00074883684,0.00088438473],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041079678,0.000059577676,0.00031345498,0.057060514,0.0008000773,0.0001932778,0.000042133677,0.00026358222,0.0011697925,0.0011296794,0.018821146,0.91973597],"study_design_scores_gemma":[0.0007398366,0.0014023813,0.009718749,0.07417581,0.0052481913,0.0048650936,0.00020868349,0.00046432964,0.0025230353,0.0033668184,0.89720976,0.00007727927],"about_ca_topic_score_codex":0.0006873711,"about_ca_topic_score_gemma":0.0013324362,"teacher_disagreement_score":0.0043539447,"about_ca_system_score_codex":0.00047096398,"about_ca_system_score_gemma":0.00072091806,"threshold_uncertainty_score":0.014565408},"labels":[],"label_agreement":null},{"id":"W2146208080","doi":"10.1517/14740338.2011.586628","title":"The relationship among proton pump inhibitors, bone disease and fracture","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Intensive care medicine; Observational study; Fragility; Disease; Osteoporosis; Internal medicine","score_opus":0.046587861553520085,"score_gpt":0.34863409142449814,"score_spread":0.30204622987097807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146208080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057839155,0.99905485,0.000018681225,0.00037553243,0.00019601492,0.0000024186843,0.000009636073,0.0000013875672,0.0002836017],"genre_scores_gemma":[0.0006144486,0.99856937,0.000047704238,0.00021687924,0.0002973794,0.0000035380376,0.000015862617,3.5294624e-7,0.00023441247],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99950695,0.000108071006,0.00007609839,0.00006148324,0.00021760499,0.000029759205],"domain_scores_gemma":[0.99907637,0.00045777284,0.00023043653,0.000010353829,0.00019564935,0.00002936497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008585169,0.00080023,0.0017169678,0.0018455671,0.00020714765,0.00084099115,0.00077815756,0.0016760628,0.00569373],"category_scores_gemma":[0.002010412,0.00027553382,0.0007165755,0.0026624217,0.0003138689,0.0008723963,0.0004701315,0.0011129959,0.0015478595],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017727028,0.000055966317,0.0006813985,0.06814208,0.00054165145,0.00037445338,0.00005986939,0.00028609115,0.00062407413,0.001272532,0.059470117,0.86831445],"study_design_scores_gemma":[0.00018160432,0.0003176377,0.010419629,0.046974886,0.0015541821,0.0061994377,0.0001966347,0.0002586761,0.000528249,0.0026012019,0.9307183,0.000049475155],"about_ca_topic_score_codex":0.0025441537,"about_ca_topic_score_gemma":0.003943026,"teacher_disagreement_score":0.00569373,"about_ca_system_score_codex":0.0006128466,"about_ca_system_score_gemma":0.0013983054,"threshold_uncertainty_score":0.01904744},"labels":[],"label_agreement":null},{"id":"W2146324261","doi":"10.1517/14740338.1.3.269","title":"A safety look at currently available statins","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Medicine; Tolerability; Statin; Adverse effect; Discontinuation; Gemfibrozil; Intensive care medicine; Drug; Pharmacology; Dyslipidemia; Internal medicine; Cholesterol; Disease","score_opus":0.06159846988091728,"score_gpt":0.3495888478837957,"score_spread":0.2879903780028784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146324261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019242197,0.9953395,0.00016685559,0.0015212311,0.00076032325,0.000010696498,0.000019992704,0.000007730843,0.0019812637],"genre_scores_gemma":[0.0010015977,0.9938844,0.00037972498,0.0020451844,0.0012044513,0.000017722421,0.000039060356,0.0000026999753,0.0014250814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993284,0.00019816858,0.00010860171,0.000063529886,0.00026665197,0.00003473523],"domain_scores_gemma":[0.9988381,0.00059527555,0.00018891972,0.000028948165,0.0003030655,0.00004565945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012131787,0.00080224907,0.0019126092,0.002078189,0.00034246253,0.0011751793,0.0007495718,0.0018051415,0.005709577],"category_scores_gemma":[0.0023986574,0.0002876642,0.0009862671,0.0014892642,0.00034475524,0.0021338693,0.00039988346,0.001426995,0.002008231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014716052,0.00006531997,0.00026756473,0.024651568,0.00018002685,0.00070082967,0.00009137579,0.00022965652,0.00171966,0.0024162284,0.0581553,0.9113753],"study_design_scores_gemma":[0.00006185527,0.00026160927,0.0014028165,0.014920497,0.00035940896,0.0026444842,0.00015546735,0.000094311006,0.00042770102,0.0025105102,0.9771413,0.000020029594],"about_ca_topic_score_codex":0.0008401081,"about_ca_topic_score_gemma":0.0018261194,"teacher_disagreement_score":0.005709577,"about_ca_system_score_codex":0.00070087373,"about_ca_system_score_gemma":0.0011818238,"threshold_uncertainty_score":0.019100487},"labels":[],"label_agreement":null},{"id":"W2154484972","doi":"10.1517/14740338.7.5.547","title":"Efficacy and safety of aromatase inhibitors in early breast cancer","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Medicine; Tamoxifen; Adjuvant; Breast cancer; Aromatase; Adverse effect; Quality of life (healthcare); Oncology; Clinical trial; Internal medicine; Aromatase inhibitor; Randomized controlled trial; Gynecology; Safety profile; Cancer","score_opus":0.012634255241117436,"score_gpt":0.30578251926398653,"score_spread":0.2931482640228691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154484972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000120300065,0.99911445,0.000047236514,0.0001700319,0.00006861594,0.0000029362825,0.00001067958,0.0000021578192,0.00046345987],"genre_scores_gemma":[0.001436801,0.9977488,0.000098590725,0.00018261233,0.00013491893,0.0000054614134,0.00002115321,8.558328e-7,0.00037072657],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999511,0.00011687215,0.00007454003,0.000063143896,0.00020818009,0.000026206868],"domain_scores_gemma":[0.9991559,0.00042420017,0.00017585733,0.000014193277,0.00019952559,0.000030370635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015158448,0.0006349001,0.0023122148,0.0012705318,0.00017194905,0.00074121874,0.0010636466,0.0013017452,0.0028685483],"category_scores_gemma":[0.0017142384,0.00023940961,0.00054309604,0.0013141944,0.00035549572,0.00070713373,0.00031588864,0.0011555023,0.0017917047],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002131151,0.000054035638,0.00031123546,0.019933091,0.00014992361,0.00028950584,0.000027559778,0.0002403347,0.001202566,0.0010492414,0.015051478,0.9614779],"study_design_scores_gemma":[0.00021584192,0.0005652543,0.004562692,0.01197442,0.00066229916,0.004932578,0.00009690431,0.00023890407,0.0019887486,0.0022584917,0.97246784,0.0000360422],"about_ca_topic_score_codex":0.0010408345,"about_ca_topic_score_gemma":0.0017711492,"teacher_disagreement_score":0.0028685483,"about_ca_system_score_codex":0.00068327796,"about_ca_system_score_gemma":0.00087209576,"threshold_uncertainty_score":0.009596288},"labels":[],"label_agreement":null},{"id":"W2155380597","doi":"10.1517/14740330903311023","title":"Renal adverse effects of nonsteroidal anti-inflammatory drugs","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Nephrotoxicity; Renal function; Adverse effect; Nephritic syndrome; Side effect (computer science); Pharmacology; Drug; Internal medicine; Heart failure; Kidney; Proteinuria","score_opus":0.013915099351497897,"score_gpt":0.3104675364276032,"score_spread":0.29655243707610535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155380597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016572548,0.99759537,0.00011795093,0.00027620717,0.00020238721,0.000007856494,0.000026462621,0.0000074809077,0.001600636],"genre_scores_gemma":[0.0014206108,0.99660033,0.00020220444,0.00027684946,0.00024962725,0.000007852004,0.000050580766,0.0000011880581,0.0011908556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995327,0.00008233582,0.00007320369,0.00004335881,0.00023737276,0.000031165288],"domain_scores_gemma":[0.9993642,0.0002102784,0.0001697814,0.000015287045,0.00020762967,0.000032799944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006779391,0.0008188971,0.0017865859,0.0013578857,0.00019470634,0.0006946887,0.000761966,0.00085622293,0.0074502877],"category_scores_gemma":[0.0010162246,0.00019180475,0.00062203547,0.0016141252,0.00023722643,0.0006782671,0.00038410237,0.00078365265,0.002880129],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073825846,0.000053283187,0.00022495596,0.020498816,0.00018136189,0.00037315075,0.0000315859,0.00018214971,0.001397982,0.0006076882,0.030391272,0.945984],"study_design_scores_gemma":[0.00006563319,0.00017979577,0.0034120968,0.00849616,0.000425981,0.0044449745,0.00007202802,0.00013488716,0.0010493818,0.0011167639,0.9805767,0.000025592115],"about_ca_topic_score_codex":0.0011556923,"about_ca_topic_score_gemma":0.003068661,"teacher_disagreement_score":0.0074502877,"about_ca_system_score_codex":0.0004933063,"about_ca_system_score_gemma":0.0010083354,"threshold_uncertainty_score":0.024923682},"labels":[],"label_agreement":null},{"id":"W2159244051","doi":"10.1517/14740338.2014.942219","title":"Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil","year":2014,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Medicine; Psoriasis; Adalimumab; Etanercept; Adverse effect; Infliximab; Discontinuation; Odds ratio; Internal medicine; Efalizumab; Intensive care medicine; Dermatology; Rheumatoid arthritis; Disease","score_opus":0.020439595718758717,"score_gpt":0.2603271935728105,"score_spread":0.23988759785405175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159244051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958668,0.00087831507,0.00010297684,0.00020382882,0.00000399805,0.00003589564,0.00039830923,0.0000058855476,0.0025039334],"genre_scores_gemma":[0.9993074,0.0004056731,0.0000782419,0.00004127492,0.00000271708,0.000009424612,0.0000932276,9.027204e-7,0.000061090854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990414,0.0003923168,0.00017637362,0.000096237876,0.0002308367,0.00006284365],"domain_scores_gemma":[0.99447256,0.0012197231,0.0035911938,0.00015540884,0.00037479738,0.00018620731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010050648,0.00012777088,0.00022114739,0.0008722725,0.0002694311,0.0003853514,0.00016591678,0.00021532706,0.0014244493],"category_scores_gemma":[0.0062819943,0.00015984791,0.00026665552,0.00078708405,0.00029448085,0.00020231916,0.00031875048,0.0002455497,0.000116101415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003880632,0.000024828418,0.9905083,0.00007970525,0.000035019955,0.00019077527,0.001175181,0.000022666372,0.00044619158,0.000032956523,0.00017471181,0.0072707194],"study_design_scores_gemma":[0.000011373349,0.00010419661,0.9954268,0.000088654706,0.000036724756,0.0016991594,0.0012727493,0.00013294845,0.00017363363,0.000033810466,0.0010103788,0.000009425997],"about_ca_topic_score_codex":0.009602293,"about_ca_topic_score_gemma":0.010837918,"teacher_disagreement_score":0.009602293,"about_ca_system_score_codex":0.00053052395,"about_ca_system_score_gemma":0.00044557825,"threshold_uncertainty_score":0.019092858},"labels":[],"label_agreement":null},{"id":"W2160309422","doi":"10.1517/14740338.2011.579899","title":"Drugs with anticholinergic properties: a current perspective on use and safety","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Anticholinergic; Perspective (graphical); Intensive care medicine; Pharmacology; Adverse effect","score_opus":0.07299585514305262,"score_gpt":0.3554412384383344,"score_spread":0.2824453832952818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160309422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003805634,0.9990662,0.000026800504,0.0004136652,0.00011227028,0.0000017177457,0.0000072675443,0.0000015505374,0.00033265408],"genre_scores_gemma":[0.0006089796,0.9986914,0.000068781555,0.00024886584,0.00025179485,0.0000033539154,0.000008754957,4.868007e-7,0.00011763272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881434,0.000300433,0.00024396488,0.00013209971,0.0004547357,0.000054409345],"domain_scores_gemma":[0.9961761,0.0022927872,0.00076178607,0.000050862127,0.0006275578,0.00009078384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016545289,0.0011636823,0.0028953142,0.0034440148,0.00035077517,0.0018352607,0.0012454357,0.00251124,0.0058875093],"category_scores_gemma":[0.0033384569,0.00039729357,0.00107629,0.0050622458,0.00086814596,0.0029550227,0.00070677797,0.0020811053,0.001916087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014130768,0.000058014182,0.0004055715,0.099927805,0.00033197252,0.00049621053,0.00018306727,0.0003200746,0.0008788481,0.003810884,0.03464377,0.8588026],"study_design_scores_gemma":[0.00007038112,0.00029623983,0.0032132403,0.09981971,0.0010675669,0.004282652,0.00047985726,0.00026058513,0.00042225,0.004337496,0.88569146,0.000058589543],"about_ca_topic_score_codex":0.001926433,"about_ca_topic_score_gemma":0.0038991263,"teacher_disagreement_score":0.0058875093,"about_ca_system_score_codex":0.0011317084,"about_ca_system_score_gemma":0.0021791188,"threshold_uncertainty_score":0.0196957},"labels":[],"label_agreement":null},{"id":"W2162939680","doi":"10.1517/14740338.4.2.193","title":"Chemotherapy-induced oral mucositis: new approaches to prevention and management","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mucositis; Intensive care medicine; Chemotherapy; Dermatology; Internal medicine; Oncology","score_opus":0.27337652476683083,"score_gpt":0.44422378717327093,"score_spread":0.1708472624064401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162939680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058040325,0.9988593,0.00009814918,0.00041552857,0.00014349865,0.000005092182,0.000006583743,0.000004561065,0.00040924133],"genre_scores_gemma":[0.00033866282,0.99891365,0.00018797052,0.00018413157,0.0001644356,0.000005911966,0.000011380647,8.220819e-7,0.00019301074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995321,0.00010750987,0.00007281444,0.000065315144,0.00019475973,0.000027502363],"domain_scores_gemma":[0.99936455,0.00029641294,0.00011171928,0.000022254517,0.00015462657,0.00005041613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012170179,0.001135409,0.0028623517,0.0028200531,0.0003093949,0.0012578376,0.0013203024,0.0016372451,0.0044855135],"category_scores_gemma":[0.0011758332,0.0003596338,0.0008450876,0.0025672794,0.0007540337,0.0020710258,0.00070596614,0.0025909177,0.002068295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067151035,0.00012630326,0.00016140343,0.020775286,0.00012986122,0.00021211227,0.0000619741,0.0003216528,0.0007464244,0.0019271094,0.022911413,0.95255935],"study_design_scores_gemma":[0.00010878995,0.0002564044,0.0022452164,0.015121522,0.0002848866,0.0023956809,0.00017328851,0.0002176352,0.00035034565,0.003388876,0.9754167,0.000040643263],"about_ca_topic_score_codex":0.0014703072,"about_ca_topic_score_gemma":0.0036107562,"teacher_disagreement_score":0.0044855135,"about_ca_system_score_codex":0.00083880464,"about_ca_system_score_gemma":0.0010670887,"threshold_uncertainty_score":0.015005529},"labels":[],"label_agreement":null},{"id":"W2171378113","doi":"10.1517/14740330902933736","title":"Immune mediation of hypersensitivity adverse drug reactions: implications for therapy","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Children’s Health Research Institute; Children's Hospital of Western Ontario","funders":"","keywords":"Medicine; Drug; Immune system; Adverse effect; Hapten; Immunology; Pharmacology; Antibody","score_opus":0.0745449441876453,"score_gpt":0.3937457570854146,"score_spread":0.3192008128977693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171378113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063153726,0.99688774,0.00013091462,0.0014241064,0.0005192125,0.0000059509134,0.000010495701,0.00000688443,0.0009515593],"genre_scores_gemma":[0.00057336345,0.997136,0.0002489137,0.00072096457,0.0006614823,0.000010460686,0.000019655694,0.000001055358,0.0006281212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996145,0.00011584399,0.000047694364,0.000040314488,0.00014623062,0.00003549709],"domain_scores_gemma":[0.999313,0.00030095872,0.00010234938,0.000023115756,0.00019545434,0.00006508305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011364862,0.0012048641,0.0024761457,0.0015556857,0.00029243456,0.0009919476,0.0015721396,0.0027679065,0.0072777006],"category_scores_gemma":[0.0012697938,0.00025215835,0.0008328993,0.0014384455,0.0007253941,0.0022578258,0.0005897077,0.0024778587,0.004610419],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001517861,0.00017932868,0.00019794148,0.016567534,0.0001223207,0.0008353365,0.000065358145,0.0005723439,0.0019251449,0.0042379815,0.08607234,0.8890726],"study_design_scores_gemma":[0.00010825726,0.00019138024,0.0009773558,0.00672878,0.0001318712,0.0024328437,0.000117736956,0.00022231025,0.00042645566,0.006135187,0.9824954,0.00003245244],"about_ca_topic_score_codex":0.0007603376,"about_ca_topic_score_gemma":0.0016109969,"teacher_disagreement_score":0.0072777006,"about_ca_system_score_codex":0.000960556,"about_ca_system_score_gemma":0.0011937546,"threshold_uncertainty_score":0.024346352},"labels":[],"label_agreement":null},{"id":"W2172641990","doi":"10.1517/14740338.2016.1120718","title":"The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Dosing; Fondaparinux; Warfarin; Intensive care medicine; Low molecular weight heparin; Population; Heparin; Venous thromboembolism; Thrombosis; Internal medicine","score_opus":0.16591350759852055,"score_gpt":0.4171466756494872,"score_spread":0.2512331680509666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172641990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006449535,0.99841034,0.000045462482,0.00092757394,0.00012467387,0.0000035845665,0.000016394175,0.0000017816975,0.00040575143],"genre_scores_gemma":[0.0008299254,0.9984326,0.00010066356,0.00038819975,0.00013785175,0.0000054766865,0.000013933131,5.8503855e-7,0.00009087026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990889,0.00028594697,0.00018947767,0.000090986105,0.00030220434,0.000042518197],"domain_scores_gemma":[0.99672794,0.0021813451,0.00053820293,0.00003946816,0.00045811146,0.000054778975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001352237,0.0005169664,0.0013423983,0.0013864647,0.0002064835,0.0011233103,0.000654183,0.0014344684,0.004519093],"category_scores_gemma":[0.005123953,0.00016698427,0.0011199318,0.0015377443,0.0004253105,0.000986323,0.00047040853,0.0014615274,0.00075364363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008265951,0.000035944184,0.0003234551,0.10492969,0.0004727059,0.00015684644,0.00011180367,0.00029163866,0.0004792009,0.0043902174,0.03605829,0.8526676],"study_design_scores_gemma":[0.00009756292,0.00016552514,0.0025871063,0.14719842,0.001673769,0.0023902452,0.00024124407,0.0002336809,0.0003423346,0.0064774263,0.838548,0.000044583212],"about_ca_topic_score_codex":0.0014192848,"about_ca_topic_score_gemma":0.002222986,"teacher_disagreement_score":0.004519093,"about_ca_system_score_codex":0.0007116473,"about_ca_system_score_gemma":0.0021268518,"threshold_uncertainty_score":0.015117884},"labels":[],"label_agreement":null},{"id":"W2304716045","doi":"10.1517/14740338.2015.1045875","title":"Safety evaluation of olaparib for treating ovarian cancer","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Olaparib; Tolerability; Oncology; Internal medicine; Nausea; Ovarian cancer; Cancer; Adverse effect","score_opus":0.18505262006867182,"score_gpt":0.4859453302992656,"score_spread":0.30089271023059383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304716045","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026687578,0.99796236,0.0000829794,0.0002637502,0.00011942619,0.000012166668,0.00003394427,0.0000033501312,0.001255264],"genre_scores_gemma":[0.0031873717,0.9953767,0.00018536359,0.00041339052,0.00016405538,0.000016070982,0.00007147377,0.0000017182872,0.0005839737],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995629,0.00010942896,0.00007569838,0.000054019743,0.00017761803,0.000020328545],"domain_scores_gemma":[0.9992519,0.00032562195,0.00019370537,0.000011552867,0.00019078303,0.000026406473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010474145,0.00045041562,0.0009945973,0.0013852754,0.00017849344,0.0006976417,0.0007388456,0.000922482,0.004117734],"category_scores_gemma":[0.0014163338,0.00016577239,0.0007383691,0.0011340275,0.00022719019,0.0005666961,0.00032878199,0.0008884689,0.0010617104],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016131865,0.000044524324,0.00019057425,0.033957385,0.00017905032,0.00017072215,0.000040539977,0.00025041628,0.0012814204,0.0012119825,0.016091093,0.94642097],"study_design_scores_gemma":[0.00019304136,0.0006247523,0.0024374907,0.023179814,0.0008380281,0.0032466343,0.0000979069,0.00030631336,0.002219964,0.001655616,0.96516323,0.00003728256],"about_ca_topic_score_codex":0.00074083806,"about_ca_topic_score_gemma":0.0014074127,"teacher_disagreement_score":0.004117734,"about_ca_system_score_codex":0.00045240793,"about_ca_system_score_gemma":0.0010572356,"threshold_uncertainty_score":0.01377517},"labels":[],"label_agreement":null},{"id":"W2327248001","doi":"10.1517/14740338.2011.579900","title":"Safe use of long-acting β-agonists: what have we learnt?","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Asthma; Adverse effect; Inhaled corticosteroids; Intensive care medicine; B2 receptor; Lung function; Bronchodilator Agents; Fluticasone propionate; Bronchodilator; Internal medicine; Lung","score_opus":0.12358159680523714,"score_gpt":0.38191590711522855,"score_spread":0.25833431030999143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327248001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000092826405,0.9915097,0.0001169298,0.0072034993,0.00070208113,0.000005909035,0.00003480014,0.0000060046996,0.0003282262],"genre_scores_gemma":[0.00072630955,0.99577904,0.00022126983,0.0022943357,0.00079765357,0.000010196065,0.00003105518,0.0000020307164,0.00013809127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816054,0.0005229243,0.00031030586,0.00024170586,0.0006566169,0.00010787398],"domain_scores_gemma":[0.98411393,0.010412346,0.001520328,0.00030080296,0.003259251,0.00039336178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006809321,0.0013430472,0.004467568,0.0018318989,0.00046482656,0.002782352,0.0019907297,0.004955565,0.007143624],"category_scores_gemma":[0.014914433,0.00060296385,0.0022478225,0.0028154803,0.0014317831,0.0066484837,0.0011258706,0.005102996,0.002515204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020867288,0.00007076564,0.00044659333,0.06984249,0.00052939367,0.00020115606,0.0001471379,0.00033215544,0.00031075565,0.003950706,0.042937037,0.88102305],"study_design_scores_gemma":[0.00026753175,0.0005428593,0.0037828689,0.1371431,0.0018528078,0.0020944776,0.00083850883,0.00042362,0.0005130375,0.017578322,0.83483857,0.00012436447],"about_ca_topic_score_codex":0.003128884,"about_ca_topic_score_gemma":0.004474126,"teacher_disagreement_score":0.007143624,"about_ca_system_score_codex":0.0014760274,"about_ca_system_score_gemma":0.00510619,"threshold_uncertainty_score":0.036011577},"labels":[],"label_agreement":null},{"id":"W2418356692","doi":"10.1080/14740338.2016.1199682","title":"Tiotropium for the treatment of asthma: a drug safety evaluation","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Anticholinergic; Salmeterol; Asthma; Bronchodilator; Tiotropium bromide; Clinical trial; Placebo; Intensive care medicine; Adverse effect; Anesthesia; Pharmacology; Internal medicine; Alternative medicine; Lung function; Lung","score_opus":0.060765193412633,"score_gpt":0.4019923326556875,"score_spread":0.34122713924305453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418356692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000091739894,0.99892247,0.000052008774,0.00031067187,0.00009317393,0.000015375215,0.0000194902,0.0000023411258,0.0004926899],"genre_scores_gemma":[0.0012638132,0.99780613,0.00016005085,0.00038876414,0.0001070706,0.000018588555,0.000029676537,9.666363e-7,0.00022504783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992874,0.00016456224,0.00012801157,0.000073504685,0.00031172516,0.00003470752],"domain_scores_gemma":[0.9984516,0.0008224728,0.00033958157,0.000024020192,0.0003150953,0.000047241472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017877895,0.00074977713,0.0021450683,0.0021708347,0.00027314265,0.00094938575,0.00079432,0.0014791833,0.004730104],"category_scores_gemma":[0.0024350237,0.0002512177,0.001545481,0.001637843,0.00037500844,0.00092047715,0.00049346953,0.001320467,0.0010155961],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019628847,0.00006571556,0.00018127699,0.11691613,0.0004721779,0.00018087876,0.00006686537,0.00021502511,0.0012121149,0.0018990745,0.018112812,0.8604817],"study_design_scores_gemma":[0.0003099454,0.0006173948,0.0025393534,0.112103246,0.002818348,0.0020850783,0.00014575473,0.00026541064,0.0010415241,0.0022230318,0.87580097,0.000050055336],"about_ca_topic_score_codex":0.0014628195,"about_ca_topic_score_gemma":0.003182423,"teacher_disagreement_score":0.004730104,"about_ca_system_score_codex":0.0007335138,"about_ca_system_score_gemma":0.001988322,"threshold_uncertainty_score":0.015823781},"labels":[],"label_agreement":null},{"id":"W2469735602","doi":"10.1080/14740338.2016.1207760","title":"A safety evaluation of omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Homoharringtonine; Myeloid leukemia; Adverse effect; Pharmacology; Tyrosine-kinase inhibitor; Oncology; Internal medicine; Intensive care medicine; Cancer","score_opus":0.07044490029049531,"score_gpt":0.39386546745387674,"score_spread":0.3234205671633814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469735602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004922423,0.9978695,0.0000623618,0.00029441188,0.0001446744,0.000017550596,0.000026680425,0.0000020352377,0.0010904907],"genre_scores_gemma":[0.005505318,0.9927901,0.00023256047,0.00055054226,0.00015884933,0.000024919858,0.000056497858,0.0000015050786,0.0006795794],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995726,0.00011750735,0.00008696751,0.000042963446,0.0001603602,0.000019553241],"domain_scores_gemma":[0.9993125,0.00030621473,0.00019622596,0.000011333128,0.00014541612,0.000028291417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010291561,0.00040328928,0.001087185,0.0011505553,0.00020131201,0.0006517932,0.00058235636,0.0010759255,0.0037676936],"category_scores_gemma":[0.0015767404,0.0001298731,0.00077526394,0.0011766416,0.00023236513,0.0006511543,0.0003142267,0.00076319196,0.00073767884],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003889028,0.00009976797,0.00021961486,0.093516275,0.00028058753,0.00053236,0.00010882812,0.00019175344,0.0034526733,0.002094301,0.013906155,0.88520885],"study_design_scores_gemma":[0.00039466252,0.0013796854,0.003163369,0.047400553,0.0016131703,0.005421743,0.00019112992,0.00023237927,0.0030159666,0.0014638796,0.9356794,0.00004402537],"about_ca_topic_score_codex":0.00067471404,"about_ca_topic_score_gemma":0.0014995999,"teacher_disagreement_score":0.0037676936,"about_ca_system_score_codex":0.00044600895,"about_ca_system_score_gemma":0.0013530807,"threshold_uncertainty_score":0.012604237},"labels":[],"label_agreement":null},{"id":"W2511950217","doi":"10.1080/14740338.2016.1223624","title":"Human pluripotent stem cell-derived cardiomyocyte based models for cardiotoxicity and drug discovery","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canada Foundation for Innovation","keywords":"Cardiotoxicity; Induced pluripotent stem cell; Medicine; Drug discovery; Stem cell; Drug; Pharmacology; Human Induced Pluripotent Stem Cells; Computational biology; Bioinformatics; Internal medicine; Embryonic stem cell; Cell biology; Biology; Toxicity","score_opus":0.02069101292525807,"score_gpt":0.277245622555107,"score_spread":0.25655460962984894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511950217","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4907301,0.06750599,0.3773259,0.0066049555,0.0018076594,0.0017281251,0.012336336,0.0011519482,0.040808965],"genre_scores_gemma":[0.80466956,0.053483758,0.09698829,0.0018465656,0.00033466448,0.00074618496,0.011725426,0.00010672506,0.030098742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994711,0.00009672904,0.00004402185,0.0000764085,0.00027089837,0.000040878866],"domain_scores_gemma":[0.9997278,0.000084347834,0.00005341163,0.000042962743,0.000060417082,0.000031078966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000987487,0.0007336529,0.000396118,0.00066902075,0.00024032507,0.0007203323,0.0006284323,0.00087302196,0.0052766465],"category_scores_gemma":[0.00031145354,0.00026915563,0.000506648,0.0003788092,0.00036673027,0.00044536954,0.00044259152,0.0011827045,0.0008902373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010306485,0.00007590211,0.00038763953,0.00024952675,0.000034781388,0.00014323938,0.00002625572,0.0006531447,0.98176044,0.002927458,0.0012155861,0.012422904],"study_design_scores_gemma":[0.00006310384,0.00065803167,0.0017483002,0.000056198776,0.00015718136,0.00053894904,0.00003334338,0.0029524365,0.95877105,0.0012607909,0.03374371,0.000016936952],"about_ca_topic_score_codex":0.00060920767,"about_ca_topic_score_gemma":0.0016825453,"teacher_disagreement_score":0.0052766465,"about_ca_system_score_codex":0.0005638887,"about_ca_system_score_gemma":0.00053742283,"threshold_uncertainty_score":0.017652154},"labels":[],"label_agreement":null},{"id":"W2521077651","doi":"10.1080/14740338.2016.1238071","title":"Proton pump inhibitors and risk of<i>Clostridium difficile</i>infection: a multi-country study using sequence symmetry analysis","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Health Canada","funders":"National Health and Medical Research Council","keywords":"Medicine; Clostridium difficile; Internal medicine; Population; Confidence interval; National health insurance; Demography; Proton-pump inhibitor; Environmental health; Microbiology","score_opus":0.04131997720681452,"score_gpt":0.3479490898163622,"score_spread":0.30662911260954767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521077651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737835,0.00059496396,0.0014308831,0.000037269263,0.000010119157,0.000042449938,0.00031129524,0.000006084799,0.00018852673],"genre_scores_gemma":[0.9987362,0.00017159965,0.00075546134,0.000024059555,0.000008971033,0.00001840568,0.00024185749,0.0000036670294,0.000039718827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99431086,0.003824359,0.0004610093,0.00075835735,0.00042834136,0.00021712274],"domain_scores_gemma":[0.9914597,0.0024644688,0.0039001391,0.0010355047,0.0006953154,0.00044477716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072396216,0.00061671814,0.0008736344,0.0012359493,0.00045071886,0.0007724429,0.00048383407,0.0005951548,0.0013371966],"category_scores_gemma":[0.00939805,0.0005283739,0.0027967095,0.0014444297,0.0003634672,0.00069007574,0.0011201057,0.0006310068,0.00022714859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084645813,0.000079296,0.993751,0.00006636672,0.0018720451,0.00008302719,0.000063564396,0.00028544804,0.00034530435,0.000021940466,0.00007027862,0.0025151898],"study_design_scores_gemma":[0.00012713754,0.00096939347,0.9942123,0.00003518043,0.001311099,0.00056051544,0.00020014003,0.00210196,0.00022515678,0.000051448907,0.00018702289,0.000018556366],"about_ca_topic_score_codex":0.0038953384,"about_ca_topic_score_gemma":0.0035665012,"teacher_disagreement_score":0.0072396216,"about_ca_system_score_codex":0.0003049629,"about_ca_system_score_gemma":0.00052390003,"threshold_uncertainty_score":0.038287282},"labels":[],"label_agreement":null},{"id":"W2550995488","doi":"10.1080/14740338.2016.1226280","title":"Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agenzia Italiana del Farmaco, Ministero della Salute; Partenariat Canadien Contre Le Cancer; Seconda Università degli Studi di Napoli; World Health Organization","keywords":"Medicine; Drug; Drug reaction; Adverse effect; Contrast (vision); Intensive care medicine; Pharmacology","score_opus":0.0293026674473134,"score_gpt":0.3483644938586854,"score_spread":0.319061826411372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550995488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5710444,0.045306854,0.09303866,0.084004216,0.0038758123,0.035024047,0.01625928,0.0027524664,0.14869435],"genre_scores_gemma":[0.79947233,0.010124575,0.14292507,0.00894298,0.00388838,0.011762166,0.013906159,0.00026027154,0.008718097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95445514,0.016678637,0.010125342,0.0025436275,0.014860022,0.0013371697],"domain_scores_gemma":[0.77773935,0.06265442,0.062434815,0.015984897,0.07650026,0.004686243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06704398,0.0007505482,0.0009539629,0.010714218,0.0015052374,0.0031303922,0.0028052106,0.0014776284,0.002460576],"category_scores_gemma":[0.120829925,0.00034876482,0.0011760583,0.004011217,0.0011365792,0.0018005987,0.0030986303,0.0014165121,0.0010286073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009804167,0.0005183973,0.5749253,0.0052336534,0.0003679565,0.0017848389,0.0033182444,0.0010372569,0.003369027,0.0045893085,0.06811167,0.3357639],"study_design_scores_gemma":[0.0002748848,0.0011186891,0.7925167,0.0055334964,0.0006178739,0.0044888505,0.0021295943,0.004949949,0.00768458,0.002407051,0.17812504,0.00015333196],"about_ca_topic_score_codex":0.010132319,"about_ca_topic_score_gemma":0.008946394,"teacher_disagreement_score":0.06704398,"about_ca_system_score_codex":0.00335371,"about_ca_system_score_gemma":0.020796832,"threshold_uncertainty_score":0.3545667},"labels":[],"label_agreement":null},{"id":"W2592568061","doi":"10.1080/14740338.2017.1300251","title":"The safety of vedolizumab for the treatment of ulcerative colitis","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Adverse effect; Internal medicine; Placebo; Population; Natalizumab; Oncology; Gastroenterology; Disease; Pathology","score_opus":0.049647231406416664,"score_gpt":0.37252849525481396,"score_spread":0.3228812638483973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592568061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041402117,0.93275374,0.0025513833,0.0419194,0.0047087027,0.00006136868,0.00037495446,0.00008249746,0.013407719],"genre_scores_gemma":[0.08984351,0.8476332,0.0028033154,0.03377158,0.01656928,0.00015345182,0.00087603903,0.000055633147,0.008293944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828535,0.0005562868,0.00018692194,0.00016568424,0.00071168493,0.00009405222],"domain_scores_gemma":[0.9962787,0.0013001718,0.00091680564,0.00008529898,0.001272892,0.00014607534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024247759,0.0003414599,0.00094247225,0.0003454496,0.00023527979,0.0011680478,0.00069263444,0.0019773035,0.0049200635],"category_scores_gemma":[0.005127498,0.00010803246,0.0007843419,0.0002943251,0.000481638,0.0007283877,0.00032693098,0.0022245084,0.002235093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008190111,0.000050390317,0.00085862976,0.0077810837,0.00029178383,0.0004348246,0.00006173833,0.0003895725,0.006608571,0.004176311,0.10786142,0.8706668],"study_design_scores_gemma":[0.0005623937,0.0015524501,0.00506354,0.008178076,0.0005825887,0.0032855312,0.00007789548,0.0007009737,0.0047499537,0.0062584453,0.9689389,0.000049230493],"about_ca_topic_score_codex":0.0006263186,"about_ca_topic_score_gemma":0.0009668648,"teacher_disagreement_score":0.0049200635,"about_ca_system_score_codex":0.00085401104,"about_ca_system_score_gemma":0.00092438026,"threshold_uncertainty_score":0.016459286},"labels":[],"label_agreement":null},{"id":"W2729777670","doi":"10.1080/14740338.2017.1351540","title":"Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Rivastigmine; Medicine; Galantamine; Donepezil; Tolerability; Discontinuation; Adverse effect; Pharmacovigilance; Dementia; Pharmacology; Drug; Intensive care medicine; Cognitive decline; Disease; Psychiatry; Internal medicine","score_opus":0.14198100075957254,"score_gpt":0.4582685492821365,"score_spread":0.31628754852256397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729777670","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014531858,0.9977387,0.000092362185,0.00037622382,0.00016418472,0.000020624322,0.00005994449,0.0000061963133,0.001396468],"genre_scores_gemma":[0.0013610118,0.9972434,0.00022200686,0.00036882257,0.00013101553,0.000021368473,0.00008849977,0.0000018868358,0.0005620313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995394,0.00010569054,0.00009905734,0.000047468347,0.0001824938,0.000025909798],"domain_scores_gemma":[0.9989791,0.00044546637,0.00023621363,0.000018182505,0.00028331098,0.00003772608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012888513,0.0006711608,0.0015013217,0.0015136055,0.00017752986,0.00082722655,0.0008888402,0.0012205865,0.006857251],"category_scores_gemma":[0.0019089853,0.00017872608,0.0012873177,0.0013628496,0.00020694312,0.00081367587,0.00040924604,0.0012113664,0.0017659401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014664042,0.00004479011,0.00011353669,0.06657313,0.00029713963,0.00012631806,0.00004801613,0.00019059367,0.0008823668,0.0017218259,0.029952984,0.89990264],"study_design_scores_gemma":[0.0002080899,0.00031792728,0.0015355261,0.07082412,0.001431209,0.0016658016,0.00007866261,0.00019113786,0.00077522575,0.0016802986,0.92126226,0.000029717537],"about_ca_topic_score_codex":0.0010337288,"about_ca_topic_score_gemma":0.0025439153,"teacher_disagreement_score":0.006857251,"about_ca_system_score_codex":0.00051453785,"about_ca_system_score_gemma":0.0013815956,"threshold_uncertainty_score":0.022939801},"labels":[],"label_agreement":null},{"id":"W2735238612","doi":"10.1080/14740338.2017.1351541","title":"Breast cancer treatment-induced cardiotoxicity","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Hôpital Charles-Le Moyne; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Medicine; Cardiotoxicity; Breast cancer; Cancer; Oncology; Internal medicine; Intensive care medicine; Chemotherapy","score_opus":0.12144268613943457,"score_gpt":0.4237113256021117,"score_spread":0.3022686394626771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735238612","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015807546,0.9972663,0.00010323362,0.0005705143,0.000248173,0.000009600566,0.00006116624,0.00000794458,0.0015750019],"genre_scores_gemma":[0.0017762448,0.99671257,0.00011647104,0.0004964653,0.0002266097,0.000007774638,0.00006432259,0.0000018913356,0.00059773837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996119,0.00009690611,0.0000594201,0.000055959346,0.00015005477,0.000025728967],"domain_scores_gemma":[0.99941754,0.00029811435,0.00013330184,0.000013316633,0.00011817797,0.00001956569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050843315,0.00048126696,0.0009601726,0.0009368048,0.00017712575,0.0008388822,0.00047988468,0.00087688275,0.0065843766],"category_scores_gemma":[0.001282085,0.0001283574,0.0007157974,0.0008869709,0.00030530934,0.0005273648,0.00041164848,0.0009907325,0.0014811003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084317144,0.00003042651,0.00023580284,0.05398826,0.00024935717,0.0002150815,0.000060598468,0.00026228905,0.0012973939,0.0025411274,0.049497373,0.89153796],"study_design_scores_gemma":[0.00003352905,0.000107910935,0.0012337132,0.022094905,0.00041170057,0.0024333776,0.00007052273,0.00008423143,0.00076121156,0.0019073132,0.9708453,0.000016360373],"about_ca_topic_score_codex":0.0008142739,"about_ca_topic_score_gemma":0.0014807393,"teacher_disagreement_score":0.0065843766,"about_ca_system_score_codex":0.0004789791,"about_ca_system_score_gemma":0.00096302055,"threshold_uncertainty_score":0.022026956},"labels":[],"label_agreement":null},{"id":"W2766516861","doi":"10.1080/14740338.2018.1397625","title":"A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut Universitaire de Gériatrie de Montréal; Dalhousie University","funders":"","keywords":"Deprescribing; Medicine; Discontinuation; Polypharmacy; Adverse drug event; Harm; Patient safety; Adverse effect; Continuation; Drug; Narrative review; Beers Criteria; Intensive care medicine; Medical emergency; Psychiatry; Health care; Pharmacology; Psychology; Social psychology","score_opus":0.15349776963131986,"score_gpt":0.47612439269213896,"score_spread":0.32262662306081913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766516861","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010763592,0.998221,0.00009197304,0.00064947264,0.00016554215,0.000025008743,0.000054982705,0.0000035952144,0.00068079977],"genre_scores_gemma":[0.0011871363,0.99769187,0.00020256013,0.00052411336,0.00012203752,0.000035184203,0.000042186304,0.0000012738626,0.00019370254],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99831843,0.0005609152,0.00045957862,0.00013911499,0.0004641719,0.000057799003],"domain_scores_gemma":[0.99324,0.004968201,0.001033031,0.000071448194,0.00060634606,0.0000808891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002141442,0.0009485693,0.0014234369,0.002893594,0.0004157848,0.0014933854,0.00092415133,0.0015632965,0.0053908103],"category_scores_gemma":[0.0120611405,0.00029617615,0.0018271838,0.0029562314,0.00046116102,0.0014893089,0.00079445855,0.0013465823,0.00067251176],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009777019,0.000031974087,0.00031971757,0.416878,0.0006504441,0.00035682807,0.00055545574,0.0002322703,0.0002992541,0.0035695282,0.040439233,0.5365695],"study_design_scores_gemma":[0.000041318253,0.00009741042,0.0016135137,0.43298855,0.0022706464,0.0016519856,0.0003572,0.00009194925,0.00020408475,0.0018842184,0.5587685,0.00003058798],"about_ca_topic_score_codex":0.0028076796,"about_ca_topic_score_gemma":0.0061850976,"teacher_disagreement_score":0.0053908103,"about_ca_system_score_codex":0.0012389643,"about_ca_system_score_gemma":0.0047987862,"threshold_uncertainty_score":0.0180341},"labels":[],"label_agreement":null},{"id":"W2979546650","doi":"10.1080/14740338.2019.1675634","title":"A drug safety review of treating eosinophilic asthma with monoclonal antibodies","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Expert opinion; Asthma; Adverse effect; Nice; Clinical trial; Intensive care medicine; European commission; Eosinophilic; European union; Immunology; Pharmacology; Pathology","score_opus":0.035632735430708364,"score_gpt":0.35501349510202185,"score_spread":0.31938075967131346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979546650","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006313986,0.99813086,0.000066088345,0.00050084334,0.00037827814,0.000009834994,0.000032810054,0.0000038641056,0.0008142637],"genre_scores_gemma":[0.00046712707,0.9980216,0.00012227034,0.0006166183,0.0002502325,0.000010130948,0.00004438714,0.0000010626567,0.00046658434],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994843,0.00011550382,0.00010164502,0.000067133675,0.000202508,0.000028791042],"domain_scores_gemma":[0.99893886,0.0005679817,0.00020799783,0.00001473894,0.00023550795,0.000034801124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009579267,0.0007647991,0.0014132834,0.0026323122,0.00026176122,0.00094950746,0.0008339361,0.0013929384,0.0058362572],"category_scores_gemma":[0.001817835,0.0002748003,0.000985719,0.0025988286,0.00029537504,0.0011195121,0.00052066887,0.001429544,0.001747845],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105869534,0.00004906273,0.00009390869,0.12681544,0.00023576582,0.00023531163,0.000089305366,0.00024150145,0.0013122638,0.0031547793,0.078617096,0.78904974],"study_design_scores_gemma":[0.000032164924,0.0001343954,0.000532399,0.03983594,0.00044751304,0.00089097954,0.000051066618,0.00006978395,0.0002993511,0.0010719203,0.9566195,0.000014885402],"about_ca_topic_score_codex":0.0013693736,"about_ca_topic_score_gemma":0.0025911543,"teacher_disagreement_score":0.0058362572,"about_ca_system_score_codex":0.00063388015,"about_ca_system_score_gemma":0.0016803265,"threshold_uncertainty_score":0.019524217},"labels":[],"label_agreement":null},{"id":"W2989937144","doi":"10.1080/14740338.2020.1698545","title":"The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; McMaster University; University of Toronto; Centre for Addiction and Mental Health","funders":"National Research Foundation of Korea; Lundbeckfonden","keywords":"Clozapine; Medicine; Pharmacology; Internal medicine; Intensive care medicine; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.07745435242841285,"score_gpt":0.45906443011764303,"score_spread":0.38161007768923016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989937144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013583254,0.9989261,0.000044784527,0.00047288992,0.00009910927,0.000011292353,0.0000614808,0.0000029572423,0.00024547914],"genre_scores_gemma":[0.0020575179,0.9970667,0.00014356537,0.00043558588,0.000121072204,0.000023281826,0.00005972853,0.0000018481475,0.000090732865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887305,0.00034266856,0.00035601086,0.00013461085,0.00024806324,0.000045582427],"domain_scores_gemma":[0.99417686,0.004176181,0.00090353284,0.00006245719,0.0006080471,0.00007287814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025480653,0.00083674025,0.0017435523,0.002849789,0.00025574418,0.0015036431,0.0009886388,0.0009894765,0.0036649932],"category_scores_gemma":[0.010037044,0.00028112237,0.0016331325,0.0027417606,0.00044045757,0.0011422645,0.0006545921,0.0010942698,0.00049180316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002827098,0.000029109111,0.0004256181,0.44699597,0.001086142,0.00018098994,0.00030148536,0.00026162693,0.00037492363,0.0028788808,0.027203262,0.5199793],"study_design_scores_gemma":[0.00012733554,0.00024539305,0.0040233308,0.540198,0.0073023494,0.0016759819,0.00040687947,0.00025730292,0.00037821944,0.0026581653,0.44266713,0.000059857215],"about_ca_topic_score_codex":0.003051162,"about_ca_topic_score_gemma":0.007127014,"teacher_disagreement_score":0.0036649932,"about_ca_system_score_codex":0.0012029908,"about_ca_system_score_gemma":0.0038290117,"threshold_uncertainty_score":0.0134756565},"labels":[],"label_agreement":null},{"id":"W3011295729","doi":"10.1080/14740338.2020.1744562","title":"An update on the safety of apremilast for the treatment of plaque psoriasis","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Apremilast; Medicine; Psoriasis; Adverse effect; Dermatology; Thalidomide; Drug; Intensive care medicine; Pharmacology; Psoriatic arthritis; Internal medicine","score_opus":0.036359056662185425,"score_gpt":0.33205896088783493,"score_spread":0.2956999042256495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011295729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001646415,0.9964933,0.0001351012,0.0008091776,0.00064200425,0.000011863858,0.000076172924,0.000009385853,0.0016583181],"genre_scores_gemma":[0.0011066194,0.9961661,0.0002915851,0.0010035009,0.0005000741,0.000015159347,0.00011587101,0.0000033242409,0.00079782814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995154,0.00011111323,0.00010849221,0.0000527999,0.00018696282,0.000025144504],"domain_scores_gemma":[0.9988967,0.00057399203,0.00015995755,0.000017377613,0.00030940727,0.000042617183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009892267,0.000507474,0.001208879,0.0016104017,0.00022483915,0.000896574,0.00084829004,0.0012636249,0.006344261],"category_scores_gemma":[0.0019969882,0.00022697475,0.0009453817,0.0012646423,0.0002632634,0.0010450806,0.00039501613,0.0016656409,0.0020521297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013481943,0.000049023027,0.00013235638,0.035938464,0.00017654157,0.00022913402,0.000063777305,0.0001465858,0.0012830548,0.0015182405,0.06065756,0.8996703],"study_design_scores_gemma":[0.00004666435,0.00015272631,0.0008133147,0.011455425,0.00042608893,0.0014053266,0.000041423704,0.000076051634,0.00035719734,0.0007783899,0.98442924,0.000018297182],"about_ca_topic_score_codex":0.0010511236,"about_ca_topic_score_gemma":0.0022686233,"teacher_disagreement_score":0.006344261,"about_ca_system_score_codex":0.00052074925,"about_ca_system_score_gemma":0.0011589113,"threshold_uncertainty_score":0.021223664},"labels":[],"label_agreement":null},{"id":"W3034357715","doi":"10.1080/14740338.2020.1776699","title":"Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence","year":2020,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Tolerability; Ketamine; Medicine; Adverse effect; Nausea; Anesthesia; Blood pressure; Dissociative; Psychiatry; Internal medicine","score_opus":0.01756774449392825,"score_gpt":0.25818466346288543,"score_spread":0.24061691896895718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034357715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77202404,0.17184451,0.0008669199,0.009711922,0.0003867146,0.0012329131,0.018990386,0.00009791141,0.024844602],"genre_scores_gemma":[0.91326845,0.068717085,0.0018326803,0.0035595957,0.00025280073,0.000257923,0.01076899,0.00003422813,0.0013081647],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9960443,0.00064232916,0.000371875,0.00025507118,0.0023652404,0.00032116962],"domain_scores_gemma":[0.9862453,0.0016843949,0.003757055,0.0001833056,0.007298705,0.0008312782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045023467,0.00023262006,0.00060161366,0.00033273493,0.00037891557,0.00074422255,0.00070962845,0.00038545037,0.0012358057],"category_scores_gemma":[0.014044869,0.00010613446,0.0004894506,0.0009451088,0.00037075204,0.00019454287,0.00026625083,0.00040602466,0.00021411628],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012211618,0.0005044474,0.33234236,0.005289024,0.0014012707,0.00021448357,0.00070535956,0.0009174241,0.0021036046,0.00032416167,0.054689977,0.5892964],"study_design_scores_gemma":[0.0016425967,0.0024736966,0.9751701,0.0018037083,0.0007782418,0.00018060648,0.00031204452,0.00036070505,0.000507893,0.00005959787,0.016670268,0.000040535684],"about_ca_topic_score_codex":0.44945267,"about_ca_topic_score_gemma":0.6471099,"teacher_disagreement_score":0.55054736,"about_ca_system_score_codex":0.006240393,"about_ca_system_score_gemma":0.014145656,"threshold_uncertainty_score":0.8936731},"labels":[],"label_agreement":null},{"id":"W3130785468","doi":"10.1080/14740338.2021.1889513","title":"A safety review of approved intrathecal analgesics for chronic pain management","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Chronic pain; Adverse effect; Discontinuation; Opioid; Morphine; Analgesic; Anesthesia; Intensive care medicine; Pharmacology; Internal medicine; Physical therapy","score_opus":0.04108772081446854,"score_gpt":0.36668461784210266,"score_spread":0.3255968970276341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130785468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012989053,0.99779344,0.00010488143,0.00038213865,0.00021222526,0.000022661012,0.00007949185,0.000005765102,0.0012694461],"genre_scores_gemma":[0.00094800943,0.99786586,0.00019562093,0.00039791976,0.00010912759,0.00002127628,0.00006919789,0.0000015873443,0.0003914996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99940276,0.0001484139,0.00013115481,0.000070792805,0.00021643081,0.000030329884],"domain_scores_gemma":[0.9985697,0.0007373421,0.0002716561,0.000023813525,0.0003608175,0.000036640988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010354207,0.0006327309,0.0013131803,0.0022929735,0.0002990282,0.00080452085,0.00088918227,0.0011084471,0.008167628],"category_scores_gemma":[0.0025200932,0.00024009055,0.0011711657,0.0022408767,0.00026114698,0.00077944185,0.00039867725,0.0009733137,0.0016440793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010768111,0.000048214857,0.00012908725,0.12222097,0.00029317383,0.00014368951,0.00007753279,0.0001800233,0.0009889301,0.0019060991,0.0369067,0.83699787],"study_design_scores_gemma":[0.00007029374,0.0001964309,0.0012198702,0.06910644,0.0011248592,0.0009902683,0.00007824018,0.000116154704,0.00044754456,0.0010663825,0.92555946,0.000024117086],"about_ca_topic_score_codex":0.0014287505,"about_ca_topic_score_gemma":0.0032656733,"teacher_disagreement_score":0.008167628,"about_ca_system_score_codex":0.00052661257,"about_ca_system_score_gemma":0.0019800975,"threshold_uncertainty_score":0.027323425},"labels":[],"label_agreement":null},{"id":"W3160031138","doi":"10.1080/14740338.2021.1912010","title":"Newer formulations of intravenous iron: a review of their chemistry and key safety aspects – hypersensitivity, hypophosphatemia, and cardiovascular safety","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Hypophosphatemia; Ferumoxytol; Intravenous iron; Iron deficiency; Safety profile; Anemia; Adverse effect; Intensive care medicine; Internal medicine","score_opus":0.0212790669287603,"score_gpt":0.29322410819075895,"score_spread":0.27194504126199864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160031138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001431727,0.99764687,0.00017504953,0.0008306919,0.00033348257,0.000008353439,0.00001977392,0.0000060092098,0.0008367074],"genre_scores_gemma":[0.00084600574,0.99708813,0.00024914043,0.00066417875,0.000551146,0.000011392462,0.00003536796,0.0000020520995,0.0005526146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970883,0.000066220404,0.000049527316,0.00003874149,0.000117276715,0.000019340427],"domain_scores_gemma":[0.99933004,0.0003845479,0.00009936952,0.000012177963,0.00014662382,0.000027302392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069443154,0.00057797297,0.00080912764,0.0014180634,0.00017766008,0.0007418975,0.0005892242,0.0009732122,0.003597325],"category_scores_gemma":[0.001171943,0.00021778703,0.0005271175,0.0009908245,0.00034145633,0.0010994594,0.00035868294,0.0016814796,0.0015131177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104142986,0.00007085543,0.0001591487,0.023981174,0.000096261145,0.00023530639,0.00008575813,0.00028784733,0.0018330084,0.0033092455,0.05818188,0.91165537],"study_design_scores_gemma":[0.000024419624,0.00015425627,0.0005126426,0.0051181167,0.0001066992,0.0013314581,0.000042401065,0.00011503524,0.00040483603,0.0014826882,0.99069136,0.000016030795],"about_ca_topic_score_codex":0.00074654917,"about_ca_topic_score_gemma":0.0012132273,"teacher_disagreement_score":0.003597325,"about_ca_system_score_codex":0.0004171416,"about_ca_system_score_gemma":0.00065407355,"threshold_uncertainty_score":0.012034237},"labels":[],"label_agreement":null},{"id":"W3169367773","doi":"10.1080/14740338.2021.1919620","title":"A drug safety evaluation of enzalutamide to treat advanced prostate cancer","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Medicine; Prostate cancer; Oncology; Clinical trial; Cancer; Internal medicine; Androgen receptor","score_opus":0.08988337752740705,"score_gpt":0.46237497673581374,"score_spread":0.3724915992084067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169367773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014932212,0.9982455,0.00006522685,0.00031654115,0.00016461343,0.000011886646,0.000038829454,0.0000040500095,0.0010040173],"genre_scores_gemma":[0.0019571877,0.9966174,0.0001448712,0.00055235403,0.00011832436,0.000016044429,0.00005982706,0.0000016806075,0.00053236395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960035,0.000117304364,0.00007043019,0.00005058225,0.00013848406,0.000022875345],"domain_scores_gemma":[0.9991335,0.00045654684,0.00017607123,0.000014257017,0.00018984101,0.000029833887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000985128,0.0005445007,0.0012558564,0.0014339301,0.00018807178,0.00087589154,0.0007530047,0.0011602439,0.0056274626],"category_scores_gemma":[0.0019120804,0.00016630387,0.0010070979,0.0014235908,0.000265827,0.00068859034,0.00036416523,0.0011853758,0.0010522883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021907705,0.00004902546,0.00012594461,0.0811018,0.00035600158,0.00013386241,0.000048401645,0.00025509612,0.001064876,0.0021152478,0.028218571,0.88631207],"study_design_scores_gemma":[0.00020596788,0.0004503603,0.0013434719,0.050445564,0.0016130544,0.0012545731,0.00007650106,0.00022090974,0.00095398934,0.0018802603,0.94152695,0.000028350214],"about_ca_topic_score_codex":0.0017271412,"about_ca_topic_score_gemma":0.0035219004,"teacher_disagreement_score":0.0056274626,"about_ca_system_score_codex":0.00059577887,"about_ca_system_score_gemma":0.0015604226,"threshold_uncertainty_score":0.01882571},"labels":[],"label_agreement":null},{"id":"W3181815039","doi":"10.1080/14740338.2021.1950138","title":"A systematic review on pediatric medication errors by parents or caregivers at home","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Innovation and Advanced Education","keywords":"Medicine; Medical prescription; Scopus; Dosing; MEDLINE; Pediatric hospital; Intervention (counseling); Family medicine; Pediatrics; Intensive care medicine; Medical emergency; Nursing; Pharmacology","score_opus":0.09589084297413045,"score_gpt":0.4528886906321413,"score_spread":0.3569978476580109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181815039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005072594,0.9983333,0.0000750146,0.00020244018,0.000099983656,0.00012238647,0.00033631333,0.0000043565115,0.0003189466],"genre_scores_gemma":[0.0053639463,0.99365133,0.00020914993,0.0002883053,0.000058556467,0.00016858529,0.00015839918,0.0000022328277,0.000099544945],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937597,0.0020024045,0.0020936443,0.0004752167,0.0015025426,0.00016649008],"domain_scores_gemma":[0.97505003,0.017359292,0.005245205,0.00028016072,0.0018891814,0.00017614111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046240413,0.001063325,0.004561515,0.007293585,0.00046056174,0.0016701618,0.0013810634,0.0013885425,0.0070701493],"category_scores_gemma":[0.032180723,0.00061727915,0.0037118332,0.010628492,0.00052602915,0.0018613479,0.0009549909,0.0008768239,0.0004737423],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009792885,0.000012462635,0.0008228254,0.93433154,0.003014707,0.00014057712,0.00024139539,0.000056988847,0.00006358923,0.00015247079,0.0032460215,0.057819437],"study_design_scores_gemma":[0.00010767967,0.000086822845,0.004231739,0.94615006,0.019190969,0.00044712887,0.00023469863,0.000040871488,0.00008563973,0.00013966356,0.029266639,0.000018116509],"about_ca_topic_score_codex":0.00869913,"about_ca_topic_score_gemma":0.021252545,"teacher_disagreement_score":0.00869913,"about_ca_system_score_codex":0.0024125162,"about_ca_system_score_gemma":0.008167524,"threshold_uncertainty_score":0.024454534},"labels":[],"label_agreement":null},{"id":"W3185792067","doi":"10.1080/14740338.2021.1962283","title":"Evaluating safety in hyaluronic acid lip injections","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Canadian Institute of Mining, Metallurgy and Petroleum; McGill University Health Centre","funders":"","keywords":"Medicine; Soft tissue; Filler (materials); Narrative review; Clinical trial; Adverse effect; Intensive care medicine; Randomized controlled trial; Patient safety; Surgery; Dentistry; Pathology; Health care; Internal medicine","score_opus":0.13835687824297893,"score_gpt":0.4747249426467594,"score_spread":0.3363680644037805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185792067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021460956,0.9985291,0.00008501773,0.00027837243,0.00012676584,0.000017064707,0.000041985204,0.000002816511,0.0007043823],"genre_scores_gemma":[0.0033951378,0.9955531,0.00023110394,0.00029348148,0.0001415653,0.000020034617,0.000052250143,0.0000015580769,0.00031171838],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987839,0.00035089592,0.0002767497,0.00010895073,0.0004416437,0.000037958755],"domain_scores_gemma":[0.9961957,0.002323709,0.00083155633,0.000041053114,0.0005651356,0.000042899064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021559997,0.00053182995,0.0015963742,0.0019336712,0.00013392017,0.0010798542,0.00068899995,0.0009784409,0.0057694567],"category_scores_gemma":[0.0051499493,0.0001720135,0.0012528527,0.0015856314,0.00033937022,0.0008681456,0.00042863912,0.0008354655,0.0007278267],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002222717,0.000042957836,0.00031270485,0.11287752,0.00054208457,0.000093235816,0.00006150246,0.00016074852,0.00066493015,0.0012244121,0.00965607,0.8741414],"study_design_scores_gemma":[0.00029517227,0.0009907869,0.0066553922,0.21867365,0.0059752725,0.0025016903,0.00029897055,0.00044538197,0.0031126293,0.0029828465,0.7579858,0.00008246379],"about_ca_topic_score_codex":0.0012232617,"about_ca_topic_score_gemma":0.00203605,"teacher_disagreement_score":0.0057694567,"about_ca_system_score_codex":0.0005752268,"about_ca_system_score_gemma":0.001663525,"threshold_uncertainty_score":0.019300759},"labels":[],"label_agreement":null},{"id":"W4214898817","doi":"10.1080/14740338.2022.2047928","title":"Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; British Columbia Centre on Substance Use; University of Calgary","funders":"National Institute on Drug Abuse; National Institutes of Health","keywords":"Medicine; Ketamine; Placebo; Depression (economics); Adverse effect; Meta-analysis; Internal medicine; Confidence interval; Relative risk; Randomized controlled trial; Major depressive disorder; Anesthesia","score_opus":0.09425174148257835,"score_gpt":0.39450474612543573,"score_spread":0.30025300464285737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214898817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025307073,0.9959616,0.00033188774,0.00017793172,0.00010232289,0.00033133966,0.00035574858,0.000020123742,0.00018828461],"genre_scores_gemma":[0.08937234,0.90501845,0.002008609,0.001015473,0.00019639415,0.0014343961,0.00065495225,0.00002608173,0.00027333223],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98809284,0.0052265488,0.004028979,0.0009590216,0.0013607871,0.0003317351],"domain_scores_gemma":[0.9762856,0.016700866,0.004422272,0.00049733435,0.0018133501,0.00028056657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015282181,0.0027919565,0.021249887,0.0066124634,0.00071635493,0.0036606533,0.0022786453,0.0025020132,0.0037155924],"category_scores_gemma":[0.04243457,0.0015288652,0.0357893,0.0071305074,0.0009776219,0.00205607,0.0016907912,0.0019660925,0.00031701697],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016196639,0.00002259823,0.0018024434,0.61310613,0.37031668,0.00009324335,0.00008163703,0.00029795474,0.00017783142,0.00010919638,0.0006176923,0.01175497],"study_design_scores_gemma":[0.0007348914,0.00021099897,0.0023902468,0.056098104,0.9382609,0.00011262812,0.000044804343,0.00012453643,0.0001177788,0.00015774288,0.0017260078,0.000021384203],"about_ca_topic_score_codex":0.006583494,"about_ca_topic_score_gemma":0.017744567,"teacher_disagreement_score":0.021249887,"about_ca_system_score_codex":0.003382468,"about_ca_system_score_gemma":0.0050164755,"threshold_uncertainty_score":0.08082086},"labels":[],"label_agreement":null},{"id":"W4223456429","doi":"10.1080/14740338.2022.2063274","title":"Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?","year":2022,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Higher Education Funding Council for England","keywords":"Medicine; Serotonergic; Psychiatry; Pharmacology; Serotonin; Internal medicine","score_opus":0.05152653116104238,"score_gpt":0.3701219538538488,"score_spread":0.3185954226928064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223456429","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045548757,0.028310327,0.0001033838,0.06577749,0.90420896,0.00002669723,0.000052946536,0.000033988996,0.0014406266],"genre_scores_gemma":[0.0004081011,0.01562155,0.00011579632,0.047308344,0.9329163,0.00002545105,0.00002493,0.000015903912,0.00356358],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954034,0.001080583,0.0007830991,0.0005070989,0.0019016529,0.0003242154],"domain_scores_gemma":[0.9735039,0.013799118,0.001957032,0.0007574348,0.007738699,0.002243746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010863573,0.0026775415,0.0038371722,0.0033145957,0.0024569083,0.0060251122,0.003525405,0.022878911,0.010875012],"category_scores_gemma":[0.03212027,0.0011834308,0.0029959308,0.0014876492,0.002450989,0.004740833,0.0016550857,0.021002106,0.006593072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006711861,0.00001733999,0.0000322723,0.0007035658,0.00005143597,0.00008750538,0.00001344912,0.000014969862,0.000057601595,0.0003582352,0.98544216,0.013154254],"study_design_scores_gemma":[0.00026860365,0.000066398774,0.00043656505,0.001668117,0.00023988409,0.0002698934,0.000051534676,0.0001317687,0.00009517583,0.0018626715,0.9948797,0.000029573252],"about_ca_topic_score_codex":0.0023570624,"about_ca_topic_score_gemma":0.0073557044,"teacher_disagreement_score":0.022878911,"about_ca_system_score_codex":0.0037048582,"about_ca_system_score_gemma":0.004062828,"threshold_uncertainty_score":0.05745274},"labels":[],"label_agreement":null},{"id":"W4226209427","doi":"10.1080/14740338.2022.2058488","title":"The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Medicine; Major depressive disorder; Treatment-resistant depression; Depression (economics); Placebo; Suicidal ideation; Internal medicine; Meta-analysis; Adjunctive treatment; Randomized controlled trial; Anesthesia; Poison control; Injury prevention; Emergency medicine","score_opus":0.05097786294773289,"score_gpt":0.3585261489271402,"score_spread":0.3075482859794073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226209427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033374315,0.99516475,0.00035311066,0.0001447452,0.00009990195,0.0003073434,0.00039372698,0.000020284897,0.00017872077],"genre_scores_gemma":[0.11113577,0.88414216,0.0018936566,0.00062642136,0.00017113422,0.0010881643,0.0006980555,0.000018903085,0.00022576711],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931235,0.003016995,0.0021037066,0.00070417474,0.00085504504,0.00019665397],"domain_scores_gemma":[0.98594487,0.009883774,0.0024578152,0.0003886163,0.0011140261,0.00021094011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010514159,0.00244054,0.01862278,0.0065547787,0.00062078045,0.0030308086,0.0021993082,0.0021398214,0.0031811781],"category_scores_gemma":[0.025622718,0.001410335,0.030743761,0.0066530267,0.00077252305,0.0015913683,0.00132014,0.0014755523,0.00024655892],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016001312,0.000031001855,0.0016394539,0.5915571,0.38953263,0.00009295046,0.00007658383,0.00036855013,0.0002201848,0.0001076821,0.0004575171,0.014316196],"study_design_scores_gemma":[0.00052602094,0.00024342732,0.0023062092,0.04260236,0.9521351,0.000086003456,0.00004592646,0.00015389285,0.00012721255,0.00015238191,0.0015985371,0.000022918894],"about_ca_topic_score_codex":0.0064681484,"about_ca_topic_score_gemma":0.013208371,"teacher_disagreement_score":0.01862278,"about_ca_system_score_codex":0.0028539386,"about_ca_system_score_gemma":0.004433039,"threshold_uncertainty_score":0.055604815},"labels":[],"label_agreement":null},{"id":"W4245658224","doi":"10.1517/eods.2.2.161.21387","title":"Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Menstrual Health and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Dysphoria; Serotonin; Psychiatry; Pharmacology; Internal medicine; Receptor; Anxiety","score_opus":0.02238667350330823,"score_gpt":0.31324809314630525,"score_spread":0.290861419642997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245658224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13674836,0.7746654,0.012057278,0.038772702,0.0010488885,0.0003442666,0.0001470972,0.00015693788,0.03605897],"genre_scores_gemma":[0.6159536,0.34766504,0.0075883865,0.011229469,0.00623019,0.0001731854,0.00015770183,0.000042727053,0.01095975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995577,0.00020715264,0.00003479838,0.000034569155,0.00013001326,0.000035843743],"domain_scores_gemma":[0.99903935,0.0004839832,0.00024161134,0.000038922943,0.0001424875,0.00005362966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011364184,0.0002865037,0.0010134261,0.00025132333,0.00017982026,0.00035495017,0.00035561723,0.0010404885,0.0022335493],"category_scores_gemma":[0.0014958299,0.00007853586,0.00028911151,0.00016535215,0.0003109189,0.00047750052,0.0002140924,0.00079098705,0.0005056739],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013617836,0.00031857705,0.0021633613,0.002792001,0.00010281533,0.0019800442,0.00024570606,0.00038413837,0.033622187,0.0025019355,0.00835025,0.9461772],"study_design_scores_gemma":[0.0054317764,0.035089597,0.10911094,0.004603518,0.0008510189,0.06627824,0.0011548771,0.003097856,0.083829686,0.014650992,0.6757648,0.00013676727],"about_ca_topic_score_codex":0.0001667569,"about_ca_topic_score_gemma":0.00045703223,"teacher_disagreement_score":0.0022335493,"about_ca_system_score_codex":0.00027654786,"about_ca_system_score_gemma":0.00024821376,"threshold_uncertainty_score":0.007471919},"labels":[],"label_agreement":null},{"id":"W4251134584","doi":"10.1517/eods.3.1.25.25270","title":"The safety of antihypertensives for treatment of pregnancy hypertension","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre","funders":"","keywords":"Medicine; Pregnancy; Observational study; Hypertension in Pregnancy; Drugs in pregnancy; Ambulatory; Intensive care medicine; Ambulatory blood pressure; Blood pressure; Antihypertensive drug; Pharmacotherapy; Drug; Fetus; Obstetrics; Preeclampsia; Internal medicine; Pharmacology","score_opus":0.04079530696978833,"score_gpt":0.309136369948734,"score_spread":0.26834106297894567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251134584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033143777,0.990831,0.00034977673,0.0021530702,0.0003362003,0.00001529367,0.00006439869,0.000004151828,0.0029317674],"genre_scores_gemma":[0.043551132,0.9504626,0.0010315331,0.0024215512,0.0015822658,0.000043606564,0.000092962066,0.000005239127,0.0008091683],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99446565,0.0023476684,0.0009767018,0.00025459213,0.001877797,0.000077565244],"domain_scores_gemma":[0.98898625,0.007879626,0.0018661917,0.0001970833,0.0009776753,0.00009313267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047750184,0.00028074416,0.0014354836,0.0007979011,0.00021577696,0.00088441215,0.0005820575,0.001391572,0.0020765539],"category_scores_gemma":[0.010456996,0.00014362301,0.00074547925,0.0006772462,0.00033588268,0.000715885,0.00030963245,0.0009425392,0.00042180988],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014854518,0.00009994984,0.002226371,0.029084982,0.0010769427,0.000558642,0.00022850922,0.00022679323,0.006440302,0.0029847864,0.006792393,0.9487949],"study_design_scores_gemma":[0.0018653258,0.019983293,0.06725341,0.06592076,0.009171075,0.017457306,0.0011480897,0.0006639667,0.021045486,0.015778054,0.7795211,0.00019207428],"about_ca_topic_score_codex":0.00037839214,"about_ca_topic_score_gemma":0.00074947963,"teacher_disagreement_score":0.0047750184,"about_ca_system_score_codex":0.00042184707,"about_ca_system_score_gemma":0.0009268643,"threshold_uncertainty_score":0.025252998},"labels":[],"label_agreement":null},{"id":"W4286110999","doi":"10.1080/14740338.2022.2103536","title":"Safety and tolerability of spesolimab in patients with ulcerative colitis","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Boehringer Ingelheim","keywords":"Medicine; Tolerability; Ulcerative colitis; Adverse effect; Intensive care medicine; Internal medicine; Gastroenterology; Disease","score_opus":0.009818968218653348,"score_gpt":0.23554349803142818,"score_spread":0.22572452981277483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286110999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764514,0.019341039,0.0006010383,0.00059614005,0.0000809041,0.00024619722,0.00061868236,0.000089730755,0.0019749224],"genre_scores_gemma":[0.9966119,0.0016553195,0.0003355406,0.00042149684,0.00014730974,0.00011545439,0.0004309953,0.0000066374373,0.00027543402],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992824,0.00036580852,0.0000841915,0.00008157615,0.000117988704,0.00006809355],"domain_scores_gemma":[0.99794537,0.00066797365,0.00086088123,0.000091352245,0.00018401256,0.00025049679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020489595,0.00054032,0.001286673,0.00024087266,0.00025165352,0.00048630012,0.00023903187,0.00070382986,0.0018673172],"category_scores_gemma":[0.0025549363,0.0001603179,0.0009934759,0.00033613836,0.00028094073,0.00039689877,0.00015717153,0.001110231,0.00042792424],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40956506,0.0051898,0.10873314,0.0030012163,0.0024711099,0.0010671917,0.00039866669,0.0020731383,0.03613332,0.00012578111,0.005469545,0.42577207],"study_design_scores_gemma":[0.08424608,0.52161855,0.35651857,0.0004294026,0.0032369578,0.005325145,0.00031718527,0.0027868177,0.012857246,0.00043602329,0.012145372,0.00008273104],"about_ca_topic_score_codex":0.00014848806,"about_ca_topic_score_gemma":0.0002841617,"teacher_disagreement_score":0.0020489595,"about_ca_system_score_codex":0.00026006467,"about_ca_system_score_gemma":0.0003245197,"threshold_uncertainty_score":0.010836065},"labels":[],"label_agreement":null},{"id":"W4293834588","doi":"10.1080/14740338.2022.2120607","title":"Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Carleton University; University of British Columbia; University of Ottawa","funders":"","keywords":"Medicine; Pediatrics; Adverse effect; Internal medicine","score_opus":0.05542161233639507,"score_gpt":0.37158030379435447,"score_spread":0.3161586914579594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293834588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056387,0.0044539333,0.00042473697,0.00013528635,0.000035136603,0.00008275159,0.0034332783,0.000011319504,0.0008595426],"genre_scores_gemma":[0.9974789,0.0006841793,0.00012819293,0.000035911286,0.000023053273,0.0000356341,0.0015075835,0.0000036018796,0.0001028419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99049735,0.00352745,0.0024545195,0.001423657,0.001500696,0.00059628213],"domain_scores_gemma":[0.9755096,0.0061281417,0.01474453,0.0010413469,0.0016785825,0.00089793134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004274209,0.00037801504,0.000798386,0.0033247464,0.00027713407,0.0007379428,0.00045824386,0.0004057766,0.0020596099],"category_scores_gemma":[0.015178909,0.00027840844,0.0025014146,0.0023615507,0.0003636419,0.0006087837,0.0016695769,0.0006247143,0.00021570433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007405723,0.000015195389,0.99374086,0.00018719949,0.00087693456,0.00015931489,0.000066580564,0.00017865168,0.0002355422,0.000038449372,0.00025996022,0.0035008073],"study_design_scores_gemma":[0.000012831867,0.00017229552,0.99869674,0.000031814863,0.0001666288,0.00035343997,0.00010411853,0.00020397456,0.00005886126,0.0000182658,0.00017416099,0.00000674579],"about_ca_topic_score_codex":0.00877258,"about_ca_topic_score_gemma":0.0068992665,"teacher_disagreement_score":0.00877258,"about_ca_system_score_codex":0.0010759435,"about_ca_system_score_gemma":0.00049746566,"threshold_uncertainty_score":0.022604406},"labels":[],"label_agreement":null},{"id":"W4303633844","doi":"10.1080/14740338.2022.2134342","title":"How do safety warnings on medicines affect prescribing?","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research","keywords":"Medicine; SAFER; Transparency (behavior); Patient safety; Intervention (counseling); Affect (linguistics); Access to medicines; Public relations; Public health; Family medicine; Health care; Nursing","score_opus":0.18995852560681586,"score_gpt":0.48312188938221584,"score_spread":0.2931633637754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303633844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029646518,0.99563247,0.00011129072,0.0024570879,0.00027233886,0.000011728456,0.00009763927,0.0000042638826,0.0011166654],"genre_scores_gemma":[0.0055571296,0.9923383,0.00018502436,0.0013466747,0.0002392243,0.000016580914,0.000057190104,0.0000026711434,0.0002571424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99642605,0.0017901327,0.00053838023,0.00034101345,0.0008048878,0.00009964163],"domain_scores_gemma":[0.9817281,0.014902076,0.0019518507,0.00014332005,0.0011747117,0.0000998942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036927075,0.0005646128,0.0013828112,0.0014669473,0.00022961067,0.0015627154,0.0009565905,0.0021840462,0.007115177],"category_scores_gemma":[0.024949655,0.0002698921,0.0017555443,0.0017367053,0.00059041294,0.0016087659,0.0005268774,0.0016137509,0.0008634569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022565937,0.00003147364,0.00072803214,0.18377976,0.0009485591,0.0001045399,0.00043097982,0.00034587493,0.00031118785,0.004202152,0.02651065,0.7823812],"study_design_scores_gemma":[0.0001638264,0.0003254593,0.007368351,0.35926482,0.004034194,0.0010008211,0.0005715939,0.00030831707,0.0008027243,0.005132538,0.6209469,0.000080477956],"about_ca_topic_score_codex":0.006012546,"about_ca_topic_score_gemma":0.009509991,"teacher_disagreement_score":0.007115177,"about_ca_system_score_codex":0.0011934538,"about_ca_system_score_gemma":0.0034554491,"threshold_uncertainty_score":0.023802638},"labels":[],"label_agreement":null},{"id":"W4317871119","doi":"10.1080/14740338.2023.2172158","title":"Can COVID-19 have a clinically significant effect on drug metabolism?","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Drug; 2019-20 coronavirus outbreak; Drug metabolism; Pharmacology; Internal medicine; Intensive care medicine; Virology; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.020936756237832307,"score_gpt":0.3709943633978683,"score_spread":0.350057607160036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317871119","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018468336,0.07927537,0.00024623825,0.09256634,0.82335365,0.00004231435,0.00021386491,0.00008933003,0.004028133],"genre_scores_gemma":[0.0014005941,0.048972595,0.00022860731,0.044804525,0.89607817,0.000035816483,0.00010448027,0.000034512635,0.008340761],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974017,0.00058103865,0.00043564665,0.00027790808,0.0011244903,0.00017929974],"domain_scores_gemma":[0.98867995,0.0060924306,0.0008929384,0.00033033112,0.0031044425,0.0008999435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006481286,0.0020034676,0.003412257,0.0014975187,0.0012038391,0.0032493684,0.0024866671,0.01375099,0.013012742],"category_scores_gemma":[0.017384825,0.000793077,0.0023991845,0.00084596296,0.0015034998,0.0029778243,0.0010036697,0.0126294615,0.007370279],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017604645,0.000026395497,0.00007568407,0.0008928877,0.00009813928,0.00018430324,0.00001560092,0.000025264177,0.00009950998,0.0004998242,0.9704869,0.027419461],"study_design_scores_gemma":[0.00042170926,0.00010240442,0.0006764921,0.0015425298,0.00033668085,0.00038359436,0.000047526653,0.00014591264,0.0001945885,0.0021406678,0.99397767,0.00003023895],"about_ca_topic_score_codex":0.0017357754,"about_ca_topic_score_gemma":0.0051028533,"teacher_disagreement_score":0.01375099,"about_ca_system_score_codex":0.0020306981,"about_ca_system_score_gemma":0.0020835665,"threshold_uncertainty_score":0.043531954},"labels":[],"label_agreement":null},{"id":"W4321003910","doi":"10.1080/14740338.2023.2181340","title":"Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"ZonMw","keywords":"Medicine; Adalimumab; Etanercept; Rheumatoid arthritis; Psoriatic arthritis; Internal medicine; Drug reaction; Drug; Adverse drug reaction; Rheumatology; Pharmacology","score_opus":0.01145086819823524,"score_gpt":0.25840616164251806,"score_spread":0.24695529344428283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321003910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668253,0.0105886115,0.00016547348,0.00021272132,0.000049639344,0.0000128874735,0.0004665589,0.0000037981608,0.0018178447],"genre_scores_gemma":[0.9977609,0.0014718992,0.00007538938,0.0001089595,0.00006756622,0.000009913068,0.00026020114,0.0000023333735,0.00024287253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988084,0.00038582753,0.00018344527,0.00021796345,0.00028948253,0.00011492419],"domain_scores_gemma":[0.9947555,0.0015381072,0.003073537,0.00012364415,0.00026885967,0.00024032033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012724252,0.00015601717,0.0003798623,0.00042738588,0.00013093713,0.00049809535,0.00013581081,0.0003188058,0.003321015],"category_scores_gemma":[0.0048172195,0.00008807998,0.00053028634,0.0005981124,0.00014712954,0.0002646743,0.00023815127,0.000272949,0.00041046942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008814503,0.000046298886,0.9808677,0.00011874758,0.00019086139,0.00013133457,0.00014790079,0.000041548945,0.00023401802,0.000023383254,0.00020383851,0.017112916],"study_design_scores_gemma":[0.000020230738,0.00020612753,0.99856323,0.000026541169,0.00005844035,0.0005097637,0.00007610198,0.00004592862,0.000046856323,0.00002549002,0.00041739995,0.0000038944686],"about_ca_topic_score_codex":0.00048101126,"about_ca_topic_score_gemma":0.0005985601,"teacher_disagreement_score":0.003321015,"about_ca_system_score_codex":0.00016079523,"about_ca_system_score_gemma":0.00013087197,"threshold_uncertainty_score":0.011109948},"labels":[],"label_agreement":null},{"id":"W4385658077","doi":"10.1080/14740338.2023.2244421","title":"Epidemiology of adverse drug reactions to antihypertensive, antithrombotic and antidiabetic medications among adult inpatients at a National Referral Hospital, Uganda","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; International Development Research Centre; Wellcome Trust; Health Research","keywords":"Medicine; Antithrombotic; Epidemiology; Drug; Drug reaction; Referral; Diabetes mellitus; Adverse effect; Pharmacoepidemiology; Intensive care medicine; Adverse drug reaction; Emergency medicine; Medical prescription; Pharmacology; Internal medicine; Family medicine","score_opus":0.19431172838170033,"score_gpt":0.4919582185759955,"score_spread":0.2976464901942951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385658077","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993505,0.00021389508,0.000020318992,0.000029856648,0.0000023550165,0.000012518025,0.00017026292,0.0000019212894,0.00019841273],"genre_scores_gemma":[0.99944144,0.00023116071,0.00006695938,0.000036160447,0.000005262726,0.000011413993,0.00015433393,6.570874e-7,0.0000527166],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.999137,0.00019654263,0.00022788801,0.00012510394,0.00016300268,0.0001505313],"domain_scores_gemma":[0.99762565,0.00019419944,0.0015605488,0.00006888859,0.0001867051,0.0003640351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045807115,0.00024695747,0.0003536302,0.0013013063,0.0006908094,0.00071313884,0.00039367858,0.0003024346,0.0011828217],"category_scores_gemma":[0.0020744917,0.00037206706,0.00025805365,0.0013783566,0.0003929478,0.0003902858,0.00095467485,0.00040127232,0.00014602554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015241519,0.000011148999,0.9987902,0.000016740412,0.0000074356008,0.00016104817,0.00017940933,0.0000060918564,0.00007394899,0.0000047473386,0.000058844544,0.00067506114],"study_design_scores_gemma":[0.0000016816817,0.000057225243,0.99834216,0.000023232886,0.000004720727,0.0007404956,0.0006581612,0.000031595606,0.000024562933,0.000004555192,0.00010930709,0.0000024411852],"about_ca_topic_score_codex":0.009303615,"about_ca_topic_score_gemma":0.010427609,"teacher_disagreement_score":0.009303615,"about_ca_system_score_codex":0.0006156197,"about_ca_system_score_gemma":0.00067833916,"threshold_uncertainty_score":0.018498957},"labels":[],"label_agreement":null},{"id":"W4385827303","doi":"10.1080/14740338.2023.2248883","title":"Serotonin 5-HT <sub>2B</sub> receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Psilocybin; Medicine; Serotonin; Agonism; 5-HT receptor; Pharmacology; Lysergic acid diethylamide; Receptor; Serotonin Antagonists; Hallucinogen; Internal medicine","score_opus":0.04017881504522608,"score_gpt":0.3698573903593072,"score_spread":0.3296785753140811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385827303","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006966428,0.044167653,0.00019612318,0.07522692,0.87521297,0.00006402864,0.0001647299,0.000069767935,0.0048281993],"genre_scores_gemma":[0.00063031254,0.026971469,0.0002784742,0.059543014,0.89794195,0.00006161954,0.00008351272,0.000032027972,0.01445761],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736965,0.0005295229,0.00038007792,0.0002829781,0.0012315052,0.00020618866],"domain_scores_gemma":[0.98910695,0.0049458146,0.0009077268,0.00025731654,0.0034462216,0.0013360903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005228405,0.002011077,0.003170554,0.001806515,0.0017743617,0.004038983,0.0025020193,0.018611286,0.014362334],"category_scores_gemma":[0.013910036,0.0008669309,0.0026150555,0.0009403841,0.0016583572,0.002210548,0.0010453281,0.014841608,0.009555775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005268206,0.000013129081,0.000014406704,0.0003325829,0.000022884402,0.00008456541,0.000005690731,0.000014484638,0.00005268653,0.00025585954,0.99018735,0.008963649],"study_design_scores_gemma":[0.00023611898,0.000056641376,0.0003205646,0.0011864015,0.00012471323,0.00032483024,0.000020752557,0.0001009219,0.00009255834,0.0016139267,0.9959026,0.000019926634],"about_ca_topic_score_codex":0.003925675,"about_ca_topic_score_gemma":0.012876693,"teacher_disagreement_score":0.018611286,"about_ca_system_score_codex":0.0030574328,"about_ca_system_score_gemma":0.0043239673,"threshold_uncertainty_score":0.048046827},"labels":[],"label_agreement":null},{"id":"W4386084010","doi":"10.1080/14740338.2023.2247976","title":"An update on the safety of long-term vedolizumab use in inflammatory bowel disease","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Allergan; Biogen; Pfizer; Amgen","keywords":"Vedolizumab; Medicine; Inflammatory bowel disease; Ulcerative colitis; Pouchitis; Clinical trial; Internal medicine; Crohn's disease; Disease; Intensive care medicine; Immunology","score_opus":0.0758371502196532,"score_gpt":0.38842080031011567,"score_spread":0.31258365009046246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386084010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036725964,0.9856074,0.00035637297,0.008527064,0.00159216,0.00001913794,0.00020728276,0.000022881932,0.0033004861],"genre_scores_gemma":[0.0044747526,0.9849604,0.00063209806,0.0061463453,0.0024304423,0.00004220317,0.0002871151,0.000009656657,0.0010170478],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845433,0.0005439039,0.0003790487,0.000110328816,0.00045114054,0.00006121493],"domain_scores_gemma":[0.9918892,0.004927493,0.0011719671,0.000096913,0.0017641495,0.0001502883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032370845,0.00048812927,0.0014829612,0.0010364496,0.00024581273,0.001385753,0.0010651788,0.0019088908,0.0046880036],"category_scores_gemma":[0.008854609,0.0002301007,0.0013600372,0.0011558364,0.00042318203,0.0014452464,0.0005495161,0.0022914447,0.0015503686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022728778,0.0000318824,0.00043809213,0.02718348,0.00038978452,0.00025015677,0.0001098263,0.00020229856,0.0005954505,0.0017234698,0.11183064,0.85701764],"study_design_scores_gemma":[0.00009798155,0.00021958999,0.0019840111,0.02584659,0.00091962103,0.0010125512,0.000073840754,0.000119552395,0.000262331,0.0014672094,0.967973,0.000023672561],"about_ca_topic_score_codex":0.0014673691,"about_ca_topic_score_gemma":0.003138408,"teacher_disagreement_score":0.0046880036,"about_ca_system_score_codex":0.0010013288,"about_ca_system_score_gemma":0.0016431967,"threshold_uncertainty_score":0.017119527},"labels":[],"label_agreement":null},{"id":"W4386209201","doi":"10.1080/14740338.2023.2253144","title":"Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Psilocybin; Serotonergic; Medicine; Lysergic acid diethylamide; Psychotherapist; Hallucinogen; Pharmacology; Neuroscience; Psychology; Serotonin; Internal medicine","score_opus":0.051419392729938396,"score_gpt":0.4360025776403967,"score_spread":0.3845831849104583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386209201","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006922385,0.027120091,0.00013940326,0.058547188,0.91130084,0.0000337409,0.00006531843,0.00003291905,0.0026912834],"genre_scores_gemma":[0.00069052784,0.018253678,0.00018071274,0.03794027,0.9345512,0.000032071224,0.000024407134,0.000017289714,0.008309845],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9976172,0.00041948323,0.000357517,0.00027619212,0.0011451361,0.00018443863],"domain_scores_gemma":[0.9869257,0.0074101985,0.00069029094,0.0003151452,0.0035271728,0.0011315303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064225895,0.0019215561,0.0025359062,0.0018205339,0.0021283198,0.004626241,0.002391476,0.015079077,0.009166604],"category_scores_gemma":[0.016338382,0.00074810174,0.001744027,0.00097638945,0.002248197,0.0026888917,0.00090873986,0.01501534,0.004579097],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005709065,0.000017537768,0.00002646016,0.00050118746,0.000024393497,0.00011791882,0.000015363848,0.000014673379,0.00008010259,0.00063472876,0.9860685,0.012442],"study_design_scores_gemma":[0.0001319525,0.000051689018,0.0004520619,0.0011338869,0.00011782572,0.0003461332,0.000051736264,0.000117132215,0.0001279103,0.0021822897,0.99526656,0.000020918455],"about_ca_topic_score_codex":0.0030556647,"about_ca_topic_score_gemma":0.0095383255,"teacher_disagreement_score":0.015079077,"about_ca_system_score_codex":0.0030317928,"about_ca_system_score_gemma":0.004023466,"threshold_uncertainty_score":0.033966303},"labels":[],"label_agreement":null},{"id":"W4386820153","doi":"10.1080/14740338.2023.2248872","title":"Janus kinase inhibitor—Tofacitinib associated with pemphigus: an analysis of the FDA adverse event reporting system data","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Chinese Pharmaceutical Association","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Adverse effect; Janus kinase; Adverse Event Reporting System; Pemphigus; Dermatology; Safety profile; Pharmacology; Internal medicine","score_opus":0.0475409499849269,"score_gpt":0.33562638444909326,"score_spread":0.28808543446416635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386820153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98648757,0.0013695591,0.0014360098,0.0002216536,0.000016740969,0.00016522681,0.009380129,0.000033030145,0.0008901421],"genre_scores_gemma":[0.9919172,0.00032266634,0.0011068109,0.00007925164,0.000024149092,0.00008626476,0.006360901,0.0000061187416,0.000096700714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9872334,0.0042739906,0.0038648995,0.0011486829,0.0030844419,0.00039467227],"domain_scores_gemma":[0.9083636,0.029777145,0.0530764,0.0033272358,0.004631094,0.00082455564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010346671,0.00021492012,0.00043269066,0.0042562033,0.00029920728,0.0007633065,0.00031997444,0.00029947696,0.001072102],"category_scores_gemma":[0.023766184,0.00012960723,0.0010272738,0.0042677056,0.00025264037,0.00044170636,0.0006218188,0.0003706641,0.00018562001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032064156,0.00003222188,0.9918115,0.00014535506,0.00036448843,0.00019621635,0.00005025086,0.00021961192,0.0005761575,0.000055498902,0.0004071389,0.0058207884],"study_design_scores_gemma":[0.000024797506,0.0002062892,0.9947737,0.000047723337,0.00022257285,0.0008957685,0.00013471431,0.0018226301,0.00059786276,0.00005588844,0.0012072058,0.000010864992],"about_ca_topic_score_codex":0.0022522362,"about_ca_topic_score_gemma":0.0020204806,"teacher_disagreement_score":0.010346671,"about_ca_system_score_codex":0.0005915623,"about_ca_system_score_gemma":0.000937057,"threshold_uncertainty_score":0.05471903},"labels":[],"label_agreement":null},{"id":"W4387362397","doi":"10.1080/14740338.2023.2267971","title":"The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministerie van Volksgezondheid, Welzijn en Sport","keywords":"Medicine; Vaccination; Rheumatoid arthritis; Comorbidity; Cohort; Adverse effect; Malaise; Logistic regression; Coronavirus disease 2019 (COVID-19); Pediatrics; Odds ratio; Internal medicine; Disease; Immunology; Infectious disease (medical specialty)","score_opus":0.027165265555898085,"score_gpt":0.3680216653711588,"score_spread":0.3408563998152607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387362397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972209,0.0007969682,0.0001863791,0.00019768464,0.000027354925,0.000022141858,0.0011096642,0.0000022244328,0.0004367648],"genre_scores_gemma":[0.99871945,0.00029726076,0.00011340773,0.00006676039,0.000015205916,0.000028095368,0.00062741124,0.0000038293656,0.00012862732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998454,0.00056641025,0.00019294582,0.0003128617,0.00022097396,0.0002527446],"domain_scores_gemma":[0.9960251,0.0009918424,0.0018248985,0.00031374404,0.0003387321,0.00050567125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022320673,0.00020061895,0.00046156585,0.0006429208,0.00041508838,0.0011936158,0.0006599287,0.00042650296,0.0013958552],"category_scores_gemma":[0.0069834427,0.00033574266,0.0010788814,0.0012805553,0.0003186572,0.000645513,0.00064729154,0.0008198887,0.00017443302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062959465,0.000018523611,0.9989792,0.000017533972,0.000089949666,0.000053715852,0.0000720681,0.000022786213,0.000029161747,0.000016198144,0.000134845,0.000503098],"study_design_scores_gemma":[0.00001260859,0.000055687018,0.99898356,0.000026170443,0.0000446451,0.000114798204,0.00022298869,0.00020383166,0.000017186941,0.00002268393,0.00029151546,0.0000042976044],"about_ca_topic_score_codex":0.043288853,"about_ca_topic_score_gemma":0.037382603,"teacher_disagreement_score":0.043288853,"about_ca_system_score_codex":0.00087298086,"about_ca_system_score_gemma":0.0013019225,"threshold_uncertainty_score":0.086073756},"labels":[],"label_agreement":null},{"id":"W4388132398","doi":"10.1080/14740338.2023.2274416","title":"Risk of serious skin and subcutaneous tissue disorders for nimesulide among the pediatric population: a jeopardy identified through the analysis of global individual case safety reports","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Nimesulide; Double jeopardy; Population; Subcutaneous tissue; Dermatology; Intensive care medicine; Surgery; Internal medicine; Environmental health","score_opus":0.04328827465123892,"score_gpt":0.42146180062452104,"score_spread":0.37817352597328213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388132398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98942727,0.00479566,0.001326756,0.00026732066,0.000016632313,0.000106709704,0.0025512476,0.000030937117,0.0014774039],"genre_scores_gemma":[0.9961534,0.001500078,0.0009057169,0.00005219875,0.000024317726,0.000035861653,0.0012103129,0.00000716632,0.00011096086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937291,0.0019940953,0.0011932045,0.0010832447,0.0016644566,0.00033593492],"domain_scores_gemma":[0.9712583,0.005536736,0.019022718,0.0015545792,0.002112512,0.00051532727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055558444,0.00030004198,0.00037610365,0.0066901925,0.00024060662,0.0011490488,0.0003777515,0.0002804467,0.0015126445],"category_scores_gemma":[0.016907398,0.00019645762,0.0007612391,0.0050049885,0.0005128681,0.00095085864,0.0011516409,0.0003498171,0.00019757044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005909659,0.0000074550394,0.99064976,0.00007715311,0.000099657285,0.00015553004,0.00018717685,0.000040202907,0.00012884072,0.000071215945,0.00018111119,0.008342802],"study_design_scores_gemma":[0.000004156552,0.00010728818,0.9951545,0.00007528615,0.0001671367,0.0016835195,0.0007895585,0.00034695267,0.00032756498,0.00015234626,0.0011820331,0.00000961201],"about_ca_topic_score_codex":0.0023701335,"about_ca_topic_score_gemma":0.0018925745,"teacher_disagreement_score":0.0066901925,"about_ca_system_score_codex":0.0005745329,"about_ca_system_score_gemma":0.0007311964,"threshold_uncertainty_score":0.029382408},"labels":[],"label_agreement":null},{"id":"W4388376519","doi":"10.1080/14740338.2023.2280137","title":"The safety of oral antifungals for the treatment of onychomycosis","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Itraconazole; Fluconazole; Terbinafine; Ketoconazole; Adverse effect; Posaconazole; Griseofulvin; Pharmacology; Liver function; Antifungal; Dermatology; Intensive care medicine; Internal medicine","score_opus":0.11716897643670479,"score_gpt":0.43305810991604665,"score_spread":0.3158891334793419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388376519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004480824,0.9714044,0.00038231382,0.0065964456,0.00064074417,0.00019147,0.0055362303,0.000024391804,0.010743215],"genre_scores_gemma":[0.084715724,0.90129524,0.0013164954,0.0047927694,0.0014282309,0.00028847382,0.0041793794,0.000030567437,0.0019530912],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9908627,0.002705052,0.002749201,0.0006204531,0.0028952553,0.00016727083],"domain_scores_gemma":[0.9591064,0.022385327,0.012823817,0.00040826027,0.0048985835,0.0003776125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053447667,0.00032257332,0.0015236463,0.0034076432,0.00036753964,0.0017275079,0.0008043764,0.0016227299,0.01735094],"category_scores_gemma":[0.03827789,0.00013495235,0.0015093618,0.0046412535,0.00054033333,0.001408415,0.0005710386,0.000989148,0.0022673837],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012506436,0.00006797609,0.007839166,0.31625533,0.0017682469,0.00078864285,0.0002983067,0.00019780199,0.0013122611,0.001986564,0.061192315,0.6070428],"study_design_scores_gemma":[0.00075974537,0.0014260116,0.04299172,0.43521234,0.009790949,0.005271624,0.00085407717,0.00043598202,0.0027954427,0.003785579,0.49656403,0.000112616166],"about_ca_topic_score_codex":0.0032267007,"about_ca_topic_score_gemma":0.005132134,"teacher_disagreement_score":0.01735094,"about_ca_system_score_codex":0.0014914151,"about_ca_system_score_gemma":0.0034822458,"threshold_uncertainty_score":0.058044672},"labels":[],"label_agreement":null},{"id":"W4389677779","doi":"10.1080/14740338.2023.2294924","title":"Long QT syndrome after using EGFR-TKIs in older patients with advanced non-small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Korea Health Industry Development Institute","keywords":"Medicine; Lung cancer; Cancer; Gefitinib; Lung; Internal medicine; Intensive care medicine; Oncology; Epidermal growth factor receptor","score_opus":0.009137389951940248,"score_gpt":0.31485448300877644,"score_spread":0.3057170930568362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389677779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979983,0.0008379649,0.00013453104,0.000106199266,0.000016855134,0.0000147267065,0.00058166735,0.0000028344905,0.0003068658],"genre_scores_gemma":[0.9988458,0.00033642247,0.00006314268,0.00006112486,0.00003415843,0.0000114935665,0.0005740608,9.816293e-7,0.0000729254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992161,0.00015374037,0.00014700541,0.00022021432,0.00016897255,0.000093952905],"domain_scores_gemma":[0.99672323,0.00034252717,0.0022991924,0.00012837023,0.00019244797,0.00031420717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001052193,0.00018811696,0.0004786147,0.0004819197,0.00044295323,0.0004641323,0.00021456876,0.00032029767,0.00089657534],"category_scores_gemma":[0.0030720823,0.00016007334,0.0008097347,0.0011525182,0.0002257719,0.00045903606,0.0004457023,0.00080917624,0.00009293282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113432216,0.000014609118,0.9984865,0.00001598366,0.000060399754,0.00009062642,0.00002873853,0.000031348074,0.000061586805,0.000020109352,0.00007855714,0.0009980331],"study_design_scores_gemma":[0.000018855764,0.00014005382,0.9987552,0.000016456002,0.00006956613,0.00049113046,0.000069438465,0.00016945317,0.000030020054,0.0000534876,0.00018259232,0.0000037249686],"about_ca_topic_score_codex":0.003914115,"about_ca_topic_score_gemma":0.0051630065,"teacher_disagreement_score":0.003914115,"about_ca_system_score_codex":0.00052711857,"about_ca_system_score_gemma":0.00042704603,"threshold_uncertainty_score":0.0077826977},"labels":[],"label_agreement":null},{"id":"W4389681767","doi":"10.1080/14740338.2023.2295397","title":"The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Medicine; Adverse Event Reporting System; Suicidal ideation; Liraglutide; Adverse effect; Odds ratio; Internal medicine; Poison control; Pharmacology; Psychiatry; Suicide prevention; Emergency medicine; Endocrinology; Diabetes mellitus","score_opus":0.02239137260098223,"score_gpt":0.3025923590626875,"score_spread":0.28020098646170527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389681767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9359793,0.036071442,0.004009959,0.004520436,0.00023862412,0.0003905032,0.009725591,0.000090657144,0.008973514],"genre_scores_gemma":[0.9851649,0.0079438295,0.0021290022,0.0009135372,0.00022845095,0.0001394011,0.0029301515,0.0000066451034,0.00054423866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99057615,0.0043695257,0.002191424,0.0005890135,0.0020962046,0.00017762835],"domain_scores_gemma":[0.9439486,0.0126404585,0.03869123,0.0010317283,0.003275471,0.000412592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006974491,0.00021037897,0.00031941,0.0013298544,0.00014397444,0.00075689575,0.00035413678,0.0004657495,0.0017496238],"category_scores_gemma":[0.023018781,0.000117568554,0.00057795946,0.0014150653,0.0002981966,0.0004110558,0.00035972256,0.00043424414,0.00024074524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005131414,0.00006974793,0.95410365,0.0006861233,0.0005898571,0.00016963408,0.0000930554,0.00015948842,0.00045823876,0.00017604753,0.0019476252,0.041033316],"study_design_scores_gemma":[0.000056773424,0.0004865631,0.98998296,0.0005079829,0.00045220164,0.0016353304,0.00018679042,0.0008138082,0.001157899,0.00027086455,0.0044242227,0.000024558909],"about_ca_topic_score_codex":0.0013991193,"about_ca_topic_score_gemma":0.0016805633,"teacher_disagreement_score":0.006974491,"about_ca_system_score_codex":0.00039308605,"about_ca_system_score_gemma":0.00051933975,"threshold_uncertainty_score":0.036885083},"labels":[],"label_agreement":null},{"id":"W4390403997","doi":"10.1080/14740338.2023.2299391","title":"A safety evaluation of ruxolitinib for the treatment of polycythemia vera","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministry of Health, British Columbia","keywords":"Ruxolitinib; Polycythemia vera; Medicine; Myelofibrosis; Myeloproliferative neoplasm; Haematopoiesis; Disease; Immunology; Thrombocytosis; Stem cell; Internal medicine; Bone marrow; Platelet","score_opus":0.07678855501728588,"score_gpt":0.3890195278381949,"score_spread":0.312230972820909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390403997","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43578762,0.48031965,0.0054999315,0.020961199,0.0021510134,0.0015880286,0.0057778885,0.0002916385,0.047623076],"genre_scores_gemma":[0.91074085,0.07023964,0.0026317656,0.0075693214,0.0012269968,0.00044384177,0.0027711648,0.00002852491,0.0043478543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993569,0.00027627853,0.00007278973,0.000092308226,0.00015838719,0.00004329239],"domain_scores_gemma":[0.9986008,0.0005333679,0.00041138826,0.00005680063,0.00027954785,0.000118091084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012177976,0.00021875725,0.00061028806,0.00030813116,0.00021844129,0.00082908897,0.00029412057,0.0008792845,0.004092312],"category_scores_gemma":[0.0028218841,0.00005839542,0.0006117833,0.0002687702,0.00019494747,0.00036693938,0.0001600358,0.00083969795,0.00072441803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016927151,0.0013195828,0.0060887667,0.006153065,0.00091584213,0.0016996334,0.0001929027,0.0013015148,0.029150425,0.0020963775,0.026767513,0.90738726],"study_design_scores_gemma":[0.028672058,0.14216675,0.061409134,0.00846871,0.0066327034,0.026069496,0.0003864244,0.0060509895,0.043924384,0.004612123,0.67143583,0.00017140005],"about_ca_topic_score_codex":0.00024107391,"about_ca_topic_score_gemma":0.00068555766,"teacher_disagreement_score":0.004092312,"about_ca_system_score_codex":0.00048471944,"about_ca_system_score_gemma":0.0007348918,"threshold_uncertainty_score":0.013690114},"labels":[],"label_agreement":null},{"id":"W4393114465","doi":"10.1080/14740338.2024.2335215","title":"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Glucagon-like peptide-1; Glucagon-like peptide 1 receptor; Medicine; Receptor; Glucagon; Peptide; Agonist; Endocrinology; Pharmacology; Internal medicine; Biochemistry; Insulin; Chemistry; Diabetes mellitus; Type 2 diabetes","score_opus":0.008898181884863885,"score_gpt":0.2885847164336534,"score_spread":0.2796865345487895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393114465","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023850245,0.05169234,0.00010496891,0.06169221,0.8847831,0.000021301112,0.00008464118,0.00004419194,0.0015533933],"genre_scores_gemma":[0.00038838366,0.049740344,0.00011614488,0.046537124,0.89729124,0.000028116503,0.00007377734,0.00004219857,0.005782663],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99642354,0.0009825964,0.00045900082,0.00035844653,0.0015444192,0.00023195702],"domain_scores_gemma":[0.97672075,0.013547774,0.001230562,0.00031587522,0.006368696,0.001816286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007896682,0.0025075376,0.004185035,0.0025466646,0.0021909154,0.005041038,0.0048094834,0.0150627,0.013958106],"category_scores_gemma":[0.027157243,0.0008730003,0.00222495,0.0014368348,0.0025007688,0.0059650172,0.0014519023,0.016562875,0.012804899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033973767,0.000004861037,0.000008015397,0.000515355,0.000017103965,0.00005016402,0.000011804217,0.000009194922,0.000017081193,0.00030504275,0.99181104,0.007216324],"study_design_scores_gemma":[0.0000959016,0.000040798506,0.00013774395,0.001798806,0.00011222174,0.00029521354,0.00005030372,0.000080539205,0.000056562523,0.0017639257,0.99554765,0.00002026578],"about_ca_topic_score_codex":0.0024664958,"about_ca_topic_score_gemma":0.007051155,"teacher_disagreement_score":0.0150627,"about_ca_system_score_codex":0.0029177305,"about_ca_system_score_gemma":0.0037465487,"threshold_uncertainty_score":0.046694458},"labels":[],"label_agreement":null},{"id":"W4399076922","doi":"10.1080/14740338.2024.2361300","title":"Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS)","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Adverse Event Reporting System; Medicine; Food and drug administration; Adverse effect; Orexin receptor; Orexin; Association (psychology); Adverse drug event; Pharmacovigilance; Pharmacology; Environmental health; Internal medicine; Medical emergency; Receptor","score_opus":0.045348961043192734,"score_gpt":0.34622012807160324,"score_spread":0.3008711670284105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399076922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98022276,0.007582538,0.0020053326,0.00083159993,0.000048123457,0.00021748764,0.005235622,0.000084020416,0.0037725302],"genre_scores_gemma":[0.9938746,0.0017119835,0.0016214562,0.00026452614,0.00005373385,0.00006895037,0.0020850499,0.000007731193,0.00031189612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917973,0.0028553093,0.0023050355,0.00054289825,0.0023158079,0.00018356282],"domain_scores_gemma":[0.93662965,0.0126326205,0.04457456,0.0014847952,0.0040709455,0.0006074087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057861577,0.00020851637,0.00029433405,0.0018362332,0.00016889945,0.0004595299,0.00023867366,0.00028017545,0.0013507496],"category_scores_gemma":[0.019388514,0.0001385291,0.0005541555,0.0015266415,0.00022347283,0.00029488513,0.00038772536,0.00048647815,0.00015547467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000291705,0.000037800528,0.983757,0.00019531566,0.0002507396,0.00008966454,0.0000740527,0.00007769906,0.00045928283,0.000057843885,0.00067587703,0.014033127],"study_design_scores_gemma":[0.000018703908,0.00036806182,0.99493825,0.00011650344,0.0001767236,0.0011331962,0.00014775823,0.0005265742,0.001031086,0.00007464879,0.0014540789,0.000014389403],"about_ca_topic_score_codex":0.0019214912,"about_ca_topic_score_gemma":0.0024381704,"teacher_disagreement_score":0.0057861577,"about_ca_system_score_codex":0.00040737714,"about_ca_system_score_gemma":0.00036815504,"threshold_uncertainty_score":0.030600429},"labels":[],"label_agreement":null},{"id":"W4399747109","doi":"10.1080/14740338.2024.2368827","title":"The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS)","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Adverse Event Reporting System; Medicine; Ketamine; Food and drug administration; Adverse effect; Drug; Pharmacovigilance; Emergency medicine; Administration (probate law); Anesthesia; Pharmacology; Intensive care medicine; Internal medicine; Medical emergency","score_opus":0.02108355986093473,"score_gpt":0.3166153105612791,"score_spread":0.2955317507003444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399747109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8172171,0.060268853,0.0027552247,0.002816163,0.00022382446,0.0005283411,0.107893966,0.0002004072,0.00809606],"genre_scores_gemma":[0.9393679,0.02008381,0.0023070527,0.00072143815,0.00020487781,0.00043318642,0.03603436,0.000020705209,0.0008266905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924136,0.0024006318,0.0027418274,0.00060859055,0.0016754485,0.00015997405],"domain_scores_gemma":[0.9017612,0.018496152,0.07291834,0.0019414881,0.0042431485,0.00063965376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005459487,0.00023735632,0.000489019,0.0034451429,0.00015245227,0.00062802725,0.00045894025,0.00031211582,0.0019273061],"category_scores_gemma":[0.02840105,0.00018673645,0.00075397803,0.0048224255,0.00021781673,0.000593535,0.00047370553,0.00044082094,0.0003047129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005582763,0.00003094553,0.96400917,0.0021114128,0.00079986826,0.00014723653,0.00010190658,0.00014854778,0.00021710814,0.00012491358,0.0035014576,0.0282491],"study_design_scores_gemma":[0.000031259457,0.00011157298,0.99323237,0.0007210622,0.00034785602,0.0006065649,0.000101546226,0.00018155218,0.00027037988,0.00010766442,0.004271252,0.000016947304],"about_ca_topic_score_codex":0.004924258,"about_ca_topic_score_gemma":0.0054427558,"teacher_disagreement_score":0.005459487,"about_ca_system_score_codex":0.000594888,"about_ca_system_score_gemma":0.00065082643,"threshold_uncertainty_score":0.028872848},"labels":[],"label_agreement":null},{"id":"W4401715832","doi":"10.1080/14740338.2024.2393274","title":"Considerations for practical use of tree-based scan statistics for signal detection using electronic healthcare data: a case study with insulin glargine","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Insulin glargine; Health care; Detection theory; SIGNAL (programming language); Statistics; Tree (set theory); Health records; Data mining; Insulin; Computer science; Internal medicine; Detector; Mathematics; Telecommunications","score_opus":0.33295204115155824,"score_gpt":0.5283326762861714,"score_spread":0.19538063513461318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401715832","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24653654,0.0052533164,0.6389736,0.08589464,0.0008130883,0.003143439,0.0014568608,0.0005624857,0.017365979],"genre_scores_gemma":[0.60774857,0.0019359598,0.38155323,0.004948392,0.00049465965,0.002225649,0.00027935187,0.00021439187,0.0005997747],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.77030927,0.19737235,0.0128983315,0.004146816,0.014082345,0.0011908512],"domain_scores_gemma":[0.24936868,0.7005961,0.019929184,0.013598824,0.01465348,0.0018536631],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20526056,0.0007840269,0.0014274293,0.0024574553,0.0011721032,0.0042438353,0.0030921544,0.0039847447,0.0056010922],"category_scores_gemma":[0.4442587,0.0005555509,0.0028949056,0.0033133468,0.0024127604,0.0050908816,0.0018935176,0.003547496,0.0006617211],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021397222,0.00074389426,0.54081184,0.0031442763,0.0012234013,0.032792706,0.011154865,0.014760528,0.0012752116,0.04543848,0.023844514,0.32267058],"study_design_scores_gemma":[0.0016287698,0.006874411,0.17313741,0.013457665,0.0022043013,0.12207636,0.023164144,0.25971282,0.00935985,0.27458745,0.11288113,0.0009157397],"about_ca_topic_score_codex":0.003811364,"about_ca_topic_score_gemma":0.005051124,"teacher_disagreement_score":0.20526056,"about_ca_system_score_codex":0.0019225734,"about_ca_system_score_gemma":0.005216668,"threshold_uncertainty_score":0.9800552},"labels":[],"label_agreement":null},{"id":"W4402194288","doi":"10.1080/14740338.2024.2396396","title":"Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec; Ottawa Hospital; Dalhousie University; Université Laval; University of Ottawa","funders":"Cilag; National Health and Medical Research Council; H. Lundbeck A/S; Lundbeckfonden; Servier; Bristol-Myers Squibb; Eli Lilly and Company; Shire; QuantIC; Gedeon Richter; Canadian Institutes of Health Research; Sunovion; Teva Pharmaceutical Industries; Novo Nordisk; Sanofi","keywords":"Medicine; Psychiatry; Weight gain; Intensive care medicine; Internal medicine; Body weight","score_opus":0.12679275899886266,"score_gpt":0.42275965345624095,"score_spread":0.2959668944573783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402194288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011667557,0.99952507,0.00002410822,0.0001335325,0.000045346347,0.000013537009,0.00004774671,0.000002183827,0.00009174675],"genre_scores_gemma":[0.0014331437,0.9981622,0.00008404726,0.00015094524,0.00005986217,0.000025639394,0.000047069414,0.0000010002134,0.000036130077],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99818844,0.00039308623,0.0007320414,0.00023289189,0.00036734797,0.00008621842],"domain_scores_gemma":[0.991232,0.006061914,0.0019152311,0.000082388964,0.0006115728,0.00009689386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027372725,0.0011493444,0.005178654,0.0042604855,0.00032881869,0.0020266753,0.001410822,0.0015557522,0.005072865],"category_scores_gemma":[0.009586294,0.00063238124,0.004510996,0.005439801,0.00046517936,0.0012943965,0.00082185795,0.0011418109,0.00046770216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003662896,0.000066447756,0.00087532133,0.6988835,0.005376633,0.000094872885,0.00010941255,0.00020346085,0.00018591691,0.00043629084,0.0069773723,0.28642455],"study_design_scores_gemma":[0.0004045474,0.00040679166,0.01012785,0.7860384,0.06789363,0.0010654979,0.00029582815,0.00033652698,0.00031009738,0.0013142615,0.13172807,0.00007847784],"about_ca_topic_score_codex":0.0038830193,"about_ca_topic_score_gemma":0.007663985,"teacher_disagreement_score":0.005178654,"about_ca_system_score_codex":0.001174538,"about_ca_system_score_gemma":0.004034204,"threshold_uncertainty_score":0.016970396},"labels":[],"label_agreement":null},{"id":"W4402455942","doi":"10.1080/14740338.2024.2401024","title":"Comparative risk of infection of medications used for type 2 diabetes","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Dapagliflozin; Type 2 diabetes; Food and drug administration; Diabetes mellitus; Drug; Urinary system; Canagliflozin; Randomized controlled trial; Intensive care medicine; Pharmacology; Internal medicine; Endocrinology","score_opus":0.08427157789930105,"score_gpt":0.4222656409577348,"score_spread":0.3379940630584337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402455942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021914631,0.99895334,0.000051243704,0.00018193356,0.000109444234,0.000016781529,0.00013449474,0.0000016749477,0.00033187223],"genre_scores_gemma":[0.0073256968,0.99138474,0.0002534998,0.0004444601,0.0002018328,0.000050123526,0.000175891,0.0000025848335,0.00016119421],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99654573,0.0011580643,0.0009982968,0.0003767062,0.00082375115,0.000097463286],"domain_scores_gemma":[0.9918903,0.005775374,0.0015257008,0.000087393106,0.0006355726,0.000085677355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032115285,0.0006726771,0.0036796206,0.002613616,0.00019230614,0.0012359222,0.0008510217,0.0012431885,0.0075164977],"category_scores_gemma":[0.011290102,0.00025540814,0.00423376,0.003066593,0.00027403448,0.0008246326,0.0005265988,0.0011438995,0.0004578876],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012172849,0.00005208021,0.0018158808,0.51485544,0.017564934,0.00015301969,0.00007868236,0.00023678601,0.0003789559,0.0014447713,0.010361515,0.4518406],"study_design_scores_gemma":[0.001528789,0.0011713051,0.022094835,0.52808386,0.119707584,0.0025931457,0.00032556025,0.00046661685,0.0011804343,0.004588211,0.31811628,0.00014343337],"about_ca_topic_score_codex":0.001994034,"about_ca_topic_score_gemma":0.0032708333,"teacher_disagreement_score":0.0075164977,"about_ca_system_score_codex":0.0008779713,"about_ca_system_score_gemma":0.0018640476,"threshold_uncertainty_score":0.025145233},"labels":[],"label_agreement":null},{"id":"W4404474075","doi":"10.1080/14740338.2024.2430306","title":"Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based study","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Medicine; Accidental; Population; Pharmacology; Glucagon-like peptide-1; Internal medicine; Endocrinology; Environmental health; Diabetes mellitus","score_opus":0.07159680861154213,"score_gpt":0.4388225693700137,"score_spread":0.3672257607584716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404474075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997959,0.0003326869,0.0002334075,0.00010684717,0.000012244161,0.000033463188,0.0005952652,0.00000698217,0.0007199234],"genre_scores_gemma":[0.99932814,0.0001490196,0.000087506574,0.000092969574,0.000014867827,0.000018767827,0.0002121137,0.0000027730953,0.000093816234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963644,0.001212796,0.00065651885,0.000805848,0.0006813545,0.0002792324],"domain_scores_gemma":[0.9904321,0.0015804666,0.005768063,0.0008555169,0.00085979956,0.00050420075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024075727,0.00035943085,0.00042297292,0.0014047286,0.0005843655,0.0011500057,0.0006900491,0.0009346495,0.0034953458],"category_scores_gemma":[0.009454903,0.0005570724,0.0011354111,0.0019829397,0.0006023978,0.0011629825,0.0009093232,0.00091897947,0.00050731876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060375638,0.000045841305,0.9987534,0.00002002943,0.00010535826,0.00006955466,0.000107905325,0.000013618484,0.000046441375,0.000012515904,0.00009624172,0.00066873484],"study_design_scores_gemma":[0.000012980224,0.00020860741,0.9981166,0.000022399023,0.00012132147,0.00065464625,0.00037987062,0.0001653904,0.00004986726,0.000026525073,0.00023298754,0.000008792345],"about_ca_topic_score_codex":0.0064453958,"about_ca_topic_score_gemma":0.004543469,"teacher_disagreement_score":0.0064453958,"about_ca_system_score_codex":0.0005224484,"about_ca_system_score_gemma":0.0006029259,"threshold_uncertainty_score":0.0128157735},"labels":[],"label_agreement":null},{"id":"W4405065092","doi":"10.1080/14740338.2024.2438751","title":"Safety assessment of tafamidis: a real-world adverse event analysis from the FAERS database","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; Medicine; Adverse effect; Quarter (Canadian coin); Pharmacovigilance; Database; MEDLINE; Pharmacology","score_opus":0.016010363082259983,"score_gpt":0.343212526316856,"score_spread":0.327202163234596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405065092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83082664,0.012899535,0.0062295087,0.0010888026,0.000056727837,0.0012697275,0.14342833,0.00033620934,0.003864568],"genre_scores_gemma":[0.8384712,0.0043517626,0.007849359,0.00048558114,0.00009927999,0.0012379148,0.14683941,0.000038843544,0.00062685163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9889206,0.003167651,0.0036363876,0.0014333972,0.0025974165,0.00024449604],"domain_scores_gemma":[0.9596164,0.013720748,0.020282801,0.002224272,0.0035966209,0.0005591093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009499334,0.00041842757,0.0011115766,0.0028997352,0.00027980414,0.0013119483,0.0006555051,0.00077638065,0.0024505402],"category_scores_gemma":[0.022766951,0.00015410277,0.0014980279,0.003262327,0.0002597782,0.00076848624,0.0007612007,0.00068210496,0.00070868776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005874198,0.00052501156,0.8560312,0.006380929,0.0036904106,0.0014058991,0.00037385477,0.004436918,0.001930836,0.0007360707,0.018624902,0.099989735],"study_design_scores_gemma":[0.0010625906,0.0021972503,0.9374626,0.0011753587,0.0034022816,0.0054668095,0.0005825504,0.014544282,0.0037283262,0.001075873,0.0291554,0.00014669045],"about_ca_topic_score_codex":0.0015826366,"about_ca_topic_score_gemma":0.0017241973,"teacher_disagreement_score":0.009499334,"about_ca_system_score_codex":0.0007820383,"about_ca_system_score_gemma":0.0015787204,"threshold_uncertainty_score":0.050237834},"labels":[],"label_agreement":null},{"id":"W4405790898","doi":"10.1080/14740338.2024.2447072","title":"Is Duchenne gene therapy a suitable treatment despite its immunogenic class effect?","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Duchenne muscular dystrophy; Genetic enhancement; Weakness; Cardiomyopathy; Intensive care medicine; Disease; Bioinformatics; Internal medicine; Gene; Surgery; Heart failure; Genetics","score_opus":0.03765620373132751,"score_gpt":0.36017075118431663,"score_spread":0.32251454745298913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405790898","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034260345,0.9893624,0.00045922142,0.004440834,0.0013095582,0.000009964987,0.000059816557,0.000020322486,0.003995386],"genre_scores_gemma":[0.0036210448,0.9862059,0.000520954,0.0038408109,0.0011845867,0.000018901499,0.00012031626,0.000009409789,0.004478042],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998011,0.00004394023,0.000020383111,0.00003960473,0.0000762573,0.000018768798],"domain_scores_gemma":[0.9997539,0.00011921689,0.000037538204,0.0000071657537,0.00006329164,0.00001886312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044877443,0.0002998504,0.00067678705,0.0005237383,0.000173798,0.0007472379,0.00049949647,0.0012485861,0.0060930178],"category_scores_gemma":[0.00079257914,0.0000930844,0.00041640498,0.00038092007,0.00040652388,0.0007285425,0.00028937985,0.0018170314,0.0025098012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107384985,0.000042851276,0.00011681324,0.010934185,0.000083397594,0.00031516154,0.000055605284,0.0001880387,0.003336483,0.006992514,0.07689155,0.900936],"study_design_scores_gemma":[0.000021297408,0.00007566027,0.00026983253,0.0027871153,0.00005032928,0.0011186902,0.00003079749,0.000047371283,0.0006200197,0.0018352302,0.9931339,0.000009829492],"about_ca_topic_score_codex":0.0006118614,"about_ca_topic_score_gemma":0.0014477562,"teacher_disagreement_score":0.0060930178,"about_ca_system_score_codex":0.00049538695,"about_ca_system_score_gemma":0.0006423573,"threshold_uncertainty_score":0.02038318},"labels":[],"label_agreement":null},{"id":"W4407267045","doi":"10.1080/14740338.2025.2460454","title":"Association of ocular adverse events with varenicline solution use: a population-based study","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Varenicline; Adverse effect; Population; Pharmacology; Intensive care medicine; Environmental health; Internal medicine; Nicotine","score_opus":0.013241548894679567,"score_gpt":0.29976375839986685,"score_spread":0.2865222095051873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407267045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969574,0.0011149835,0.00029015224,0.00006146781,0.000011286317,0.000057051715,0.00086294184,0.000009141149,0.000635538],"genre_scores_gemma":[0.99898726,0.0002521499,0.0001389901,0.00006959298,0.00002451375,0.000037823294,0.00040557914,0.0000027557226,0.000081282626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821943,0.00041847723,0.00031803857,0.0004992441,0.00039998553,0.00014474556],"domain_scores_gemma":[0.9958121,0.0007959148,0.0025361318,0.00027750194,0.0003163718,0.00026196343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001608847,0.00035052397,0.0005404766,0.0010306485,0.00030945655,0.00084254803,0.0003946757,0.0006799514,0.002224138],"category_scores_gemma":[0.003929651,0.00030079955,0.0010606328,0.0016310045,0.000372305,0.0007978399,0.00046756177,0.00073784793,0.0003008592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023164824,0.00007307608,0.99782735,0.00004503495,0.00024728512,0.000048285692,0.000034471555,0.000025660584,0.00014831385,0.000014875047,0.00009153608,0.0012123346],"study_design_scores_gemma":[0.000037494796,0.00045341693,0.99829596,0.00002031475,0.00020631935,0.00040008602,0.00010809768,0.00016152085,0.00005451128,0.00003234921,0.00022172336,0.000008253663],"about_ca_topic_score_codex":0.0013469644,"about_ca_topic_score_gemma":0.0012267652,"teacher_disagreement_score":0.002224138,"about_ca_system_score_codex":0.00029347383,"about_ca_system_score_gemma":0.00038740115,"threshold_uncertainty_score":0.008508503},"labels":[],"label_agreement":null},{"id":"W4407700738","doi":"10.1080/14740338.2025.2465870","title":"Evaluating bowel obstruction and ileus events in patients on GLP-1 receptor agonists: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Ileus; Systematic review; Bowel obstruction; Internal medicine; Tegaserod; Intensive care medicine; Gastroenterology; MEDLINE; Irritable bowel syndrome; Surgery","score_opus":0.07329668357785438,"score_gpt":0.3981136809968496,"score_spread":0.32481699741899517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407700738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002228834,0.9965397,0.00030457808,0.0001657871,0.00009687861,0.0002018827,0.00032071766,0.000011584632,0.00013014578],"genre_scores_gemma":[0.09177957,0.90311074,0.002134738,0.00082503806,0.0003018136,0.0011043736,0.0005505462,0.000018325489,0.00017480562],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98588276,0.006904215,0.0041364064,0.0012024852,0.0015361527,0.00033797682],"domain_scores_gemma":[0.97512823,0.018513113,0.0043100645,0.00052367855,0.0013191217,0.00020574141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016864723,0.0028517612,0.022079257,0.0085978815,0.00056168134,0.0039743567,0.0018772653,0.0021741313,0.0032425926],"category_scores_gemma":[0.036120657,0.0015305715,0.038422555,0.007943275,0.00079311937,0.0017685218,0.0013500899,0.0015100497,0.00021223028],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010491256,0.000025523685,0.0039383695,0.5299896,0.44891906,0.00011322487,0.000057087178,0.00048378916,0.00015153128,0.00013386394,0.00046582246,0.014672891],"study_design_scores_gemma":[0.000553305,0.0002513419,0.0043051476,0.0623591,0.9295512,0.00015604043,0.000045542376,0.0002165682,0.00012608974,0.00029312688,0.002113834,0.000028729492],"about_ca_topic_score_codex":0.0051100748,"about_ca_topic_score_gemma":0.010477181,"teacher_disagreement_score":0.022079257,"about_ca_system_score_codex":0.0029745488,"about_ca_system_score_gemma":0.004030169,"threshold_uncertainty_score":0.089190185},"labels":[],"label_agreement":null},{"id":"W4409390867","doi":"10.1080/14740338.2025.2493351","title":"Does the use of generative AI chatbots by patients introduce risk of adverse drug events?","year":2025,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Drug; Adverse effect; Intensive care medicine; Pharmacology","score_opus":0.009750782252618122,"score_gpt":0.2941775190829544,"score_spread":0.2844267368303363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409390867","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017446576,0.07246198,0.00076776725,0.18912074,0.7322159,0.000060476304,0.00016766484,0.000102756094,0.0049282447],"genre_scores_gemma":[0.0023112039,0.0623821,0.00058548176,0.16823748,0.75540507,0.00011418039,0.00011069951,0.000077881785,0.010775855],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99361306,0.0021864614,0.00093058153,0.0006341689,0.0023773299,0.0002584659],"domain_scores_gemma":[0.92617464,0.056725573,0.0033292952,0.00075189024,0.010936809,0.0020818298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011036202,0.0010270532,0.0017382007,0.001879139,0.0013736142,0.0048310626,0.0024969082,0.013018265,0.009427375],"category_scores_gemma":[0.059150342,0.00049018714,0.0019086628,0.000896475,0.002175671,0.0033318521,0.001185905,0.014591942,0.006010836],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010236842,0.000012607362,0.000062809384,0.0016735789,0.000073528456,0.00016037561,0.00005295475,0.000026446498,0.00009913555,0.0017564357,0.9492052,0.046774443],"study_design_scores_gemma":[0.000089783425,0.000061684776,0.00021208923,0.0021757658,0.00015885946,0.0002167956,0.00005986372,0.00008675724,0.00015452763,0.0014494623,0.9953117,0.000022640397],"about_ca_topic_score_codex":0.0009576342,"about_ca_topic_score_gemma":0.0024404004,"teacher_disagreement_score":0.013018265,"about_ca_system_score_codex":0.002055755,"about_ca_system_score_gemma":0.003101523,"threshold_uncertainty_score":0.058365703},"labels":[],"label_agreement":null},{"id":"W4411253013","doi":"10.1080/14740338.2025.2517232","title":"Analysis of the relationship between histamine H1 receptor antagonists and broad dementia events using the FAERS, JADER, and CVAR databases","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CVAR; Medicine; Database; Pharmacology; Computer science; Risk management","score_opus":0.03665619841939237,"score_gpt":0.3101971100633989,"score_spread":0.2735409116440065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411253013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9019259,0.00630354,0.0032272416,0.00034958986,0.00004166604,0.00064350513,0.085665196,0.000072174225,0.0017711176],"genre_scores_gemma":[0.95552635,0.0010533794,0.0033419356,0.00017460846,0.000057451296,0.0005552364,0.039071817,0.000016911506,0.00020245336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9810099,0.0052580875,0.006071764,0.0036899003,0.003065581,0.00090462074],"domain_scores_gemma":[0.9471624,0.019137006,0.024815096,0.0033334212,0.0047467425,0.00080533663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013173736,0.00054559426,0.0012382116,0.0082128,0.00043853276,0.0013254175,0.0010272436,0.0005167193,0.001679925],"category_scores_gemma":[0.039609544,0.00035061722,0.0026391777,0.008576204,0.00024788597,0.0010245206,0.0013969304,0.00073483086,0.00021930611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008095838,0.00003888184,0.9888704,0.00042724976,0.0026825962,0.000086229324,0.00007530787,0.0004233934,0.00011925207,0.00018835491,0.001285757,0.0049929703],"study_design_scores_gemma":[0.00015256951,0.00019752495,0.9897026,0.00015929289,0.0023140926,0.00048300275,0.00027659908,0.0036926284,0.00032642134,0.00019931124,0.002463187,0.00003282533],"about_ca_topic_score_codex":0.026470806,"about_ca_topic_score_gemma":0.022147594,"teacher_disagreement_score":0.026470806,"about_ca_system_score_codex":0.0012630787,"about_ca_system_score_gemma":0.001839743,"threshold_uncertainty_score":0.0696702},"labels":[],"label_agreement":null},{"id":"W4411778543","doi":"10.1080/14740338.2025.2526787","title":"Use of medroxyprogesterone acetate and risk of meningiomas: a comparative safety study","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia","keywords":"Medicine; Medroxyprogesterone acetate; Environmental health; Internal medicine; Pharmacology; Estrogen","score_opus":0.055066350056986714,"score_gpt":0.34371568104549627,"score_spread":0.28864933098850953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411778543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93950856,0.0563471,0.00047281588,0.00027651002,0.00010195009,0.00019135069,0.0013623824,0.000007348931,0.0017320156],"genre_scores_gemma":[0.98130006,0.016179541,0.00036954187,0.00019610103,0.00028627602,0.00010658413,0.0010729148,0.0000038999083,0.00048515803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978802,0.0009570695,0.00025451012,0.00031673964,0.00051292276,0.00007844305],"domain_scores_gemma":[0.9907257,0.004250841,0.0035248043,0.00058085186,0.00057723594,0.00034056953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038100572,0.00032006387,0.0007739711,0.0010031778,0.0001345353,0.00055022835,0.00043772935,0.00072749215,0.003813898],"category_scores_gemma":[0.00846986,0.00020030088,0.001589579,0.0008749282,0.00039149294,0.00038435383,0.00031140665,0.0003632284,0.00034981623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15572241,0.0032788822,0.68104124,0.008276063,0.034102447,0.000710022,0.00029160647,0.0003786657,0.0036154322,0.00052890327,0.0014373482,0.11061686],"study_design_scores_gemma":[0.012597442,0.065347396,0.88508105,0.00097259,0.024203084,0.002651379,0.00022941231,0.0007379456,0.0014926037,0.00041125104,0.0061998176,0.000075981276],"about_ca_topic_score_codex":0.00071543147,"about_ca_topic_score_gemma":0.00061890064,"teacher_disagreement_score":0.003813898,"about_ca_system_score_codex":0.00037953505,"about_ca_system_score_gemma":0.00045206974,"threshold_uncertainty_score":0.020149767},"labels":[],"label_agreement":null},{"id":"W4414613758","doi":"10.1080/14740338.2025.2568242","title":"Auditory system adverse events with sacubitril/valsartan: an active-comparator restricted disproportionality analysis using the FDA adverse event reporting system database","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Vestibular and auditory disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Adverse effect; Event (particle physics); Auditory event; Lisinopril; MEDLINE; Adverse Event Reporting System; Risk assessment; Warrant","score_opus":0.037236860189816076,"score_gpt":0.34145001000881675,"score_spread":0.30421314981900066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414613758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561963,0.00689843,0.006718441,0.00020679201,0.00004543744,0.0017200012,0.026166307,0.00009187548,0.001956381],"genre_scores_gemma":[0.97914344,0.0010267964,0.0042239246,0.0001524838,0.00005734597,0.0010348863,0.01410464,0.00002858996,0.00022794373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9592102,0.014126642,0.013389851,0.00626195,0.006357938,0.0006533585],"domain_scores_gemma":[0.9186933,0.032903474,0.03798249,0.004561265,0.0051307506,0.0007286886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022011556,0.0005076874,0.0012252587,0.0060597355,0.00038712093,0.0015299793,0.00087752513,0.00046944074,0.002765399],"category_scores_gemma":[0.043444816,0.00029543362,0.004704017,0.005286304,0.00035190178,0.0012510838,0.0019056494,0.0008043227,0.0004035389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070037125,0.00031783213,0.9532938,0.0024104256,0.010384364,0.00029228174,0.00022563995,0.0011324956,0.0009954291,0.00036652078,0.0013876869,0.022189762],"study_design_scores_gemma":[0.0006268952,0.002317124,0.9705551,0.00044755402,0.009769067,0.0015885034,0.00041862487,0.0074314047,0.0013081093,0.0003484223,0.0051043276,0.00008499144],"about_ca_topic_score_codex":0.0015341735,"about_ca_topic_score_gemma":0.001352047,"teacher_disagreement_score":0.022011556,"about_ca_system_score_codex":0.0006882885,"about_ca_system_score_gemma":0.0008945134,"threshold_uncertainty_score":0.11640966},"labels":[],"label_agreement":null},{"id":"W4416292676","doi":"10.1080/14740338.2025.2588634","title":"Utility and limitations of the FDA adverse events reporting system public dashboard for safety analyses: a case study with vesicular monoamine transporter 2 inhibitors","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Neurocrine Biosciences","keywords":"Pharmacovigilance; Adverse Event Reporting System; Dashboard; Adverse effect; Postmarketing surveillance; Quality (philosophy); Public health; MEDLINE","score_opus":0.22096002355757186,"score_gpt":0.4648317167819514,"score_spread":0.24387169322437954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416292676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59281385,0.024095329,0.16091138,0.14035706,0.0017556377,0.0063253096,0.0059420336,0.0013919863,0.06640746],"genre_scores_gemma":[0.8729217,0.008600466,0.0919564,0.017899038,0.0008149115,0.0022725766,0.0016201675,0.00038462377,0.003530149],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.84277683,0.09815403,0.025936497,0.00499931,0.025954591,0.002178714],"domain_scores_gemma":[0.42968565,0.4600872,0.049747236,0.017713023,0.03985666,0.0029101693],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11727595,0.00092735625,0.0010667025,0.004611349,0.003517106,0.007765803,0.0035680619,0.0058973357,0.0045539388],"category_scores_gemma":[0.32419172,0.0008095248,0.0021803987,0.004812734,0.0025679865,0.0075909654,0.0033041697,0.0043883906,0.0009911804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018177299,0.0022376752,0.32763007,0.009069654,0.0008626003,0.11986412,0.052559342,0.008009371,0.0024641142,0.029439876,0.06085901,0.38518652],"study_design_scores_gemma":[0.00077982194,0.0031236983,0.08624801,0.02604378,0.0023174766,0.1865954,0.062454946,0.035547707,0.016632013,0.033296973,0.5460646,0.0008955918],"about_ca_topic_score_codex":0.010370051,"about_ca_topic_score_gemma":0.011609191,"teacher_disagreement_score":0.88272405,"about_ca_system_score_codex":0.006005306,"about_ca_system_score_gemma":0.010017197,"threshold_uncertainty_score":0.620222},"labels":[],"label_agreement":null}]}